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 Individuals with schizophrenia demonstrate auditory processing impairments that localize to 
primary auditory cortex, and likely contribute to disruptions of higher level processes and 
resultant disability.  To inform the development of new treatments and preventative measures, 
we sought to understand which synapse populations contribute to primary auditory cortex 
pathology.  We used quantitative fluorescence microscopy to assess intracortical excitatory, 
thalamocortical, and inhibitory boutons in primary auditory cortex deep layer 3 of individuals 
with schizophrenia.  We found that intracortical excitatory and thalamocortical boutons are 
unaltered in schizophrenia despite reduced density of dendritic spines, their primary postsynaptic 
targets.  However, levels of the 65 kiloDalton isoform of glutamate decarboxylase (GAD65) 
protein are reduced within inhibitory boutons in primary auditory cortex of subjects with 
schizophrenia.  Further, reductions in within-bouton GAD65 protein are correlated with 
previously measured reductions in spine density.   
As the onset of schizophrenia typically occurs during late adolescence and young 
adulthood, adolescence represents a potential window of opportunity for preventing the 
pathophysiology underlying symptom onset.  However, adolescent trajectories of auditory cortex 
synaptic components and associated auditory cortex functional changes that could be targeted for 
prevention have not been characterized.  In mouse auditory cortex, we found that spine and 
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excitatory bouton numbers decrease between early adolescence and young adulthood, followed 
by reduction of within-bouton GAD65 protein levels between late adolescence and young 
adulthood.  As a behavioral readout of auditory cortex function, we measured gap-mediated 
prepulse inhibition of the acoustic startle reflex (gap-PPI) in mice between early adolescence and 
young adulthood.  Gap-PPI responses increase during adolescence, suggesting that adolescent 
development of auditory cortex synapses contributes to auditory cortex functional maturation.   
Our findings suggest that spine and within-bouton GAD65 protein deficits are related 
pathological features of primary auditory cortex in schizophrenia, and that within-bouton 
GAD65 protein declines subsequent to the onset of auditory cortex spine pruning between early 
adolescence and young adulthood.  From these observations, we propose a model where 
excessive spine pruning in auditory cortex leads to an excessive reduction in within-bouton 
GAD65 protein.  Testing this model will promote development of strategies to prevent auditory 
cortex pathophysiology and downstream perceptual and cognitive deficits in schizophrenia. 
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1.0  INTRODUCTION 
Schizophrenia is a chronic illness associated with lifelong debilitation and reduced quality of life 
that affects approximately 0.7% of the world’s population (World Health Organization, 2013).  
Age of onset, defined by the first appearance of psychotic symptoms (American Psychiatric 
Association, 1994) is typically during the late adolescent to early adult years; generally between 
18 and 30 years of age (Tandon et al., 2009).  Disease onset in males is about 4 years earlier than 
in females (Hafner et al., 1993), and females also exhibit a second peak in age of onset later in 
life, between age 45 and 55 (Hafner et al., 1991).  Individuals with schizophrenia have an 
increased risk for comorbid illnesses and death by suicide, and overall the lifespan in individuals 
with schizophrenia is reduced by approximately 15-20 years (Auquier et al., 2007).   The 
debilitating consequences of schizophrenia coupled with the typically young age of onset 
illustrate the devastating impact on the life of affected individuals. 
 A definite cause of schizophrenia has yet to be identified.  Evidence suggests a strong 
role of genetics in the etiology of schizophrenia, as monozygotic twins demonstrate 45-60% 
concordance for schizophrenia and the estimate of heritability is about 80% (Sullivan et al., 
2003).  A number of potential schizophrenia susceptibility genes have been identified (Owen et 
al., 2004), but no one genetic factor appears to be responsible.  This suggests that risk for 
schizophrenia is likely to be conferred through the converging effects of multiple genes 
(Gottesman and Shields, 1967).  The fact that the concordance rate between monozygotic twins 
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is not 100% also suggests that environmental influences contribute to the likelihood of 
developing schizophrenia.  Many environmental risk factors for developing schizophrenia have 
been identified (Brown, 2011), and include prenatal exposure to maternal infection (Brown and 
Derkits, 2010), obstetric complications (Cannon et al., 2003), birth during winter or early spring 
(Davies et al., 2003), urban upbringing (Vassos et al., 2012), and cannabis use (Smit et al., 
2004).  Taken together, this suggests that both genetics and environmental factors contribute to 
the etiology of schizophrenia. 
Schizophrenia is characterized by a variety of symptoms, which can be categorized into 
positive, negative, and cognitive domains (Tandon et al., 2008; Tandon et al., 2009).  Positive 
symptoms describe the presence of perceptions or behaviors involving distortions of reality, 
including disorganized thought processes, delusions, and hallucinations.  Hallucinations may 
occur in any sensory modality, but are typically auditory and verbal in nature.  Negative 
symptoms refer to the absence of behaviors which should be present, including alogia (absence 
of speech), avolition (absence of motivation), anhedonia (inability to experience pleasure), and 
flattened affect (inability to express emotion).  Negative symptoms have been shown to 
contribute to occupational impairments (Lysaker and Bell, 1995). Cognitive symptoms include 
impairments in memory performance, executive function, attention, as well as poor language and 
reading ability (Salisbury, 2008), and impaired social cognition (Green et al., 2008).  Deficits in 
cognition are highly prevalent, and are present to some degree in the pre-morbid phase of the 
illness, in addition to being observed in first-degree relatives, suggesting that these symptoms are 
related to the etiology of schizophrenia and are not a consequence of long-term illness (Tandon 
et al., 2009).  Although evidence for a strong link between positive symptoms and functional 
outcome is lacking (Green, 1996), symptoms such as hallucinations are debilitating, and 
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psychotic symptoms do contribute to reduced occupational functioning (Racenstein et al., 2002).   
However, positive symptoms are relatively well controlled by current antipsychotic medications 
(Miyamoto et al., 2005), while current available treatments do not reduce the impact of negative 
or cognitive symptoms on the life of an affected individual (Keshavan et al., 2008).  Therefore, 
we need to increase our understanding of the neuropathological processes that contribute to 
negative and cognitive symptoms in order to implement more effective treatments. 
Abnormal functioning of the auditory system could contribute to all three symptom 
domains.  For example, auditory verbal hallucinations may arise in part from increased activity 
of the primary auditory cortex (Dierks et al., 1999).   As we will review in the following sections, 
disruptions in auditory processing can hinder verbal communication, which could contribute to 
negative symptoms such as social withdrawal, and cognitive impairments including language and 
reading impairments and decreases in social cognition.  As auditory processing impairments 
seem to contribute to multiple symptom domains, a more complete understanding of the 
neurobiological contributions to these impairments may ultimately allow for design of novel 
treatments which address more than just the positive symptoms.   
This thesis investigates the contribution of excitatory and inhibitory synapse impairments 
to auditory cortex pathology in schizophrenia, as well as the developmental trajectories of 
excitatory and inhibitory synapse components during adolescence, a key time period for 
schizophrenia symptom emergence, and finally the behavioral correlates of auditory cortex 
adolescent development.  In the following sections, we will begin by reviewing the basic 
organization of the cortical auditory regions, which will inform a discussion of auditory 
behavioral, electrophysiological and anatomical abnormalities observed in individuals with 
schizophrenia.  We will then discuss what is known about excitatory and inhibitory synapse 
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development in the cortex during adolescence, a key developmental period for symptom onset, 
and discuss a relevant genetic animal model that can be used to study altered adolescent cortical 
synapse development. 
1.1 ORGANIZATION OF THE AUDITORY CORTEX 
1.1.1 Auditory cortical regions 
In primate cortex, there are three hierarchical auditory processing areas: the core, the belt, and 
the parabelt (Kaas and Hackett, 2000).  In humans, the anatomical location of the core, belt and 
parabelt regions are Heschl’s gyrus, the banks of Heschl’s sulcus, and the planum temporale, 
respectively (Sweet et al., 2005).  Heschl’s gyrus extends transversely across the superior 
temporal plane, within the sylvian fissure.  The core corresponds to Brodmann’s area 41 (Garey, 
1999) and exhibits characteristics attributable to primary sensory cortex, including short latency 
responses to pure tones.  The core also possesses biochemical characteristics of primary sensory 
regions, such as prominent expression of cytochrome oxidase, parvalbumin, and 
acetylcholinesterase in the middle cortical layers (Tootell et al., 1985; Hackett et al., 1998).  
Auditory projections from the ventral subdivision of the medial geniculate nucleus (MGNv) 
terminate in the core region, which is the primary auditory region.  Neurons in the belt receive 
extensive feedforward projections from the core, and respond to higher-order characteristics of 
auditory stimuli, such as narrow frequency bands of noise rather than tones (Rauschecker et al., 
1995).  The parabelt receives information from the core, via the belt, and functional studies 
suggest activity in the parabelt is consistent with its role as a tertiary auditory region (Molinari et 
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al., 1995; Hackett et al., 1998; Griffiths and Warren, 2002).  The parabelt sends projections to 
nearby areas in the parietal and temporal lobes, as well as to regions of the frontal cortex 
(Hackett et al., 1999), where presumably, multimodal integration and higher-order processing 
can occur. 
1.1.2 Auditory cortex circuitry 
The laminar organization of primary auditory cortex (Figure 1.1) is generally similar to the 
organization reported for other primary sensory regions (Rockel et al., 1980), but there are some 
notable differences (Read et al., 2002; Linden and Schreiner, 2003).  The principal sensory 
thalamocortical projections (also referred to as the lemniscal pathway) arise from the MGNv.  
The primary cells receiving thalamocortical input are pyramidal neurons in deep layer 3 and 
layer 4, rather than spiny stellate cells as in layer 4 of the primary visual cortex (Smith and 
Populin, 2001).  The medial division of the MGN (MGNm) projects to layers 1 and 6 (Winer and 
Larue, 1989), while the dorsal division of the MGN (MGNd) projects to layers 1, 2, 5, and 6 
(Winer, 1985; Winer and Prieto, 2001).  Following the initial activation of thalamocortical 
synapses, information flows to supragranular layers 2 and 3, which are densely packed and 
supply corticocortical projections, including projections to the contralateral primary auditory 
cortex, a feature of primary auditory cortex that is not shared by the primary visual cortex 
(Linden and Schreiner, 2003).  In contrast with other sensory cortices, layer 2/3 pyramidal 
neurons also send projections back to layer 4 (Barbour and Callaway, 2008).  From the 
supragranular layers, information flows to the infragranular layers.  Layer 5 is relatively sparsely 
populated and contains large pyramidal neurons which project to all divisions of the MGN 
(Winer and Prieto, 2001; Winer et al., 2001), as well as to the inferior colliculus (Mitani and 
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Shimokouchi, 1985; Winer et al., 1998) and the dorsal cochlear nucleus (Weedman and Ryugo, 
1996).  Layer 6 supplies feedback projections to the MGNv, which are thought to modulate 
thalamic responses (Villa et al., 1991; Zhang and Suga, 1997; Yan and Ehret, 2002).   
1.1.3 Role of primary auditory cortex excitation and inhibition in auditory processing 
Excitation and inhibition in the auditory cortex help to shape responses to auditory stimuli.  
Excitatory responses in primary auditory cortex neurons can be elicited via two broad 
classifications of glutamatergic input, thalamocortical and intracortical.  Tone-evoked excitatory 
responses are reported to be about 60% attributable to thalamic inputs, as opposed to excitation 
arising within the cortex (Liu et al., 2007).  Intracortical excitatory transmission is thought to 
play a role in amplification and sharpening of auditory cortex neuron responses (Liu et al., 2007).  
Approximately 20% of auditory cortex neurons are GABAergic (Prieto et al., 1994), and 
inhibition that balances excitation is also important for frequency tuning and temporal precision 
of auditory cortex responses (Wehr and Zador, 2003; Wu et al., 2008).  The primary auditory 
cortex is specialized for processing fast temporal information, and inhibitory responses in 
auditory cortex are faster than in other cortical areas (Hefti and Smith, 2000).  Evidence suggests 
that delayed inhibition from GABAergic inhibitory synapses increases the precision of excitatory 
neuron firing (Wehr and Zador, 2003) and helps to refine frequency tuning curves of neurons in 
primary auditory cortex, as tuning curves can be broadened or narrowed through application of 
GABAA receptor antagonists and agonists, respectively (Wang et al., 2000; Wang et al., 2002; 
Kaur et al., 2005).  One model suggests that inhibition which is more broadly tuned than 
excitation will narrow the recipient neuron’s tuning curve by generating relatively more 
inhibition than excitation at the lateral “edges” of the frequency tuning curve (Wu et al., 2008).  
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Together, evidence suggests that both excitation and inhibition in primary auditory cortex are 













Figure 1.1. Schematic depicting primary auditory cortex circuitry.  Black ovals represent pyramidal neurons, 
small spheres represent thalamocortical (green) or intracortical (red) excitatory inputs to primary auditory cortex.  




1.2 DYSFUNCTIONAL AUDITORY PROCESSING IN SCHIZOPHRENIA 
1.2.1 Auditory perceptual impairments in schizophrenia: contribution to negative and 
cognitive symptoms and functional outcome 
Correlative studies suggest that basic auditory processing dysfunction in schizophrenia may 
contribute to symptoms.  Individuals with schizophrenia show reduced ability to match two tones 
separated by a brief interval, suggesting that tone discrimination ability and/or auditory sensory 
memory may be impaired (Strous et al., 1995).  Correlated with these tone discrimination 
deficits, individuals with schizophrenia also exhibit poor recognition of vocally expressed 
emotion across a range of emotions (Leitman et al., 2010a).   Deficits in emotion identification 
appear to be derived from an inability to utilize pitch-based acoustic features and frequency 
modulation as cues (Leitman et al., 2010a; Kantrowitz et al., 2013).  Inability to interpret 
emotion in spoken language would be expected to substantially impact social communication 
and may lead to social withdrawal and impaired social cognition.   
However, the role of vocal pitch extends further than the expression of emotion by the 
speaker. In many non-Western languages, modulation of vocal pitch is essential for 
communication of semantic meaning. In Mandarin-speaking patients with schizophrenia, 
impaired tone matching performance is associated with poor word identification and 
discrimination between words (Yang et al., 2012).  Even in non-tonal languages, prosodic 
phrasing of sentences contributes heavily to interpretation of meaning (Frazier et al., 2006) and 
informs the listener about whether a phrase is a question or a statement.  Further, variations in 
pitch are used in language to distinguish phonemes, the simplest components of speech.  For 
example, relatively subtle differences in formant pitch, and formant pitch of preceding and 
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subsequent syllables, allow for categorical perception of syllables such as ga and da (Holt and 
Lotto, 2008).  Therefore, difficulty discriminating between closely related pitches would impact 
phoneme identification and speech comprehension (Javitt, 2009).  This evidence suggests that 
impairments in very basic auditory perception exert a detrimental effect on both the emotional 
and semantic aspects of verbal communication.  It is possible that these deficits lead to the 
reading impairments observed in schizophrenia (Revheim et al., 2006), and ultimately to 
impairments in verbal learning and memory (Kawakubo et al., 2007). 
 Evidence suggests that the negative and cognitive aspects of schizophrenia, including 
impairment in social cognition, contribute to long-term functional outcome (Green, 1996; Evans 
et al., 2004; Schmidt et al., 2011).  Further in support of a link between auditory processing 
deficits and disease severity, tone matching performance is severely impaired in patients with 
poor long term outcome, such as in those who need long-term residential care (Rabinowicz et al., 
2000).  Also, groups at high risk of developing schizophrenia demonstrate impairments in 
auditory working memory, verbal memory, and verbal processing (Simon et al., 2007).  This 
suggests that these deficits are not simply a consequence of long-term illness and represent the 
pathophysiology of schizophrenia.  Finally, auditory training paradigms have been shown to 
increase verbal memory and cognition (Adcock et al., 2009), further suggesting that auditory 
processing contributes to cognitive function.  Taken together, this evidence suggests that 
auditory processing impairments exert effects on the functional outcome and quality of life of 
individuals with schizophrenia. 
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1.2.2 Electrophysiological measures of disrupted auditory processing in schizophrenia 
The function of the auditory system can also be evaluated using auditory event related potentials 
(ERPs), which can be measured non-invasively in humans using electroencephalography (EEG) 
or magnetoencephalography (MEG).  One index of early auditory sensory processing is the 
N100, or N1, an auditory evoked potential that is indicative of auditory stimulus detection, 
reflects early cortical activity to an auditory stimulus (Naatanen and Picton, 1987), and is 
reported to be abnormal in schizophrenia (Saletu et al., 1971).  The MEG equivalent M100 
response to pairs of syllables differing in voice onset time (VOT) (for example, ba has a short 
VOT and pa has a long VOT), is abnormal in the presence of background noise in individuals 
with schizophrenia (Dale et al., 2010).  VOT is the duration of time between the offset of the 
consonant and onset of low-frequency speech sound, and responses to VOT have been recorded 
in monkey and human primary auditory cortex (Steinschneider et al., 1994; Steinschneider et al., 
1995; Steinschneider et al., 1999).  Perception of VOT is related to and may rely on mechanisms 
similar to those for detection of silent gaps embedded in acoustic stimuli (Elangovan and Stuart, 
2008) which are also encoded to some extent in primary auditory cortex (Eggermont, 1999; 
Eggermont, 2000; Kirby and Middlebrooks, 2012).  This demonstrates electrophysiological 
evidence for impaired language perception in schizophrenia, and implies that disruption in 
primary auditory cortex function underlies these deficits. 
The mismatch negativity response (MMN), another index of early auditory processing is 
also impaired in schizophrenia.  MMN reflects activity in the auditory cortex in response to an 
infrequent stimulus presented during a series of repetitive stimuli.  As the response can be 
evoked regardless of whether the subject is paying attention to the stimuli or is distracted with 
another task, it is thought to represent pre-attentive auditory sensory memory (Naatanen et al., 
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1989; Alho et al., 1994; Winkler et al., 1996).  Individuals with schizophrenia exhibit MMN 
impairments when the auditory stimuli are deviant for duration (Shelley et al., 1991) or pitch 
(tone frequency) (Javitt et al., 1993).  Subsequent MMN deficits have also been reported when 
the auditory stimulus is deviant in intensity, location, or by insertion of a silent gap in a tone 
(Thonnessen et al., 2008), suggesting impairment in discrimination of a variety of acoustic 
stimulus features.  The reductions in the MMN response to frequency deviants are correlated 
with impairments in pure tone frequency discrimination (Javitt et al., 1994; Javitt et al., 2000; 
Naatanen and Kahkonen, 2009; Leitman et al., 2010b), suggesting that altered auditory 
physiology underlies the behavioral observations in individuals with schizophrenia.  Further, 
duration-MMN is not impaired in individuals with bipolar disorder, suggesting specificity for the 
disease process of schizophrenia (Catts et al., 1995).  When phonemes are used as stimuli in a 
MMN paradigm, patients with schizophrenia demonstrate impaired MMN responses (Kasai et 
al., 2002), suggesting inability to distinguish between changes in the basic elements that 
contribute to speech.  Finally, greater duration-MMN responses are associated with better daily 
functioning and social cognition (Wynn et al., 2010), suggesting that MMN impairments 
contribute to deficits that have an impact on disease outcome. 
Animal studies indicate that both frequency discrimination and MMN are dependent 
upon the supragranular auditory cortex (Javitt et al., 1994; Javitt et al., 1996; Tramo et al., 2002; 
Kaur et al., 2005; Molholm et al., 2005; Liu et al., 2007).  Intracortical recordings in non-human 
primate auditory cortex during an MMN paradigm indicate that while the initial thalamocortical 
responses are similar for the standard and the deviant stimuli, the change detection signal appears 
to be represented by increased excitatory activity in primary auditory cortex layers 2 and 3 in 
response to the deviant stimulus (Javitt et al., 1994).  Further, application of PCP and MK-801, 
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antagonists of the NMDA subtype of ionotropic glutamate receptors, prevent the increased 
supragranular response to the deviant stimulus (Javitt et al., 1996).  In contrast, application of the 
GABAA receptor antagonist bicuculline generally enhanced activity levels, and the pan-
glutamatergic antagonist kynurenic acid reduced activity in supragranular layers to the standard 
stimuli, rather than specifically reducing the response to the deviant.  This suggests that there are 
alterations in the circuitry, specifically NMDA-mediated glutamatergic circuitry, in 
supragranular primary auditory cortex in subjects with schizophrenia that may contribute to 
functional deficits in early auditory processing.    
Another auditory evoked potential found to be impaired in individuals with schizophrenia 
is the auditory steady state response (aSSR), which reflects the synchronized response of neurons 
to a temporally modulated auditory stimulus (for example, clicks or tones repeated at a rapid 
rate, amplitude modulated tones).  Individuals with schizophrenia exhibit reduced aSSR power in 
response to a 40 Hz click train (Kwon et al., 1999b; Light et al., 2006), as well as reduced aSSR 
theta (5 Hz) and gamma (80 Hz) levels of entrainment to modulated noise stimuli (Hamm et al., 
2011).  Mean power in the gamma range (40 Hz) is also reduced in response to an unmodulated 
pure tone stimuli in subjects with schizophrenia, suggesting that impairment in auditory cortex 
oscillatory activity is not restricted to steady state responses to auditory stimuli (Krishnan et al., 
2009).  Further, impairments in the 40 Hz response are reported to be present in first episode 
patients (Spencer et al., 2008), and also in first degree relatives of patients (Hong et al., 2004), 
suggesting that auditory functional impairments are not a consequence of long-term illness or 
medication, and are a primary pathological feature of schizophrenia.  The aSSR response is 
thought to be generated by the primary auditory cortex (Pastor et al., 2002; Picton et al., 2003).  
As GABAergic interneurons play a role in the generation of gamma oscillations by 
 13 
synchronizing firing rates of pyramidal neurons (Whittington et al., 2000; Vierling-Claassen et 
al., 2008), these functional deficits provide evidence for primary auditory cortex inhibitory 
neuron pathology in schizophrenia. 
1.3 ALTERATIONS OF AUDITORY CORTEX IN SCHIZOPHRENIA 
1.3.1 In vivo imaging evidence of auditory cortex alterations in schizophrenia 
The functional impairments in auditory processing in individuals with schizophrenia described 
above are highly suggestive of disruptions in primary auditory cortex.  Gray matter volume of 
the superior temporal gyrus (STG) is consistently reported to be reduced in subjects with 
schizophrenia (Shenton et al., 2001; Rajarethinam et al., 2004).  The STG contains Heschl’s 
gyrus and sulcus, as well as the planum temporale, which are the anatomical locations of primary 
and non-primary auditory cortices, respectively.  Reductions in gray matter volume of Heschl’s 
gyrus and planum temporale are reported in patients in both cross-sectional and longitudinal 
studies (Kwon et al., 1999a; Hirayasu et al., 2000; Kasai et al., 2003; Smiley et al., 2009).  
Further, reduction in volume of Heschl’s gyrus is specific for schizophrenia, as first-psychotic 
episode manic bipolar patients or first episode patients with affective psychosis showed no 
change in Heschl’s gyrus volume (Hirayasu et al., 2000; Kasai et al., 2003; McCarley et al., 
2008).  The changes in gray matter volume likely have functional consequences, as reductions in 
MMN responses to frequency and duration deviants are correlated with reduced volume of 
Heschl’s gyrus (Rasser et al., 2011).  Also, evidence suggests that Heschl’s gyrus volume is 
reduced around the time of the first psychotic episode, and correlated with MMN amplitude 
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(Salisbury et al., 2007; McCarley et al., 2008).  However, MMN impairment is not present at the 
first psychotic episode (Salisbury et al., 2002), but emerges over the next year (McCarley et al., 
2008), as the reductions in Heschl’s gyrus volume and MMN responses get worse as the illness 
progresses (Salisbury et al., 2007).  This indicates that structural changes in the auditory cortex 
precede and may play a causal role in the onset of electrophysiological auditory processing 
disturbances.  Taken together, this evidence suggests that abnormalities of primary auditory 
cortex gray matter are related to the onset and progression of schizophrenia, are not a 
consequence of long term illness or a general feature of psychosis, and likely contribute to 
auditory processing deficits.   
1.3.2 Post-mortem evidence for auditory cortex alterations in schizophrenia 
In addition to overall gray matter volume changes, evidence suggests that circuit and synapse 
level changes are present in auditory cortex of subjects with schizophrenia.  For example, 
disruptions in hemispheric asymmetries in microcolumns are reported in Heschl’s gyrus and the 
planum temporale (Chance et al., 2008).  Microcolumns are considered the smallest units of 
cortical processing (Jones, 2000) and consist of locally interacting inhibitory and excitatory 
neurons.  Disruptions in microcolumn spacing could be indicative of changes in volume taken up 
by different circuit components, such as cell bodies of neurons and glia, axons, and dendrites.  
Pyramidal neuron cell volume is reduced in deep layer 3 of primary auditory cortex and auditory 
association cortex of subjects with schizophrenia (Sweet et al., 2003; Sweet et al., 2004), but not 
in layer 5 of auditory association cortex (Sweet et al., 2004) suggesting that feedforward but not 
feedback circuits are affected.  However, the number of pyramidal neurons in deep layer 3 of 
primary auditory cortex is unchanged in schizophrenia (Dorph-Petersen et al., 2009b), indicating 
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that pyramidal cell reduction does not contribute to gray matter loss; however, reductions in 
other components such as dendrites, spines, and axons could be reduced in schizophrenia to 
contribute to the gray matter volume reduction in primary auditory cortex.  Reduced dendritic 
spine density in deep layer 3 of subjects with schizophrenia, identified by immunoreactivity for 
spinophilin (Sweet et al., 2009), suggests a deficiency in excitatory synapses, as spines are the 
most common postsynaptic target for glutamatergic boutons in the cortex.  Axon bouton 
densities identified with the presynaptic terminal marker synaptophysin are reduced in deep layer 
3 of primary auditory cortex of subjects with schizophrenia (Sweet et al., 2007).  As 
synaptophysin is expressed in all classical neurotransmitter releasing boutons in the cortex 
(Navone et al., 1986), reduction in density of synaptophysin expressing boutons could indicate 
general bouton loss or a specific reduction in density of a particular population of boutons, such 
as excitatory or inhibitory boutons.  However, it is not known whether excitatory and inhibitory 
boutons are affected in the primary auditory cortex of subjects with schizophrenia. 
1.4 RELEVANCE OF ADOLESCENT DEVELOPMENT TO SCHIZOPHRENIA 
ONSET 
The onset of schizophrenia symptoms typically occurs during late adolescence or young 
adulthood (Tandon et al., 2009), an observation which has led to the hypothesis that abnormal 
developmental processes in regions undergoing relatively protracted maturation may contribute 
to the emergence of schizophrenia symptoms during late adolescence (Feinberg, 1982; 
McGlashan and Hoffman, 2000).  Throughout the late teen years and early twenties, certain brain 
regions continue to mature via the refinement of synaptic connections and myelination of fiber 
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tracts (Paus et al., 2008).  In humans, prefrontal and superior temporal cortices are among the last 
brain regions to mature, and their development is not complete until the third decade of life 
(Huttenlocher and Dabholkar, 1997; Gogtay et al., 2004; Shaw et al., 2008).  Protracted 
maturation in these regions may leave them vulnerable to disruptive insults during development, 
and in support of this, these cortical regions are heavily implicated in the neuropathology of 
schizophrenia (Lewis and Sweet, 2009). 
Imaging studies of adolescent subjects transitioning to schizophrenia reveal excessive 
gray matter loss in prefrontal cortex (Pantelis et al., 2007).  In addition, first episode psychosis 
patients and ultra-high risk individuals who later develop psychosis show longitudinal reductions 
in STG gray matter that correlate with severity of delusions (Takahashi et al., 2009).  Together, 
this suggests that excessive gray matter loss during adolescence may precipitate the emergence 
of schizophrenia symptoms.  A key adolescent neurodevelopmental process is the pruning of 
synapses in the cortex, where synapse density peaks prior to adolescence, then declines during 
adolescence before reaching stable adult levels (Rakic et al., 1986; Zecevic et al., 1989; 
Huttenlocher and Dabholkar, 1997; Glantz et al., 2007).  It has been proposed that excessive 
elimination of synapses during adolescence could contribute to the pathophysiology of 
schizophrenia (Feinberg, 1982). 
1.4.1 Synapse pruning in the cortex during adolescence 
In mammalian cortex, synapse density peaks prior to adolescence, then declines by 
approximately 30% during adolescence before reaching stable adult levels (Huttenlocher, 1979; 
Rakic et al., 1986; Glantz et al., 2007).  In humans, synapse elimination appears to occur earlier 
in auditory than in frontal cortex, and earlier still in visual cortex compared to auditory, 
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suggesting heterochronicity in postnatal maturation of different brain regions (Figure 1.2) 
(Huttenlocher and Dabholkar, 1997).  In dorsolateral prefrontal cortex of mice, there is a 20% 
loss of dendritic spines over the month following the peak in spine density at postnatal day (P) 
28, corresponding to the beginning of adolescence (Zuo et al., 2005), and spine density stabilizes 
by the 16th postnatal week (Alvarez and Sabatini, 2007).  Adolescent synapse pruning occurs 
after mature activity-dependent connections have already been formed, as excitatory synapse 
properties of pre-adolescent monkeys are already similar to synapse properties of adults, 
indicating that adolescent pruning is independent of maturation of individual synapses 
(Gonzalez-Burgos et al., 2008).  Increased synapse pruning during adolescence could lead to 
reduced density of cortical excitatory synapses and decreased gray matter volume in individuals 

















Figure 1.2. Postnatal trajectories of synapse density in human prefrontal (x), auditory (filled circles), and 











Most evidence from non-human primates suggest that cortical inhibitory synapses do not 
undergo extensive pruning during adolescence.  Inhibitory contacts are reported to remain 
relatively unchanged in monkey somatosensory and visual cortex across development (Zecevic 
and Rakic, 1991; Bourgeois and Rakic, 1993).  Accordingly, in the monkey prefrontal cortex, the 
density of boutons expressing the GABA plasma membrane transporter (GAT-1) does not change 
across development (Erickson and Lewis, 2002).  However, in parallel with spine pruning in 
monkey prefrontal cortex, there is a decrease in the density of parvalbumin-expressing axon 
boutons of the chandelier subtype of interneuron, suggesting that pruning of inhibitory synapses 
does occur during adolescence (Anderson et al., 1995), but may be limited to certain subtypes of 
inhibitory neurons.  Conflicting reports of postnatal changes in inhibitory synapses have been 
reported in rodents.  For example, in rat visual cortex the number of type II synapses, which 
would include inhibitory synapses among other non-glutamatergic synapses, decreases 
substantially between P28 and P90 (Blue and Parnavelas, 1983).  A small decrease in symmetric 
(non-glutamatergic) synapse density is also reported during this time in mouse somatosensory 
cortex (De Felipe et al., 1997), although synapse reduction in this study was first and foremost 
attributable to asymmetric (glutamatergic) synapses.  In contrast, another report indicates that 
inhibitory synapse numbers do not decrease in rat somatosensory cortex between postnatal days 
30 and 60 (Micheva and Beaulieu, 1996).  Changes in presynaptic markers of inhibitory boutons, 
such as the GABA synthesizing enzymes, glutamate decarboxylase (GAD; GAD65 and GAD67) 
may also be indicative of inhibitory bouton loss or stability.  In human visual cortex, GAD67 
protein levels appear to remain stable throughout the lifespan, which is consistent with the idea 
that inhibitory boutons are not pruned, while GAD65 levels reach a peak around age 20 and then 
begin to slowly decline through old age (Pinto et al., 2010).  This could indicate loss of boutons 
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expressing only GAD65 beginning in young adulthood, or a reduction in GAD65 protein levels 
within boutons during adulthood.  Thus, there is evidence both for stability of inhibitory 
synapses across development, and for changes in inhibitory synapses during postnatal 
development which may be restricted to certain interneuron subtypes.  
Reduced dendritic spine density occurs in multiple cortical regions in schizophrenia 
(Lewis and Sweet, 2009), and reduced expression of GABAergic markers is also conserved 
across cortical regions (Hashimoto et al., 2008).  Together with evidence for changes in 
excitatory and inhibitory synaptic components during adolescence, this raises the possibility that 
adolescence represents a dynamic period for cortical excitatory and inhibitory synapses.   During 
adolescence, excitatory and inhibitory synapses may be vulnerable to environmental and genetic 
insults which could give rise to disruptions in primary auditory cortex circuitry in schizophrenia.  
However, relatively little is known about excitatory and inhibitory synapse development in the 
auditory cortex during adolescence.  Determining how excitatory and inhibitory synaptic 
components change during adolescence will increase our understanding of developmental 
processes which may be affected in schizophrenia. 
1.4.2 Kalirin: a schizophrenia-relevant mediator of dendritic spine development 
Findings of reduced dendritic spine density in the cortex of subjects with schizophrenia suggest 
that molecular regulators of spine development could be involved in schizophrenia 
pathophysiology (Penzes et al., 2013).  A number of studies have uncovered evidence supporting 
spine plasticity mediators as schizophrenia susceptibility genes (Bennett, 2011).  One such 
mediator is kalirin, a Rac/Rho guanine nucleotide (GTP/GDP) exchange factor (GEF) (Penzes 
and Remmers, 2012).  Given the observation of extensive dendritic spine pruning which takes 
 21 
place in the cortex during adolescence, and the interaction between kalirin and proteins involved 
in spine plasticity and remodeling, it is possible that kalirin plays a role in the adolescent pruning 
process.  In fact, mice lacking kalirin protein (kalirin KO mice) have reduced frontal cortex 
dendritic spine density in young adulthood, but not prior to the onset of synapse pruning, 
suggesting that kalirin is important for maintaining normal dendritic spine density in frontal 
cortex during adolescence (Cahill et al., 2009).   
Spine morphology and dynamics play an important role in influencing the plasticity of 
excitatory circuits in the cortex.  Small GTPases are important effectors of spine plasticity and 
actin remodeling (Penzes and Rafalovich, 2012).  Kalirin is able to activate members of the Rho 
family of GTPases, such as Rac1 and RhoA.  Activation of Rac1 increases dendritic spine 
stability and spine growth (Yoshihara et al., 2009b) while RhoA is involved in the regulation of 
dendritic growth (Rabiner et al., 2005), but also destabilizes spines (Newey et al., 2005).  Kalirin 
has been shown to play an important role in experience dependent spine plasticity (Newey et al., 
2005; Xie et al., 2007).  Upon activation of NMDA receptors, kalirin-7 is phosphorylated by 
CAMKII and is able to activate Rac1 (Newey et al., 2005; Xie et al., 2007).  Further, kalirin 
interacts with the GluR1 subunit of AMPA receptors, and is necessary for activity-dependent 
localization of AMPA receptors to dendritic spines (Newey et al., 2005; Xie et al., 2007), which 
is a key mechanism for regulating synaptic strength (Xie et al., 2007; Anggono and Huganir, 
2012).   
The kalirin gene encodes several different isoforms via alternative splicing mechanisms.  
The kalirin-7 isoform is the most abundant in the adult CNS (Johnson et al., 2000) where it is 
localized to the postsynaptic density (Penzes et al., 2001; Ma et al., 2008).  Levels of kalirin-7 
are low at birth and increase at the beginning of the second postnatal week, during the time 
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corresponding to postnatal synaptogenesis (Xie et al., 2007).  Kalirin-7 contains a single GEF 
domain, and is able to activate Rac1 (Penzes and Jones, 2008).  Kalirin-9 has been shown to be 
localized to axonal and dendritic processes, and growth cones in developing neurons (Johnson et 
al., 2000), and is also expressed outside the central nervous system, in pituitary, liver, aorta, and 
skeletal muscle (Mandela et al., 2012).  Recently, kalirin-9 has been shown to localize to 
dendritic spines (Deo et al., 2012).  In contrast, kalirin-12 is localized to the cell soma in cortex 
and cerebellum, although it is reported to localize to spines in hippocampal neuron culture (Ma et 
al., 2003).  The kalirin-9 and -12 isoforms are already at detectable levels in rat CNS by birth 
(Ma et al., 2003).  Kalirin-9 and -12 contain a second GEF domain, which activates RhoA 
(Johnson et al., 2000), and so may play different roles than kalirin-7 in regulating dendritic spine 
and circuit dynamics.  Kalirin mRNA levels are highest in layers 2-4 and layer 6 of the cortex, 
while protein expression is greatest in the soma and dendrites of layer 5 pyramidal neurons (Ma 
et al., 2001).  High levels of kalirin mRNA and protein are also found in the hippocampus, and in 
the cerebellum, although it is expressed at varying levels in other mid-brain and brainstem 
structures.  It is important to note that kalirin protein is localized to both pyramidal and non-
pyramidal neurons.  Kalirin also influences dendritic arborization and formation of excitatory 
synapses onto GABAergic interneurons (Ma et al., 2008), where it influences the expression of 
GAD65 (Ma et al., 2011).  
Several lines of evidence suggest a role for kalirin in schizophrenia.  Associations have 
been identified between the kalirin gene and schizophrenia in genome wide association studies 
(Ikeda et al., 2011).  In addition, rare (< 1%) mutations specific for the kalirin-9 and -12 isoforms 
have been found to be associated with schizophrenia (Kushima et al., 2012).  In layer 3 of 
dorsolateral prefrontal cortex of subjects with schizophrenia, kalirin mRNA is reduced and 
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correlated with reduced dendritic spine density (Hill et al., 2006).  A more recent Western blot 
study also suggests that levels of kalirin-7 (called Duo in humans) protein are reduced in anterior 
cingulate and dorsolateral prefrontal cortex (Rubio et al., 2012).  Together, this evidence 
supports a role for kalirin in dendritic spine impairment in the frontal cortex of subjects with 
schizophrenia.  However, in the primary auditory cortex of subjects with schizophrenia, levels of 
kalirin-7 protein are unchanged, and levels of kalirin-9 are actually increased (Deo et al., 2012).  
The observation of differential changes in kalirin between frontal and auditory cortex in subjects 
with schizophrenia suggests that loss of kalirin may have different effects in different cortical 
areas.  While a role for kalirin in mediating adolescent spine elimination has been established in 
the frontal cortex (Cahill et al., 2009), and suggests that reduced kalirin expression could lead to 
spine over-pruning in prefrontal cortex in schizophrenia, it is not known if kalirin contributes to 
adolescent synapse pruning in the auditory cortex. 
1.5 GOALS AND RELEVANCE OF THIS DISSERATION 
In summary, we have presented evidence that auditory processing impairments could contribute 
to some of the more debilitating negative and cognitive symptoms of schizophrenia.  Further, 
evidence from in vivo imaging and postmortem studies suggest auditory cortex alterations 
contribute to functional impairments in auditory processing.  Finally, protracted gray matter and 
synapse development in the cortex during adolescence and young adulthood, when schizophrenia 
symptoms typically emerge, suggests that abnormal developmental processes could lead to 
alterations in primary auditory cortex in subjects with schizophrenia.  Based on this evidence, we 
propose a model (Figure 1.3), where genetic and/or environmental risk factors for schizophrenia 
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contribute to abnormal adolescent auditory cortex development, leading to auditory cortex 
pathology.  Alterations in auditory cortex in subjects with schizophrenia lead to abnormal 
auditory processing, which contributes to some of the observed symptoms.   
As we have alluded to in the above sections, evidence suggests that primary auditory 
cortex synapses are disrupted in schizophrenia, but we do not know which synapse populations 
are responsible.  Correlated reductions in presynaptic boutons and postsynaptic dendritic spines 
(Sweet et al., 2007; Sweet et al., 2009) suggest a decrease in excitatory synapses in the auditory 
cortex of individuals with schizophrenia.  However, as electrophysiological evidence points to 
impairments in physiological processes thought to be mediated by inhibitory as well as 
excitatory transmission, there may also be disruptions in inhibitory synapse components.  As 
dendritic spine density is reduced in the auditory cortex, and is hypothesized to result from over 
pruning of excitatory synapses during adolescence, it is important for our understanding of the 
pathophysiology of schizophrenia that we interpret synaptic alterations in the auditory cortex in 
schizophrenia in the context of how these synaptic elements change during the highly dynamic 
period of adolescence, when symptoms typically emerge.  Therefore, the goals of the research 
outlined in this dissertation (see Figure 1.3) are first, to determine whether disruptions in 
excitatory (Chapter 2) and inhibitory (Chapter 3) synapse components contribute to the 
disruptions of primary auditory cortex circuitry observed in individuals with schizophrenia; 
second, to determine the temporal relationship between excitatory and inhibitory synapse 
component developmental trajectories in the auditory cortex between adolescence and young 
adulthood (Chapter 4); and third, to determine how development of synapse components over 
adolescence affects auditory cortex function (Chapter 5).  We hypothesize 1) that excitatory and 
inhibitory presynaptic components contribute to pathology of primary auditory cortex in 
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individuals with schizophrenia, and 2) reductions in excitatory synapse components in primary 
auditory cortex precede changes in inhibitory synapse components during adolescence, and 
maturation of these synapse components is important for developmental improvement in 
auditory processing during adolescence.  The experimental chapters are briefly summarized in 






















 Figure 1.3. Schematic of the contribution of experimental chapters to overall model.  Contributions of 
experimental chapters are denoted by red arrows.  In chapter 1, we reviewed evidence which supports a contribution 
of auditory processing impairments to the symptoms of schizophrenia.  Alterations in auditory cortex structure and 
function may contribute to those auditory processing deficits.  We propose that abnormalities of adolescent cortical 
synapse development, presumably mediated by some combination of genetic and environmental factors, leads to the 
alterations in synapse components in primary auditory cortex in schizophrenia.  In chapter 2, we will determine 
whether intracortical excitatory or thalamocortical boutons are disrupted in the primary auditory cortex in 







contribute to auditory cortex synaptic alterations in schizophrenia.  In chapter 4, we will determine how pre- and 
postsynaptic components of primary auditory cortex excitatory and inhibitory synapses change during normal 
adolescence, and in mice lacking kalirin.  Finally, in chapter 5, we will explore how auditory cortex function 
changes during adolescence, and whether disrupted development of auditory cortex induced by the absence of 
kalirin impairs behavioral maturation of auditory cortex. 
 
 
1.5.1 Intracortical excitatory and thalamocortical boutons are intact in primary auditory 
cortex in schizophrenia 
Given the reduction of dendritic spine density in auditory cortex of schizophrenia, we 
hypothesized that excitatory presynaptic boutons would be reduced to a similar degree in the 
primary auditory cortex of subjects with schizophrenia.  The primary auditory cortex receives 
extensive excitatory projections from the thalamus, as well as excitatory projections arising from 
within the cortex.  Therefore, we took advantage of the differential expression of two isoforms of 
the vesicular glutamate transporters (VGluT) between these two populations to ask whether the 
density, number, and vesicular glutamate transporter levels within VGluT1-expressing 
intracortical excitatory and VGluT2-expressing thalamocortical excitatory boutons are altered in 
deep layer 3 of primary auditory cortex of subjects with schizophrenia.  Surprisingly, we found 
no alterations in either population, suggesting excitatory presynaptic boutons are not reduced 
despite reduced density of dendritic spines, their primary postsynaptic targets.   
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1.5.2 Reduced glutamate decarboxylase 65 protein in primary auditory cortex inhibitory 
boutons in schizophrenia 
Electrophysiological abnormalities in the aSSR response and auditory stimulus evoked 
oscillatory activity suggest inhibitiory neurotransmission might be impaired in the primary 
auditory cortex in subjects with schizophrenia.  As rapid modulation of inhibition is necessary 
for oscillatory activity, we hypothesized that inhibitory boutons expressing GAD65 would be 
affected in schizophrenia, as GAD65 mediates rapid activity dependent up-regulation of GABA 
synthesis.  In this study, we used immunohistochemistry and quantitative confocal microscopy to 
examine density, number, and GAD65 protein content within GAD65-expressing boutons in 
deep layer 3 of the primary auditory cortex of individuals with schizophrenia.  We found that 
density and number of GAD65-expressing inhibitory boutons are unchanged in schizophrenia; 
however, the within-bouton GAD65 protein content is reduced by approximately 40%.  Further, 
we observed that the reduction in within-bouton GAD65 protein was correlated with previously 
measured reduction in dendritic spine density in deep layer 3.  Our findings suggest that dendritic 
spine reduction and within-bouton GAD65 protein reduction are related pathological features of 
primary auditory cortex of subjects with schizophrenia. 
1.5.3 Developmental trajectories of excitatory synaptic components and within-bouton 
GAD65 protein in mouse auditory cortex between early adolescence and young adulthood 
Our observation of correlated disruptions of dendritic spines and levels of GAD65 protein within 
boutons in the primary auditory cortex of individuals with schizophrenia (1.5.2) suggests a 
relationship between excitatory and inhibitory synapse pathology.  Based on the relationship 
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between dendritic spines and GAD65 protein levels, we hypothesized that a decrease in levels of 
GAD65 protein may occur subsequent to spine pruning during adolescence in auditory cortex.  
We utilized the kalirin KO mouse to determine how genetically-mediated dendritic spine 
disruption impacts development of excitatory and inhibitory synapse components in auditory 
cortex during adolescence.  We hypothesized that excessive spine pruning occurs in the auditory 
cortex of kalirin KO mice, as has been observed in frontal cortex.  Our findings suggest that 
levels of within-bouton GAD65 protein decline between late adolescence and young adulthood, 
while spine pruning occurred between early adolescence and young adulthood, suggesting 
changes in GAD65 protein levels occurs subsequent to spine pruning.  Surprisingly, there were 
only subtle alterations in excitatory synapse components in the mice lacking kalirin, indicating 
that molecular regulators of spine pruning may be slightly different in auditory compared to 
frontal cortex.  Together, we see that components of excitatory and inhibitory synapses in the 
auditory cortex continue to develop through adolescence and young adulthood, and that 
inhibitory bouton changes appear to follow excitatory synapse pruning.   
1.5.4 Development of prepulse inhibition of the acoustic startle reflex by silent gaps across 
adolescence in mice 
Individuals with schizophrenia exhibit alterations in inhibitory and excitatory synapse 
components in primary auditory cortex, as well as basic auditory processing impairments.  In the 
mouse auditory cortex, we observed that numbers and molecular features of pre- and 
postsynaptic components of excitatory and inhibitory synapses change between early 
adolescence and young adulthood (1.5.3).  We hypothesized that auditory cortex function 
improves over adolescence, in parallel with maturation of auditory cortex synaptic components.  
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We also hypothesized that auditory cortex improvement would be blunted in mice lacking 
kalirin, as maturation of synaptic components during adolescence also exhibited subtle 
disruptions.  Using gap-mediated prepulse inhibition of the acoustic startle reflex (gap-PPI) as a 
readout of auditory cortex function, we determined that gap-PPI responses increase during 
adolescence in wild type mice, but not in mice lacking kalirin.  This suggests that adolescent 
auditory cortex synapse refinement during adolescence is important for normal development of 
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Abstract. Schizophrenia is associated with auditory processing impairments that could 
arise as a result of primary auditory cortex excitatory circuit pathology.  We have previously 
reported a deficit in dendritic spine density in deep layer 3 of primary auditory cortex in subjects 
with schizophrenia.  As boutons and spines can be structurally and functionally co-regulated, we 
asked whether the densities of intracortical excitatory or thalamocortical presynaptic boutons are 
also reduced.  We studied 2 cohorts of subjects with schizophrenia and matched controls, 
comprising 27 subject pairs and assessed the density, number, and within-bouton vesicular 
glutamate transporter (VGluT) protein level of intracortical excitatory (VGluT1-
immunoreactive) and thalamocortical (VGluT2-immunoreactive) boutons in deep layer 3 of 
primary auditory cortex using quantitative confocal microscopy and stereologic sampling 
methods.  We found that VGluT1- and VGluT2-immunoreactive puncta densities and numbers 
were not altered in deep layer 3 of primary auditory cortex of subjects with schizophrenia.  Our 
results indicate that reduced dendritic spine density in primary auditory cortex of subjects with 
schizophrenia is not matched by a corresponding reduction in excitatory bouton density.  This 
suggests excitatory boutons in primary auditory cortex in schizophrenia may synapse with 
structures other than spines, such as dendritic shafts, with greater frequency.  The discrepancy 
between dendritic spine reduction and excitatory bouton preservation may contribute to 
functional impairments of the primary auditory cortex in subjects with schizophrenia. 
2.1 INTRODUCTION 
Individuals with schizophrenia exhibit impairments in auditory processing, including pure tone 
frequency discrimination (Javitt et al., 2000; Leitman et al., 2010b).  Electrophysiological 
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deficits observed during auditory processing tasks, such as reduction in the mismatch negativity 
(MMN) response to stimulus changes during a repetitive acoustic stimulus presentation (Javitt et 
al., 1994; Javitt et al., 2000; Naatanen and Kahkonen, 2009), are also observed in schizophrenia.   
In addition to functional abnormalities, gray matter volume loss is consistently reported in the 
anatomical region of the primary auditory cortex in the superior temporal gyrus (STG) 
(McCarley et al., 1999; Rajarethinam et al., 2004) and Heschl’s gyrus (Hirayasu et al., 2000; 
Kasai et al., 2003; Salisbury et al., 2007; Takahashi et al., 2009) of subjects with schizophrenia 
and high-risk individuals.   
Evidence suggests that alterations of excitatory, glutamatergic synapses could underlie 
the structural and functional abnormalities in the auditory cortex in schizophrenia.  For example, 
the MMN response is disrupted by blocking the NMDA subtype of ionotropic glutamate receptor 
(Javitt et al., 1996; Gunduz-Bruce et al., 2012).  In subjects with schizophrenia, spinophilin-
immunoreactive (-IR) puncta density (a marker of dendritic spines) is reduced in the primary 
auditory cortex (Sweet et al., 2009), suggesting that the density of postsynaptic components of 
excitatory synapses in the auditory cortex is reduced.  Trans-synaptic communication coordinates 
functional and structural changes between pre- and postsynaptic elements, as indicated by reports 
that postsynaptic alterations such as AMPA receptor removal (Ripley et al., 2011) or protein 
synthesis inhibition (McCann et al., 2007) lead to presynaptic bouton loss.  Therefore, reduced 
dendritic spine density in schizophrenia may be indicative of a coordinated reduction in 
excitatory bouton density.  Alternatively, if excitatory bouton density is unchanged, then this 
could indicate that the distribution of their postsynaptic targets is altered.   For example, 
excitatory boutons may synapse with dendritic shafts with greater frequency, which occurs 
following spine loss in culture (Mateos et al., 2007; Woods et al., 2011).   Here, we asked 
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whether the density of excitatory boutons in deep layer 3 of primary auditory cortex is reduced in 
individuals with schizophrenia. 
Glutamatergic inputs to the primary auditory cortex can be broadly classified into two 
groups:  thalamocortical inputs primarily to layer 4 and deep layer 3 from the medial geniculate 
nucleus of the thalamus, and intracortical excitatory inputs originating within primary auditory 
cortex and from other cortical regions.  It is important to distinguish between the two populations 
because alterations of excitatory synapses in the primary auditory cortex may have different 
functional consequences depending on whether thalamocortical boutons or intracortical 
excitatory boutons are affected.  The two populations can be differentiated at the molecular level 
by the presence of different isoforms of the vesicular glutamate transporter (VGluT).  Most 
reports indicate that VGluT1 is preferentially expressed in neurons in the cortex and 
hippocampus, and VGluT2 is preferentially expressed in neurons located in subcortical 
structures, including some nuclei of the thalamus (Fremeau, Jr. et al., 2001; Kaneko and 
Fujiyama, 2002; Fremeau, Jr. et al., 2004a; Fremeau, Jr. et al., 2004b).   Levels of VGluT protein 
have also been shown to be correlated with glutamate release and synaptic strength (Wilson et 
al., 2005), and so changes in within-bouton levels of these proteins may indicate functional 
impairments of these synapses. 
We used quantitative fluorescence confocal microscopy to examine VGluT1- and 
VGluT2-immunoreactive puncta in primary auditory cortex of two cohorts of subjects, 
comprising a total of 27 subjects with schizophrenia and an equal number of matched controls.  
We found that densities and numbers of thalamocortical and intracortical excitatory boutons, and 
within-bouton VGluT protein levels were not altered in deep layer 3 of primary auditory cortex 
of subjects with schizophrenia. Taken together with our previous finding of reduced dendritic 
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spine density in this region, our data suggest that excitatory boutons may aberrantly target non-
spine postsynaptic structures, such as dendritic shafts.   A shift in the distribution of excitatory 
synapses away from spines and onto dendritic shafts could alter excitatory circuit function in the 
primary auditory cortex.   
2.2 MATERIALS AND METHODS 
2.2.1 Subjects and animals 
We studied two cohorts (Table 2.1 and Appendix Table A.1) of subjects diagnosed with 
schizophrenia or schizoaffective disorder and matched controls included in our previous studies 
(Sweet et al., 2004; Sweet et al., 2007; Sweet et al., 2009; Dorph-Petersen et al., 2009b; Moyer et 
al., 2012).  We also studied a cohort of four male macaque monkeys (Macaca fascicularis) 
chronically exposed to haloperidol decanoate, and four control macaques matched for sex and 
weight (Sweet et al., 2007).   
All of the brain specimens were collected during autopsies conducted at the Allegheny 
County Medical Examiner’s Office with permission obtained from the subjects’ next-of-kin.  
The protocol used to obtain consent was approved by the University of Pittsburgh Institutional 
Review Board and Committee for Oversight of Research Involving the Dead.  An independent 
committee of experienced clinicians made consensus diagnoses (American Psychiatric 
Association, 1994) for each subject, using information obtained from clinical records and 
structured interviews with surviving relatives.  These procedures were IRB approved.  
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Table 2.1. Summary of subject characteristics for cohorts 1 and 2.  Each subject in cohorts 1 and 2 was 
previously matched to a normal comparison subject based on sex, and as closely as possible for age, postmortem 
interval (PMI), and group matched for handedness. There were no diagnostic group differences in age (t52 = 0.517, p 
= 0.608) or PMI (t52 = 0.584, p = 0.561) or in the distribution of handedness between diagnostic groups (χ2 = 1.46, df 
= 1, p = 0.314). Mean storage time did not differ between diagnostic groups (Cohort1: t28 = 0.040, p = 0.968; Cohort 
2: t22 = 0.596, p = 0.557). Tobacco use at time of death was more frequent in the schizophrenia group compared to 
the control group (χ2 = 5.28, df = 1, p = 0.022). Abbreviations: SD, standard deviation; F/M, female/male; R/L/A/U, 






2.2.2 Tissue processing 
2.2.2.1 Cohort 1 tissue processing 
Brains from individuals in cohort 1 were bisected and the left hemisphere of each subject was cut 
coronally into 1-2 cm-thick blocks, which were then immersed in cold 4% paraformaldehyde in 
phosphate buffer for 48 hours, equilibrated in a series of graded sucrose solutions, and stored at  
-30oC in an antifreeze solution (30% glycerol and 30% ethylene glycol in phosphate-buffered 
saline).  Superior temporal gyrus (STG)- containing blocks were generated as described 
previously (Sweet et al., 2003; Sweet et al., 2004) and 40 µm coronal cryostat sections were cut 
and then stored in antifreeze solution at -30oC until use in this study.   
2.2.2.2 Cohort 2 tissue processing 
Brain specimens from individuals in cohort 2 were harvested, bisected, blocked coronally, and 
stored in antifreeze solution at -30oC as described for cohort 1 (Sweet et al., 2005; Dorph-
Petersen et al., 2009b).  The entirety of the left STG of each subject was dissected from the fixed 
coronal blocks.  The pial surfaces of the STG blocks were painted with hematoxylin to facilitate 
identification of the pial surface later during tissue processing, and the blocks were reassembled 
in 7% low-melt agarose in their in vivo orientation.  The reassembled STG was cut into 
systematic uniformly random 3 mm slabs orthogonal to the long axis of Heschl’s gyrus.  Every 
other slab with a random start was selected for mapping the boundaries of primary auditory 
cortex and the remaining slabs were stored in antifreeze solution until use.  Mapping slabs were 
cut on a cryostat at 60 µm, and three consecutive sections from each slab were stained for 
parvalbumin (PV) immunoreactivity, acetylcholinesterase activity, and Nissl substance.  These 
sections were used to determine whether primary auditory cortex was present in a given slab, to 
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estimate the volume of primary auditory cortex, and to delineate the boundaries of primary 
auditory cortex.  The boundaries of primary auditory cortex determined using the mapping slabs 
were applied to the unused set of slabs, such that boundaries of primary auditory cortex on a 
mapping slab were applied to the adjacent unused slab immediately rostral.  The primary 
auditory cortex was dissected from the unused slabs, and further subdivided into 3 mm wide 
blocks.  Blocks from the most rostral and caudal slabs containing the region of interest were 
weighted at 1/3 relative to the weight of other blocks to account for the fact that these blocks 
only partially contained the region of interest.  This weighting method has been previously 
published (Dorph-Petersen et al., 2009b).  Briefly, it is needed because the end blocks only 
partially represent the region of interest (on average less than half due to the positive curvature of 
the boundary of the region of interest in 3 dimensions) and therefore should not have the same 
weight as the other blocks.  However, there is no way to know the precise weight without 
knowing the exact fraction of the region of interest and the Nv of the region of interest as well as 
that of the neighboring region within each block in question. Because the positive curvature is 
best approximated by a cone or a pyramid, it would take up 1/3 of the volume, leading to our 
weighting.  Block weights were factored into calculations of bouton number (Dorph-Petersen et 
al., 2009b).  Each primary auditory cortex block was then placed pial surface down in a layer of 
optimal cutting temperature compound (OCT) on a stainless steel block.  A hollow cylinder was 
placed on the block over the tissue, and the cylinder was filled with OCT and allowed to freeze 
at -20oC.  The block of tissue encased in OCT was then removed from the cylinder and placed in 
a stainless steel well where it was randomly rotated and fixed in its orientation with OCT.  The 
primary auditory cortex block was then sectioned at 50 µm in this orientation perpendicular to 
the pial surface, and sections were stored at -30oC in antifreeze solution until use in this study. 
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2.2.2.3 Antipsychotic-exposed macaque cohort tissue processing 
In order to account for possible effects of antipsychotic medications, we studied a previously 
described cohort (Sweet et al., 2007) of four male macaque monkeys (Macaca fascicularis) 
chronically exposed to haloperidol decanoate, and four control macaques matched for sex and 
weight.  All procedures were approved by the University of Pittsburgh’s Institutional Animal 
Care and Use Committee.   Animals received injections of haloperidol (mean (standard 
deviation) = 16.0 (2.1) mg/kg) every four weeks, maintaining trough serum levels of haloperidol 
of 4.3 (1.1) ng/ml, on average.  Following 9-12 months of haloperidol exposure, animals were 
euthanized with an overdose of pentobarbital, and brains were removed and immersed in 4% 
paraformaldehyde following a 45 min post mortem interval (PMI).  Free-floating sections from 
the four matched pairs were processed together within immunohistochemistry runs, and 
procedures were identical to those described for human tissue immunohistochemistry. 
2.2.3 Immunohistochemistry 
Auditory cortex containing tissue sections (3 from each subject in cohort 1, and 4 from each 
subject in cohort 2) from matched pairs were processed together in immunohistochemistry runs.  
In order to identify excitatory glutamatergic axon boutons in deep layer 3 of the primary auditory 
cortex, we utilized two antibodies directed against two isoforms of the vesicular glutamate 
transporter (VGluTs 1 and 2).  Auditory cortex containing tissue sections from matched pairs 
were processed together in immunohistochemistry runs.  Free-floating sections were rinsed in 0.1 
M phosphate buffered saline (PBS), and then incubated in 1% NaBH4 in phosphate buffer for 30 
minutes to reduce tissue autofluorescence.  Sections were rinsed again in PBS and incubated for 
3 hours in blocking buffer containing 0.3% Triton-X, 5% normal human serum, 5% normal goat 
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serum, 1% bovine serum albumin, 0.1% lysine, and 0.1% glycine in PBS.  Sections were then 
incubated with a 1:500 dilution of guinea pig anti-VGluT1 primary antibody and a 1:10,000 
dilution of rabbit anti-VGluT2 primary antibody in blocking buffer for 96 hours at 4oC.  After 
rinsing in PBS, sections were incubated overnight with 1:500 dilutions of Alexa Fluor 568 
conjugated goat anti-guinea pig and Alexa Fluor 488 conjugated anti-rabbit secondary antibodies 
(Invitrogen, Carlsbad, CA).  Sections were rinsed, mounted on gelatin-coated slides, allowed to 
dry for 1 hour, rehydrated for 10 min in distilled water, and coverslipped with Vectashield Hard 
Set mounting medium (Vector Laboratories, Burlingame, CA). 
VGluT1 was detected using a guinea pig anti-VGluT1 antibody (AB5905, Millipore, 
Billerica, MA), and VGluT2 was detected using a rabbit anti-VGluT2 antibody (V2514, HY-19; 
Sigma-Aldrich, St. Louis, MO).  Although some evidence suggests that mRNA for these 
transporters may be co-expressed (De Gois et al., 2005; Graziano et al., 2008; Hackett et al., 
2011), VGluT1 and 2 proteins demonstrate non-overlapping and complimentary patterns of 
expression throughout the brain.  VGluT1 is the predominant vesicular glutamate transporter in 
corticocortical and corticothalamic neurons, while VGluT2 is the predominant transporter 
expressed in thalamocortical neurons (Fremeau, Jr. et al., 2001; Fremeau, Jr. et al., 2004a; 
Fremeau, Jr. et al., 2004b; Hackett et al., 2011).  In monkey and human auditory cortex, we 
observed the expected pattern of VGluT1 immunoreactivity across all cortical layers, and an 
apparent increase in VGluT2 immunoreactivity in the thalamocortical termination zone in deep 
layer 3 and layer 4 (Figure 2.1A and 2.1B).  In addition, we observed minimal colocalized 
labeling of puncta with these anti-VGluT1 and -VGluT2 antibodies, although both markers 
showed extensive colocalization with an antibody targeting the presynaptic bouton marker 
synaptophysin (Figure 2.1C and 2.1D).  Also, we observed no colocalization of VGluT1- and 
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VGluT2-immunoreactive (IR) puncta with a marker of inhibitory GABAergic presynaptic 



















 Figure 2.1. Specificity of antibodies used to identify VGluT1- and VGluT2-immunoreactive puncta.  A. 
VGluT1 and VGluT2 immunoreactivity across all cortical layers of primary auditory cortex of one human subject 
from cohort 2. Blue outline in “Merge” panel represents the deep layer 3 contour, and the counting frame represents 
a sampling site. Scale bar is 200 μm. B. VGluT1 and VGluT2 immunoreactivity across all cortical layers of primary 
auditory cortex of a macaque. Image was taken using a laser scanning confocal. Scale bar is 200 μm.  C. The 
antibodies directed against VGluT1 and VGluT2 label two separate bouton populations with no observable 
colocalization of markers. Scale bar is 10 μm.  D. The VGluT1 and VGluT2 antibodies demonstrate overlap with an 
antibody directed against synaptophysin, a protein found in all classical neurotransmitter releasing boutons. The 
arrowheads indicate a bouton that is immunoreactive for VGluT1 and synaptophysin and arrows indicate a bouton 
that is immunoreactive for VGluT2 and synaptophysin. Scale bar is 10 μm. 
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2.2.4 Image collection 
Sections were coded so that the experimenter was blind to diagnostic or drug exposure group, 
and sections were organized into sets so that sections from paired subjects were imaged during 
the same imaging session.  Images were collected using a 1.42 NA 60X oil objective on an 
Olympus BX51 upright microscope (Olympus, Center Valley, PA) equipped with an Olympus 
DSU spinning disk confocal, a Hamamatsu C4742-98 CCD camera (Hamamatsu, Bridgewater, 
NJ), Olympus mercury light source, excitation/emission filter wheels, a 89000 Sedat Quad ET 
filter set (Chroma Technology Corp, Bellows Falls, VT),  and high precision Prior Scientific 
motorized XY stage (Prior Scientific, Inc., Rockland, MD) equipped with a linear XYZ encoder 
(Ludl Electronic Products, Ltd., Hawthorne, NY).   Image collection was controlled using 
SlideBook version 4.1 software (Intelligent Imaging Innovations, Denver, CO).  At each 
sampling site, the tissue thickness (Z axis depth) was measured and recorded, and tissue 
thickness did not differ between diagnostic groups (t52 = 0.844, p = 0.402).  Image stacks were 
collected with a step size of 0.22 µm between Z axis planes in the stack, starting from 10 µm 
below the tissue surface closest to the coverglass and stepping up until the tissue surface was 
reached, yielding a 10 µm thick (Z axis depth) stack comprised of 46 individual 2-dimensional 
planes.  Collected image planes were 512 x 512 pixels with 2 x 2 binning, and exposure times 
were adjusted to optimize the spread of the intensity histogram and to ensure that none of the 
pixels in the image stack were saturated.  Although mean exposure time was not significantly 
different between diagnostic groups [Mean (SD): 568 channel: Control, 308 (174) ms; 
Schizophrenia, 309 (184) ms; t52 = -0.02, p = 0.983; 488 channel: Control, 222 (51) ms; 
Schizophrenia, 230 (53) ms; t52 = -0.52, p = 0.607] any potential contributions of differences in 
sampling site exposure time to our outcome variables were corrected for by including exposure 
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times in statistical models.  For the monkey group mean exposure time did not differ between 
groups for VGluT1-IR boutons [Mean (SD): 568 channel: Control, 147 (55) ms; Antipsychotic, 
141 (27) ms; t196 = 1.03, p = 0.301] and was significantly lower for antipsychotic exposed 
monkeys than control monkeys for VGluT2-IR boutons [Mean (SD): 488 channel: Control, 237 
(74) ms; Antipsychotic, 212 (67) ms; t194 = 2.45; p = 0.02]; however, contributions of differences 
in exposure time were corrected for by including exposure time in statistical models. 
2.2.5 Image processing 
Collected image stacks were post-processed offline, using SlideBook and Automation Anywhere 
software (Automation Anywhere, Inc., San Jose, CA) to automate keystrokes and increase image 
processing efficiency.  The background fluorescence intensity of each stack was determined as 
the mode value of the intensity histogram in each of the two channels.  Background subtraction 
was done by subtracting the mode intensity (gray scale) value from all pixel intensities in that 
channel.  Images were then deconvolved with a constrained iterative algorithm using a calculated 
point spread function, a maximum of 20 iterations, and 3D frequency filtering enabled.  The 
background subtracted and deconvolved image stack was then subject to intensity segmentation 
coupled with morphological selection using our iterative masking approach (Fish et al., 2008).  
For VGluT1-immunoreactive puncta, the initial intensity threshold was set at 105% of the 
background intensity level determined above, and with each subsequent iteration the intensity 
threshold was increased by 5%, until a maximum of 12,000 gray levels was reached.  For 
VGluT2-IR puncta, the initial intensity threshold was set at 180% of the background intensity, 
and with each subsequent iteration the intensity threshold was increased by 25% until a 
maximum of 12,000 gray levels was reached.  After each segmentation step, mask objects with 
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volumes ranging from 0.2 to 2.0 µm3 (VGluT1) or 0.05 to 2.0 µm3 (VGluT2) were selected and 
merged with the mask generated in the prior segmentation step.  VGluT1- and VGluT2-IR 
bouton data (mean intensity, mean volume, mean surface area) were extracted from these image 
stacks using the generated masks to identify objects of interest.  VGluT1-IR mask objects were 
selected for final analysis if the mean intensity of the object was greater than or equal to a 20% 
increase over the background fluorescence (mode value of histogram). This further eliminated 
falsely detected background signal collected as a result of our small intensity threshold step size 
in this channel.  VGluT1- and VGluT2-IR puncta were counted automatically by determining 
whether the centroid of each automatically detected object was inside the disector. This 
corresponds to the so-called “associated point rule” (Baddeley and Jensen, 2004), which is an 
unbiased alternative to the unbiased counting frame (Gundersen, 1977).  Guard zones of 10 
pixels were applied around all edges in the X and Y dimensions of each stack, and 10 Z planes 
starting 10 planes below the coverglass were included in analysis, as antibody penetration was 
uniform (puncta counts and intensities were uniform) across these Z axis depths (10 planes x 
0.22 µm step size = 2.20 µm disector height). 
2.2.6 Quantification of VGluT1- and VGluT2-IR puncta 
VGluT1- and VGluT2-IR puncta within deep layer 3 of primary auditory cortex were quantified 
in this study using spinning disk confocal microscopy.  Stereologic sampling, confocal imaging, 
and image processing were conducted as described previously (Moyer et al., 2012).  Mean 
puncta fluorescence intensity, and mean density and number of puncta in deep layer 3 were 
determined for VGluT1- and VGluT2-IR puncta. 
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Densities reported were calculated individually at each site in order to include exposure 
time as a covariate in our analyses, as exposure time varied on a site-by-site basis.  The density 
of mask objects at each site was determined by dividing the number of objects counted at each 
site by the product of the disector height (2.2 µm) and the area of the counting frame (2553 µm2), 
and then multiplying that by the measured tissue thickness at each site divided by the cryostat 
block advance (40 µm (cohort1 and monkey cohort) or 50 µm (cohort 2)) (Dorph-Petersen et al., 
2001) to correct for tissue shrinkage.  It should be noted that the disector height of 2.2 µm used 
in the current study is very low and could only be implemented robustly because we used 
confocal microscopy allowing for a high number of thin focal planes; and because we performed 
a careful analysis of the distribution of the boutons along the Z axis (see Fig. 4 of (Dorph-
Petersen et al., 2009a)). We determined the position of the disector and corresponding guard 
zones post hoc ensuring that boutons were only sampled in the zone with uniform bouton counts. 
Such sampling was possible due to the high number of automatically detected boutons—for 
example, on average 59,208 VGluT1-IR and 11,495 VGluT2-IR puncta were detected per 
subject in cohort 1 and of these an average of 2,566 VGluT1-IR and 2,292 VGluT2-IR puncta 
per subject were sampled by the disector. Thus, while a disector height of only 2.2 µm should be 
avoided in a standard brightfield microscopy study with manual counts, we were able to robustly 
implement such a disector in the current study.  
 For cohort 2 subjects, we were also able to estimate VGluT1- and VGluT2-IR bouton 
number because of the tissue processing methods used to generate auditory cortex tissue 
sections.  To do this, mean object densities were calculated as described in equations 4 and 5 of 
Dorph-Petersen et al. (Dorph-Petersen et al., 2009b) using the numerical density (NV) approach 
with the following modification: the distances of each individual mask object from the central 
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axis were not included in the calculation under the reasonably robust assumption of homogeneity 
on the scale of the sampling site (~50 µm).  Instead, object counts at each sampling site were 
weighted by multiplying object count at each site by the distance of the sampling site from the 
central axis.  Deep layer 3 volumes for each subject were calculated as described in equations 1-
3 of Dorph-Petersen et al. (Dorph-Petersen et al., 2009b) by multiplying the volume fraction of 
deep layer 3 sampled by the total primary auditory cortex volume.  Bouton number for each 
subject was then generated by multiplying the NV by the total deep layer 3 volume (Dorph-
Petersen et al., 2009b). 
Mean puncta volume and surface area of puncta in deep layer 3 were calculated in 
SlideBook for VGluT1- and VGluT2-IR puncta.  The surface area is determined from the surface 
areas of the exposed voxel faces of each object.  Puncta shape complexity was calculated as the 
inverse of puncta sphericity (Wadell, 1935), determined with the following equation:  
Sphericity = (π1/3 (6Vp)2/3 )/Ap  
Where Vp is the IR puncta volume and Ap is the IR puncta surface area. 
2.2.7 Statistical analyses 
For each human and macaque subject, mean density, fluorescence intensity, and volume of 
VGluT1- and VGluT2-IR puncta in deep layer 3 of primary auditory cortex were calculated.  
Among the human subjects, the analyses of VGluT1- and VGluT2-IR bouton volume, surface 
area, shape complexity, density, and mean intensity were conducted separately using two 
multivariate analysis of covariance (MANCOVA) models: a primary model that included 
diagnosis and cohort as fixed effects, subject pair (nested in cohort) as a blocking factor, and 
tissue storage time and exposure time as covariates; and a secondary model without subject pair 
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as a blocking factor, that included diagnosis, sex, and cohort as fixed effects and age, PMI, tissue 
storage time, and exposure time as covariates.  To help satisfy the normality requirement for 
MANCOVA models, mean fluorescence intensity was analyzed on the natural logarithm scale.  
To account for the correlation among sampling sites within each subject and among sampling 
sites within each section for each subject, site and section nested in subject were included as 
random effects in each MANCOVA model.  Inclusion of tissue thickness, subject handedness, or 
immunohistochemistry assay order in the models had negligible impact on diagnostic group 
differences and, thus, the results reported are from MANCOVA models omitting these factors. 
 The analysis of VGluT1- and VGluT2-IR bouton number (cohort 2 subjects only) was 
conducted using two analysis of covariance (ANCOVA) models: a primary model that included 
diagnosis and pair as fixed effects, and tissue storage time as a covariate; and a secondary model 
without pair as a factor that included diagnosis and sex as fixed effects, and age, PMI, and tissue 
storage time as covariates.   
 Diagnostic comparison results were compared from both primary and secondary models 
for consistency. Due to the consistency of comparisons found in our analyses, p-values and 95% 
confidence intervals for the estimated mean difference in response between subjects with 
schizophrenia and control subjects provided in the text are based on the primary model. 
 Based on the mean densities, fluorescence intensities, volumes, surface areas, and bouton 
shape complexity for each subject, two sample t tests were used to determine the effect of the 
following: independent living status, antipsychotic use, co-morbid alcohol or substance abuse, 
death by suicide, and diagnosis of schizoaffective disorder.  In these analyses, the percent 
changes of bouton density, fluorescence intensity, volume, surface area, and shape complexity in 
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subjects with schizophrenia (relative to healthy controls) within each subject pair were the 
response variables of interest. 
 To compare mean bouton density, fluorescence intensity, volume, surface area, and shape 
complexity between antipsychotic exposed and control macaques, MANCOVA models were 
used, each of which included drug treatment as a fixed effect, pair as a blocking factor, and 
exposure time as a covariate, and site and section nested in animal were included as random 
effects.  Due to the similarity of storage time within each pair, storage time was not included as a 
covariate. 
All statistical tests were two-sided and conducted at the 0.05 significance level. 
2.3 RESULTS 
2.3.1 VGluT1-IR puncta 
The density of VGluT1-IR puncta was not significantly different between subjects with 
schizophrenia and control subjects (F(1, 23.2) = 0.34, p = 0.568, 95% CI: (-0.001, 0.002)) (Figure 
2.2A).    Because we have previously determined the total volume of primary auditory cortex 
layer 3 for cohort 2 subjects (Dorph-Petersen et al., 2009b), we were able to estimate the total 
number of VGluT1-IR puncta in primary auditory cortex deep layer 3 for the 12 subject pairs of 
cohort 2 and we found that the absolute number of VGluT1-IR puncta was not different in 
schizophrenia (F(1, 10) = 0.003, p = 0.956, 95% CI: (-1.62 x 108, 1.54 x 108)) (Figure 2.2B).  
Because of the differences in tissue processing methods, we were not able to estimate puncta 
number in subject pairs from cohort 1.  We observed no significant alterations in primary 
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auditory cortex deep layer 3 VGluT1-IR puncta fluorescence intensity (F(1, 149) = 0.42, p = 0.518, 
95% CI: (-0.09, 0.18)), indicating that relative levels of within-bouton VGluT1 protein are not 



















 Figure 2.2. VGluT1-IR puncta density, number, and mean fluorescence intensity are unaltered in deep layer 
3 of primary auditory cortex of subjects with schizophrenia.  A. (Top) VGluT1-IR puncta density for subjects in 
cohort 1 (open circles) and cohort 2 (gray circles). Reference line represents schizophrenia = control values, where 
points below the line indicate a pair where control > schizophrenia, and points above the line indicate schizophrenia 
> control. (Bottom) Diagnostic group mean puncta density for control (c) and schizophrenia (s) subjects in cohort 1 
(open bars) and cohort 2 (gray bars). Error bars are +/-SEM. B. (Top) VGluT1-IR puncta number for subjects in 
cohort 2. Reference line represents schizophrenia = control values, where points below the line indicate a pair where 
control > schizophrenia, and points above the line indicate schizophrenia > control. (Bottom) Diagnostic group 
mean puncta number for control (c) and schizophrenia (s) subjects in cohort 2. Error bars are +/-SEM. C. (Top) 
VGluT1-IR puncta fluorescence intensity for subjects in cohort 1 (open circles) and cohort 2 (gray circles). 
Reference line represents schizophrenia = control values, where points below the line indicate a pair where control > 
schizophrenia, and points above the line indicate schizophrenia > control. (Bottom) Diagnostic group mean puncta 
fluorescence intensity for control (c) and schizophrenia (s) subjects in cohort 1 (open bars) and cohort 2 (gray bars). 






We observed no effect of chronic haloperidol exposure on density (F(1, 17.3) = 0.95; p = 
0.343, 95% CI: (-0.003, 0.01)) or intensity (F(1, 18.6) = 0.36; p = 0.554, 95% CI: (-0.11, 0.21)), of 
VGluT1-IR puncta in deep layer 3 of primary auditory cortex of antipsychotic-exposed 






















 Figure 2.3. Chronic antipsychotic exposure does not alter VGluT1-IR puncta mean density or fluorescence 
intensity.  (Top) VGluT1-IR puncta mean density (A) or fluorescence intensity (B) for monkey cohort. Reference 
line represents antipsychotic = control values, where points below the line indicate a pair where control > 
antipsychotic-exposed, and points above the line indicate antipsychotic-exposed > control. (Bottom) Group means 










2.3.2 VGluT2-IR puncta 
We observed no significant change in primary auditory cortex deep layer 3 VGluT2-IR puncta 
density (F(1, 23.3) = 0.97, p = 0.335, 95% CI: (-0.0003, 0.001)) in subjects with schizophrenia 
(Figure 2.4A).  Similarly, we found that the absolute number of VGluT2-IR puncta was not 
altered in cohort 2 schizophrenia subjects relative to matched controls (F(1, 10) = 0.153, p = 0.704, 
95% CI: (-1.11 x 108, 1.58 x 108)) (Figure 2.4B).  There were also no diagnostic group 
differences in primary auditory cortex deep layer 3 VGluT2-IR puncta fluorescence intensity 
(F(1, 23.2) = 0.69, p = 0.413, 95% CI: (-0.09, 0.04)) (Figure 2.4C). 
We observed trends toward increased VGluT2-IR puncta fluorescence intensity (F(1, 20.6) 
= 3.05, p = 0.096, 95% CI: (-0.02, 0.17)) and increased VGluT2-IR bouton puncta density (F(1, 
20.5) = 3.64, p = 0.071, 95% CI: (-0.0002, 0.003)) in haloperidol-exposed macaques, although 















Figure 2.4. VGluT2-IR bouton density, number, and mean fluorescence intensity are unaltered in deep layer 
3 of primary auditory cortex of subjects with schizophrenia.  A. (Top) VGluT2-IR puncta density for subjects in 
cohort 1 (open circles) and cohort 2 (gray circles). Reference line represents schizophrenia = control values, where 
points below the line indicate a pair where control > schizophrenia, and points above the line indicate schizophrenia 
> control. (Bottom) Diagnostic group mean puncta density for control (c) and schizophrenia (s) subjects in cohort 1 
(open bars) and cohort 2 (gray bars) Error bars are +/-SEM. B. (Top) VGluT2-IR puncta number for subjects in 
cohort 2. Reference line represents schizophrenia = control values, where points below the line indicate a pair where 
control > schizophrenia, and points above the line indicate schizophrenia > control. (Bottom) Diagnostic group 
mean puncta number for control (c) and schizophrenia (s) subjects in cohort 2. Error bars are +/-SEM. C. (Top) 
Mean VGluT2-IR puncta fluorescence intensity for each schizophrenia-control subject pair in cohort 1 (open circles) 
and cohort 2 (gray circles). Reference line represents schizophrenia = control values, where points below the line 
indicate a pair where control > schizophrenia, and points above the line indicate schizophrenia > control. (Bottom) 
Diagnostic group mean puncta fluorescence intensity for control (c) and schizophrenia (s) subjects in cohort 1 (open 

















Figure 2.5. Chronic antipsychotic exposure does not alter VGluT2-IR puncta mean density or fluorescence 
intensity.  (Top) VGluT2-IR puncta mean density (A) or fluorescence intensity (B) for monkey cohort. Reference 
line represents antipsychotic = control values, where points below the line indicate a pair where control > 
antipsychotic-exposed, and points above the line indicate antipsychotic-exposed > control. (Bottom) Group means 





Here we asked whether there are alterations in intracortical excitatory or thalamocortical boutons 
in deep layer 3 of the primary auditory cortex of subjects with schizophrenia.  We report that 
neither VGluT1-IR intracortical excitatory nor VGluT2-IR thalamocortical boutons are altered in 
density or number.   To the best of our knowledge, no studies have examined densities of these 
two bouton populations in schizophrenia, although the question of whether VGluT1 or VGluT2 
mRNA or protein levels are altered has been asked.  Conflicting studies of VGluT1 expression in 
schizophrenia report reduced mRNA in prefrontal cortex and hippocampus (Eastwood and 
Harrison, 2005), no change in mRNA in the prefrontal cortex (Oni-Orisan et al., 2008; Fung et 
al., 2011), and increased mRNA and protein in anterior cingulate cortex (Oni-Orisan et al., 
2008).  Studies of VGluT2 expression in schizophrenia have found that mRNA and protein are 
unaltered in anterior cingulate and prefrontal cortices (Oni-Orisan et al., 2008), and that mRNA 
expression in inferior temporal cortex is reduced (Uezato et al., 2009).  In the present study, we 
did not find VGluT1-or VGluT2-IR puncta fluorescence intensities to be altered, suggesting that 
within-bouton VGluT protein levels are unchanged in subjects with schizophrenia.  This 
indicates that our ability to detect immunoreactive puncta was unimpaired by any changes in 
VGluT protein levels within presumptive boutons.   This also suggests that excitatory boutons in 
the auditory cortex of subjects with schizophrenia are not impaired in terms of their VGluT 
protein content.  However it remains possible that levels of other proteins involved in glutamate 
release are altered within excitatory boutons, as reductions in mRNA expression of other 
presynaptic release machinery genes have been reported in schizophrenia (Mirnics et al., 2000). 
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2.4.1 Possible implications of spine loss and excitatory bouton preservation 
Together with our previous study (Sweet et al., 2009) we found that spine density is reduced in 
auditory cortex of subjects with schizophrenia but excitatory bouton density is not reduced.  One 
interpretation of our result is that the primary auditory cortex in subjects with schizophrenia has 
a normal complement of excitatory boutons but that some of these lack postsynaptic contacts.  
Evidence of boutons which lack postsynaptic contacts has been reported in electron microscopy 
studies (Jones et al., 1997; Shepherd and Harris, 1998) which suggests that boutons are stable in 
the absence of a post-synaptic contact.  However, chronic in vivo imaging studies demonstrate 
varying rates of turnover for presynaptic boutons in the cortex (De Paola et al., 2006).  This 
would suggest that boutons do not persist without postsynaptic contacts, but instead undergo 
formation and elimination such that a cross-sectional microscopy analysis will uncover a certain 
percentage of boutons which appear to not contact postsynaptic structures.   
 Probably the most parsimonious explanation for the observed deficit in dendritic spines 
but not excitatory boutons in the primary auditory cortex in schizophrenia is that a greater 
proportion of excitatory boutons form synapses with dendritic shafts rather than spines.   This 
could result from a failure in the down-regulation of shaft synapses relative to spine synapses 
during early development, as occurs during the first few postnatal weeks in the rat hippocampus 
(Boyer et al., 1998; Fiala et al., 1998).  Alternatively, several lines of experimental evidence 
suggest that the prevalence of excitatory shaft synapses may increase when dendritic spines are 
lost.  In the hippocampus, spine loss leads to an increase in the number of synapses occurring on 
dendritic shafts (Mateos et al., 2007), and an enrichment of PSD-95 in the dendritic shaft (Woods 
et al., 2011).  Whether due to a developmental disturbance or to spine loss, it is tempting to 
speculate that individuals with schizophrenia may demonstrate an increased proportion of shaft 
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synapses relative to spine synapses.  Indeed, recent electron microscopy evidence has revealed 
an increased proportion of asymmetric synapses formed with dendritic shafts in the anterior 
cingulate cortex of subjects with schizophrenia (Barksdale et al., 2012).   Future studies could 
examine if VGluT-IR boutons in the auditory cortex of subjects with schizophrenia demonstrate 
a relative increase in frequency of apposition to dendritic shaft postsynaptic densities, which 
would suggest an increased prevalence of shaft-targeting excitatory synapses.  It would also be 
of interest to determine if expression of proteins which have been shown to mediate shaft 
synapse formation, such as GRIP1 and ephrinB3 (Aoto et al., 2007), are altered in this cortical 
region.  Finally, emphasis should be placed on characterizing animal models of structural 
excitatory synapse pathology relevant to schizophrenia.  For example, models of increased 
adolescent spine elimination such as the kalirin knockout mouse (Cahill et al., 2009), could be 
evaluated to determine whether excitatory boutons persist despite reduction in cortical spine 
density, and whether the proportions of shaft and spine synapses are altered. 
The functional implications of a relative increase in shaft synapses concurrent with a 
reduction in spine synapses are not fully understood.  Spines play important roles in segregating 
frequency inputs within the auditory cortex (Chen et al., 2011b) and serve to normalize the 
magnitude of inputs occurring at different distances from the soma (Harnett et al., 2012).  In 
addition there is a reduction in dendritic length and branching in the cortex of individuals with 
schizophrenia (Glantz and Lewis, 2000; Broadbelt et al., 2002) that would be expected to alter 
excitatory input summation, EPSP magnitude (Jaslove, 1992), summation of responses at the 
soma (Shepherd et al., 1989), and neuron firing rates (Tsay and Yuste, 2004).  Determining 
whether these alterations can account for impaired frequency discrimination and reduced 
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auditory event related potentials observed in individuals with schizophrenia, however, will 
require analysis in animal models that recapitulate these structural changes.    
2.4.2 Non-glutamatergic bouton populations in auditory cortex may be affected 
Previously, we reported that the density of synaptophysin-IR puncta is reduced in deep layer 3 of 
primary auditory cortex of subjects with schizophrenia (Sweet et al., 2007).  Synaptophysin is a 
vesicular protein that is found in classical neurotransmitter-releasing boutons (Navone et al., 
1986); therefore, this finding could represent a relative density reduction of many different types 
of boutons.  We have previously determined that the density of GAD65-IR puncta is unchanged 
in deep layer 3 of primary auditory cortex (Moyer et al., 2012) (see chapter 3), and here we 
report that the densities of presumptive intracortical and thalamocortical glutamatergic boutons 
are also unchanged.  However, densities of other potential synaptophysin-IR bouton types have 
not yet been evaluated in primary auditory cortex in schizophrenia.  For example, boutons of the 
chandelier cell population of inhibitory neurons, which appear to be affected in schizophrenia 
(Lewis, 2011), have been shown to express only the 67 kDa isoform of GAD (Fish et al., 2011) 
and thus would not have been quantified in our previous study.   Also, recent evidence suggests 
that a sub-population of inhibitory boutons originating from somatostatin-expressing 
interneurons, another population which has been implicated in the neuropathology of 
schizophrenia (Morris et al., 2008), may express only GAD67 (Rocco and Fish, 2010).  Finally, 
it is possible that the densities of non-glutamatergic, non-GABAergic boutons, such as 
cholinergic, serotonergic, or dopaminergic boutons, which are present in primary auditory cortex 
(Campbell et al., 1987), are reduced in schizophrenia. 
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2.4.3 Use of VGluTs as markers of intracortical excitatory and thalamocortical boutons 
Several potential methodological limitations are important to consider. We identified 
presumptive intracortical and thalamocortical boutons on the basis of their VGluT1 and VGluT2 
immunoreactivity.  Most reports indicate complementary and non-overlapping expression of 
VGluT1 and VGluT2 in the neocortex and subcortical structures (Fremeau, Jr. et al., 2001; 
Kaneko and Fujiyama, 2002; Fremeau, Jr. et al., 2004a; Fremeau, Jr. et al., 2004b).  Congruent 
with these reports, we observed little to no colocalization of VGluT1 and VGluT2-
immunoreactivity in human and monkey auditory cortex tissue sections (Figure 2.1D and 2.1E; 
also see (Sweet et al., 2010)).   Based on this evidence, we conclude that the failure to observe 
differences in intracortical excitatory and thalamocortical bouton characteristics between control 
and schizophrenia subjects is not due to lack of specificity of the two bouton population markers.  
However, it should be noted that VGluT1 and VGluT2 can be colocalized in boutons in 
neocortical cultures and in layer 4 of the somatosensory cortex (De Gois et al., 2005; Graziano et 
al., 2008), and VGluT1 and VGluT2 mRNA expression may overlap in the medial geniculate 
nucleus (Hackett et al., 2011) (but see (Fremeau, Jr. et al., 2004b)), suggesting that both proteins 
could be coexpressed in thalamocortical projections to the auditory cortex.  Therefore, it is not 
impossible that some VGluT1-IR puncta identified in our study could actually be thalamocortical 
rather than intracortical excitatory boutons.  In addition, although the medial geniculate nucleus 
is likely to contribute the majority of subcortical inputs to the primary auditory cortex, it is 
possible that VGluT2-IR inputs from other subcortical structures are included in our presumptive 
thalamocortical bouton analyses.  For example, the rodent primary auditory cortex receives input 
from the hypothalamus and the paraventricular nuclei of the thalamus (Budinger et al., 2008).   It 
is possible that quantifying other subcortical excitatory inputs could have masked alterations 
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which are specific to VGluT2-IR boutons originating from the auditory thalamus but are not 
present in VGluT2-IR boutons from other sources. 
2.4.4 Conclusions 
In summary, we report that intracortical excitatory and thalamocortical boutons are unaltered in 
their density, number, and level of VGluT protein in deep layer 3 of primary auditory cortex of 
individuals with schizophrenia.  Thus, presynaptic excitatory boutons appear to be preserved in 
the primary auditory cortex, despite reduced density of postsynaptic dendritic spines.  Further 
investigation is needed to understand whether excitatory boutons have intact expression of 
proteins influencing glutamate release and to evaluate the functional implications of a 
discrepancy between preservation of boutons and loss of spines.  Future studies in postmortem 
human tissue and animal models will aid the development of treatments aimed at normalizing the 
function of excitatory circuitry in schizophrenia. 
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3.0  REDUCED GLUTAMATE DECARBOXYLASE 65 PROTEIN IN PRIMARY 
AUDITORY CORTEX INHIBITORY BOUTONS IN SCHIZOPHRENIA 
This chapter has been previously published as: 
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 DA, Sweet RA.  2012. Reduced glutamate decarboxylase 65 protein in primary auditory
 cortex inhibitory boutons in schizophrenia.  Biological Psychiatry, 72(9):734-43. 
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supplemental methods to the main body of the article to satisfy the requirements for this 
dissertation. 
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Background: Schizophrenia is associated with perceptual and physiological auditory 
processing impairments which may result from primary auditory cortex excitatory and inhibitory 
circuit pathology.  High-frequency oscillations are important for auditory function, and are often 
reported to be disrupted in schizophrenia. These oscillations may in part depend on up-regulation 
of GABA synthesis by glutamate decarboxylase 65 (GAD65) in response to high interneuron 
firing rates.  It is not known whether levels of GAD65 protein, or GAD65-expressing boutons, 
are altered in schizophrenia. 
Methods:  Two cohorts of subjects with schizophrenia and matched controls, comprising 
27 pairs of subjects, were studied and relative fluorescence intensity, density, volume, and 
number of GAD65 immunoreactive boutons in primary auditory cortex were measured using 
quantitative confocal microscopy and stereologic sampling methods.  Bouton fluorescence 
intensities were used to compare the relative expression of GAD65 protein within boutons 
between diagnostic groups.  Additionally, we assessed the correlation between previously-
measured dendritic spine densities and GAD65-immunoreactive bouton fluorescence intensities. 
Results:  GAD65-immunoreactive bouton fluorescence intensity was reduced by 40% in 
subjects with schizophrenia, was correlated with previously-measured reduced spine density, and 
the reduction was greater in subjects who were not living independently at time of death.  In 
contrast, immunoreactive bouton density and number were not altered in deep layer 3 of primary 
auditory cortex of subjects with schizophrenia.   
Conclusions:  Decreased expression of GAD65 protein within inhibitory boutons could 
contribute to auditory impairments in schizophrenia.  The correlated reductions in dendritic 
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spines and GAD65 protein suggest a relationship between inhibitory and excitatory synapse 
pathology in primary auditory cortex. 
3.1 INTRODUCTION 
Individuals with schizophrenia exhibit basic auditory processing deficits (McCarley et al., 1991) 
that contribute to debilitating negative and cognitive symptoms.  One such deficit is impaired 
tone frequency discrimination (Javitt et al., 2000; Leitman et al., 2010b), assessed either 
behaviorally or as reductions in the mismatch negativity (MMN) response of the auditory event 
related potential (ERP) (Javitt et al., 1994; Javitt et al., 2000; Naatanen and Kahkonen, 2009).    
The inability to properly discriminate between different frequencies may make phoneme 
identification difficult, translating to impaired speech comprehension in subjects with 
schizophrenia (Kasai et al., 2002; Javitt, 2009).  Evidence suggests that features of schizophrenia 
stemming from disrupted tone processing have a significant impact on patients’ quality of life, as 
tone matching performance is severely impaired in subjects who require long-term residential 
care (Rabinowicz et al., 2000).  Correlated with tone matching deficits, subjects with 
schizophrenia show reduced ability to use pitch-based acoustic cues to recognize vocally 
expressed emotion (Leitman et al., 2005; Leitman et al., 2010b).  Consequently, inability to 
recognize emotional components of speech, a negative symptom of schizophrenia (Shea et al., 
2007), contributes to dysfunction in social interactions (Leitman et al., 2006).  Thus, basic 
impairments in tone frequency discrimination likely impair higher-order functions downstream 
of auditory stimulus processing, contributing to some of the signs and symptoms of 
schizophrenia. 
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Studies in animals suggest that the ability to discriminate frequency depends on auditory 
cortex function (Heffner and Heffner, 1986; Rybalko et al., 2006).  The primary auditory cortex 
is located on Heschl’s gyrus, found within the Sylvian fissure on the superior temporal gyrus 
(STG).  Reduction of STG gray matter volume is one of the most consistently reported gray 
matter volume change findings in schizophrenia subjects (McCarley et al., 1999) and those who 
are genetically at-risk (Rajarethinam et al., 2004).  Specifically, findings include reductions of 
gray matter volume in Heschl’s gyrus in both cross-sectional analyses of subjects with 
schizophrenia (Hirayasu et al., 2000; Kasai et al., 2003; Salisbury et al., 2007) and longitudinal 
studies of high risk individuals (Takahashi et al., 2009).   
One measure of auditory neurophysiology known to depend on the integrity of the 
primary auditory cortex is the auditory steady state response (aSSR) (Pastor et al., 2002; Picton 
et al., 2003; Jeschke et al., 2008).  Many studies have found the aSSR to be abnormal in patients 
with schizophrenia (Kwon et al., 1999b; Brenner et al., 2003; Light et al., 2006; Spencer et al., 
2008; Krishnan et al., 2009).  SSRs are generated in response to temporally modulated stimuli, 
are based on the synchronized activity of large populations of neurons, and represent the ability 
of neural circuits to oscillate at different frequencies (Brenner et al., 2009).  Subjects with 
schizophrenia exhibit abnormal aSSR entrainment to tones and white noise bursts modulated at 
gamma-range frequencies (30-80 Hz) (Brenner et al., 2003; Hamm et al., 2011).  Individuals 
with schizophrenia also demonstrate reduced power of induced gamma-range oscillatory activity 
in response to an unmodulated pure tone (Krishnan et al., 2009).  Altered high frequency 
oscillatory activity may reflect a physiological impairment of auditory cortex circuitry that 
contributes to reduced ability to discriminate the features of auditory stimuli (Lenz et al., 2008).   
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Inhibitory γ-amino butyric acid (GABA)-ergic interneurons contribute to the generation 
of neural oscillatory activity through the production of rhythmic inhibitory postsynaptic 
potentials in excitatory neurons, inducing synchronization of their firing (Cobb et al., 1995; 
Uhlhaas and Singer, 2010).  It has been shown that rapid adjustments to levels of inhibition are 
required for controlling changes in oscillation frequency (Atallah and Scanziani, 2009).  This 
necessity of rapid adjustments to levels of inhibition suggests that modulation of the amount of 
GABA synthesized for release might be crucial for the ability of interneurons to mediate 
oscillatory activity.  The GABA-producing activity of the 65 kDa isoform of glutamate 
decarboxylase (GAD65) is rapidly upregulated via binding to its cofactor pyridoxal-5’-phosphate 
(PLP) under conditions of increased neural activity (Martin et al., 1991; Patel et al., 2006).  Mice 
lacking GAD65 demonstrate reduced GABA release during sustained activation of inhibitory 
neurons (Tian et al., 1999).  GAD65 may therefore be particularly important for rapidly 
modulating GABA synthesis to maintain gamma range oscillatory activity in the cortex during 
conditions of sustained high interneuron firing rates (Gonzalez-Burgos and Lewis, 2008).  Thus, 
impaired gamma-range oscillatory activity in auditory cortex in schizophrenia could indicate that 
GAD65-mediated GABA synthesis in inhibitory boutons is impaired in such a way as to be 
unable to keep up with the necessary high firing rates. 
In the present study, we asked whether the relative level of GAD65 protein is reduced in 
the auditory cortex of subjects with schizophrenia.  As auditory cortex circuitry is thought to 
participate in the generation of both aSSRs and the MMN component of the auditory ERP 
(Pastor et al., 2002; Picton et al., 2003; Kaur et al., 2005; Liu et al., 2007; Jeschke et al., 2008), 
and MMN reflects activity of the supragranular cortical layers (Javitt et al., 1994; Javitt et al., 
1996), we wanted to determine whether GAD65 protein was reduced in this sub-region of 
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auditory cortex, specifically at its site of action: the bouton.  To address this, we used 
quantitative fluorescence microscopy to assess levels of GAD65 protein within deep cortical 
layer 3 inhibitory boutons.  We found that whereas the number and density of GAD65-
expressing inhibitory boutons in deep layer 3 of primary auditory cortex were unaltered, these 
boutons contained less GAD65 protein, suggesting that the amount of GABA available for 
release when auditory cortex interneurons are firing at high rates may be reduced in subjects with 
schizophrenia.   
3.2 MATERIALS AND METHODS 
3.2.1 Subjects and animals 
We studied two cohorts (Table 3.1 and Appendix Table A.1) of subjects diagnosed with 
schizophrenia or schizoaffective disorder and matched controls included in our previous studies 
(Sweet et al., 2004; Sweet et al., 2007; Sweet et al., 2009; Dorph-Petersen et al., 2009b).  All of 
the brain specimens were collected during autopsies conducted at the Allegheny County Medical 
Examiner’s Office, with permission obtained from the subjects’ next-of-kin.  The protocol used 
to obtain consent was approved by the University of Pittsburgh Institutional Review Board and 
Committee for Oversight of Research Involving the Dead.  An independent committee of 
experienced clinicians made consensus diagnoses (American Psychiatric Association, 1994) for 
each subject, using information obtained from clinical records and structured interviews with 
surviving relatives.  These procedures were IRB approved.  We also studied a cohort of four 
male macaque monkeys (Macaca fascicularis) chronically exposed to haloperidol decanoate, and 
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four control macaques matched for sex and weight (Sweet et al., 2007).  All procedures were 












Table 3.1. Summary of subject characteristics for cohorts 1 and 2.  Each subject in cohorts 1 and 2 was 
previously matched to a normal comparison subject based on sex and as closely as possible for age and postmortem 
interval and group matched for handedness. There were no diagnostic group differences in age [t(52) = 0.517, p = 
0.608] or postmortem interval [t(52) = 0.584, p = 0.561] or in the distribution of handedness between diagnostic 
groups (χ2 = 1.46, df = 1, p = 0.314). Mean storage time did not differ between diagnostic groups [cohort 1: t(28) = 
0.040, p = 0.968; cohort 2: t(22) = 0.596, p = 0.557].A, ambidextrous; ATOD, at time of death; F, female; L, left-
handed; M, male; PMI, postmortem interval; R, right-handed; U, unknown.       








3.2.2 Tissue processing 
3.2.2.1 Cohort 1 tissue processing 
Brains from individuals in cohort 1 were bisected and the left hemisphere of each subject was cut 
coronally into 1-2 cm-thick blocks, which were then immersed in cold 4% paraformaldehyde in 
phosphate buffer for 48 hours, equilibrated in a series of graded sucrose solutions, and stored at  
-30oC in an antifreeze solution (30% glycerol and 30% ethylene glycol in phosphate-buffered 
saline).  Superior temporal gyrus (STG)- containing blocks were generated as described 
previously (Sweet et al., 2003; Sweet et al., 2004) and 40 µm coronal cryostat sections were cut 
and then stored in antifreeze solution at -30oC until use in this study. 
3.2.2.2 Cohort 2 tissue processing 
Brain specimens from individuals in cohort 2 were harvested, bisected, blocked coronally, and 
stored in antifreeze solution at -30oC as described for cohort 1 (Sweet et al., 2005; Dorph-
Petersen et al., 2009b).  The entirety of the left STG of each subject was dissected from the fixed 
coronal blocks.  The pial surfaces of the STG blocks were painted with hematoxylin to facilitate 
identification of the pial surface later during tissue processing, and the blocks were reassembled 
in 7% low-melt agarose in their in vivo orientation.  The reassembled STG was cut into 
systematic uniformly random 3 mm slabs orthogonal to the long axis of Heschl’s gyrus.  Every 
other slab with a random start was selected for mapping the boundaries of primary auditory 
cortex and the remaining slabs were stored in antifreeze solution until use.  Mapping slabs were 
cut on a cryostat at 60 µm, and three consecutive sections from each slab were stained for 
parvalbumin (PV) immunoreactivity, acetylcholinesterase activity, and Nissl substance.  These 
sections were used to determine whether primary auditory cortex was present in a given slab, to 
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estimate the volume of primary auditory cortex, and to delineate the boundaries of primary 
auditory cortex.  The boundaries of primary auditory cortex determined using the mapping slabs 
were applied to the unused set of slabs, such that boundaries of primary auditory cortex on a 
mapping slab were applied to the adjacent unused slab immediately rostral.  The primary 
auditory cortex was dissected from the unused slabs, and further subdivided into 3 mm wide 
blocks.  Blocks from the most rostral and caudal slabs containing the region of interest were 
weighted at 1/3 relative to the weight of other blocks to account for the fact that these blocks 
only partially contained the region of interest.  This weighting method has been previously 
published (Dorph-Petersen et al., 2009b).  Briefly, it is needed because the end blocks only 
partially represent the region of interest (on average less than half due to the positive curvature of 
the boundary of the region of interest in 3 dimensions) and therefore should not have the same 
weight as the other blocks.  However, there is no way to know the precise weight without 
knowing the exact fraction of the region of interest and the Nv of the region of interest as well as 
that of the neighboring region within each block in question. Because the positive curvature is 
best approximated by a cone or a pyramid, it would take up 1/3 of the volume, leading to our 
weighting.  Block weights were factored into calculations of bouton number (Dorph-Petersen et 
al., 2009b).  Each primary auditory cortex block was then placed pial surface down in a layer of 
optimal cutting temperature compound (OCT) on a stainless steel block.  A hollow cylinder was 
placed on the block over the tissue, and the cylinder was filled with OCT and allowed to freeze 
at -20oC.  The block of tissue encased in OCT was then removed from the cylinder and placed in 
a stainless steel well where it was randomly rotated and fixed in its orientation with OCT.  The 
primary auditory cortex block was then sectioned at 50 µm in this orientation perpendicular to 
the pial surface, and sections were stored at -30oC in antifreeze solution until use in this study. 
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3.2.2.3 Antipsychotic-exposed macaque cohort tissue processing 
In order to account for possible effects of antipsychotic medications, we studied a previously 
described cohort (Sweet et al., 2007) of four male macaque monkeys (Macaca fascicularis) 
chronically exposed to haloperidol decanoate, and four control macaques matched for sex and 
weight.  Animals received injections of haloperidol (mean (standard deviation) = 16.0 (2.1) 
mg/kg) every four weeks, maintaining trough serum levels of haloperidol of 4.3 (1.1) ng/ml, on 
average.  Following 9-12 months of haloperidol exposure, animals were euthanized with an 
overdose of pentobarbital, and brains were removed and immersed in 4% paraformaldehyde 
following a 45 min post mortem interval (PMI).  Free-floating sections from the four matched 
pairs were processed together within immunohistochemistry runs, and procedures were identical 
to those described for human tissue immunohistochemistry. 
3.2.3 Immunohistochemistry 
In order to identify axon boutons of inhibitory GABAergic neurons in the primary auditory 
cortex, we utilized an antibody directed against GAD65.  GAD65 is highly expressed in 
GABAergic boutons, with minimal expression in interneuron cell bodies (Erlander et al., 1991).  
The antibody we selected (mouse anti-GAD65 monoclonal, Millipore, MAB351) is a clone of 
the monoclonal GAD-6 antibody developed by Chang and Gottlieb that recognizes only the 
lower molecular weight band of GAD in Western blots (Chang and Gottlieb, 1988).  We have 
verified this by Western blot, and also found that this antibody does not label brain homogenate 
from GAD65 knockout mice (Figure B.1A).  In immunohistochemistry, labeling with this 
antibody has been reported to colocalize with punctate structures immunoreactive for GAD67, 
cannabinoid receptor 1 (CB1) and parvalbumin (PV) (presumably inhibitory boutons) (Fish et 
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al., 2011), and in immunoelectron microscopy has been reported to label symmetrical synapses 
(Hagiwara et al., 2005), as well as punctate structures closely apposed to puncta immunoreactive 
for the α1 subunit of the GABAA receptor (Marty et al., 2004).  Qualitatively, we observed no 
colocalization of puncta labeled with the GAD65 antibody and antibodies against vesicular 
glutamate transporters (VGluT1 and VGluT2), which label intracortical and thalamocortical 
excitatory boutons, respectively (Figure B.1B). In summary, this evidence suggests that this 
antibody is specific for GAD65, and in immunohistochemistry is specific for non-glutamatergic 
boutons and labels structures colocalized with or closely apposed to other GABAergic synaptic 
markers. 
Auditory cortex containing tissue sections from matched pairs were processed together in 
immunohistochemistry runs.  Free-floating sections were rinsed in 0.1 M phosphate buffered 
saline (PBS), and then incubated in 1% NaBH4 in phosphate buffer for 30 minutes to reduce 
tissue autofluorescence.  Sections were rinsed again in PBS and incubated for 3 hours in 
blocking buffer containing 0.3% Triton-X, 5% normal human serum, 5% normal goat serum, 1% 
bovine serum albumin, 0.1% lysine, and 0.1% glycine in PBS.  Sections were then incubated 
with a 1:500 dilution of anti-GAD65 primary antibody (MAB351) in blocking buffer for 96 
hours at 4oC.  After rinsing in PBS, sections were incubated overnight with a 1:500 dilution of 
Alexa 405 goat anti-mouse secondary antibody (Invitrogen, Carlsbad, CA).  Sections were 
rinsed, mounted on gelatin-coated slides, allowed to dry for 1 hour, rehydrated for 10 min in 
distilled water, and coverslipped with Vectashield Hard Set mounting medium (Vector 
Laboratories, Burlingame, CA). 
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3.2.4 Image collection 
Sections were coded so that the experimenter was blind to diagnostic or drug exposure group, 
and sections were organized into sets so that sections from paired subjects were imaged during 
the same imaging session.  Images were collected using a 1.42 NA 60X oil objective on an 
Olympus BX51 upright microscope (Olympus, Center Valley, PA) equipped with an Olympus 
DSU spinning disk confocal, a Hamamatsu C4742-98 CCD camera (Hamamatsu, Bridgewater, 
NJ), Olympus mercury light source, excitation/emission filter wheels, a 89000 Sedat Quad ET 
filter set (Chroma Technology Corp, Bellows Falls, VT),  and  high precision Prior Scientific 
motorized XY stage (Prior Scientific, Inc., Rockland, MD) equipped with a linear XYZ encoder 
(Ludl Electronic Products, Ltd., Hawthorne, NY).   Image collection was controlled using 
SlideBook version 4.1 software (Intelligent Imaging Innovations, Denver, CO).  At each 
sampling site, the tissue thickness (Z axis depth) was measured and recorded, and tissue 
thickness did not differ between diagnostic groups (t52 = 0.844, p = 0.402).  Image stacks were 
collected with a step size of 0.22 µm between Z axis planes in the stack, starting from 10 µm 
below the tissue surface closest to the coverglass and stepping up until the tissue surface was 
reached, yielding a 10 µm thick (Z axis depth) stack comprised of 46 individual 2-dimensional 
planes.  Collected image planes were 512 x 512 pixels with 2 x 2 binning, and exposure times 
were adjusted to optimize the spread of the intensity histogram and to ensure that none of the 
pixels in the image stack were saturated.  Although mean exposure time was not significantly 
different between diagnostic groups (Means: Control, 1643 ms; Schizophrenia, 1796 ms; t52 = 
0.45, p = 0.654), differences were corrected for by including exposure times in statistical models.   
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3.2.5 Image processing 
Collected image stacks were post-processed offline, using SlideBook and Automation Anywhere 
software (Automation Anywhere, Inc., San Jose, CA) to automate keystrokes and increase image 
processing efficiency.  Images were deconvolved with a constrained iterative algorithm using a 
calculated point spread function, a maximum of 20 iterations, 3D frequency filtering enabled, 
and Gaussian noise smoothing with a radius of 0.5.  The background fluorescence intensity of 
each smoothed and deconvolved image stack was determined as the mode value of the intensity 
histogram.  Background subtraction was done by subtracting the mode intensity (gray scale) 
value from all pixel intensities in the image stack.  This deconvolved, smoothed, and background 
subtracted image stack was then subject to intensity segmentation coupled with morphological 
selection using our iterative masking approach (Fish et al., 2008).  For each image stack, the 
initial intensity threshold was set at 105% of the background intensity level determined above, 
and with each subsequent iteration the intensity threshold was increased by 10%, until either a 
maximum of 5000 gray levels was reached or a maximum of 60 iterations occurred.  After each 
segmentation step, mask objects with volumes ranging from 0.06 µm3 to 1.0 µm3 were selected 
and merged with the mask generated in the prior segmentation step.  The resulting mask was 
then copied back onto the original image stack which had been deconvolved as described above, 
but without the Gaussian smoothing step, in order to obtain accurate pixel intensity information.  
GAD65-IR bouton data (mean intensity, mean volume) were extracted from these image stacks 
using the generated mask to identify objects of interest.  Mask objects were selected for final 
analysis if the intensity gray level range within the object (maximum voxel intensity minus 
minimum voxel intensity) was greater than 50. This further eliminated falsely detected 
background signal, as objects identified from background noise are likely to have less intensity 
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variation between highest and lowest intensity gray scale pixels.  GAD65-IR puncta were 
counted automatically by determining whether the centroid of each automatically detected object 
was inside the disector. This corresponds to the so-called “associated point rule” (Baddeley and 
Jensen, 2004, page 69), which is an unbiased alternative to the unbiased counting frame 
(Gundersen, 1977).  Guard zones of 10 pixels were applied around all edges in the X and Y 
dimensions of each stack, and 10 Z planes starting 10 planes below the coverglass were included 
in analysis, as antibody penetration was uniform (puncta counts and intensities were uniform) 
across these Z axis depths (10 planes x 0.22 µm step size = 2.20 µm disector height). 
3.2.6 Quantification of GAD65-IR puncta 
GAD65-immunoreactive (IR) boutons within deep cortical layer 3 of primary auditory cortex 
were quantified using stereologic sampling as shown in Figure 3.1.   Densities reported were 
calculated individually at each site in order to include exposure time as a covariate in our 
analyses, as exposure time varied on a site-by-site basis.  The density of mask objects at each site 
was determined by dividing the number of objects counted at each site by the product of the the 
disector height (2.2 µm) and the area of the counting frame (2553 µm2), and then multiplying 
that by the measured tissue thickness at each site divided by the cryostat block advance (40 or 50 
µm) (Dorph-Petersen et al., 2001) to correct for tissue shrinkage.  It should be noted that the 
disector height of 2.2 µm used in the current study is very low and could only be implemented 
robustly because we used confocal microscopy allowing for a high number of thin focal planes; 
and because we performed a careful analysis of the distribution of the boutons along the Z axis 
(see Fig. 4 of (Dorph-Petersen et al., 2009a)). We determined the position of the disector and 
corresponding guard zones post hoc ensuring that boutons were only sampled in the zone with 
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uniform bouton counts. Such sampling was possible due to the high number of automatically 
detected boutons—on average 23,037 boutons were detected per subject and of these an average 
of 5,742 per subject were sampled by the disector. Thus, while a disector height of only 2.2 µm 
should be avoided in a standard brightfield microscopy study with manual counts, we were able 












Figure 3.1. Sampling of glutamate decarboxylase 65-immunoreactive boutons in primary auditory cortex 
deep layer 3.  (A) Illustration of delineation of primary auditory cortex deep layer 3 on sections containing auditory 
cortex for human and antipsychotic exposed macaque cohorts. (Left) Cohort 1: Previously, every tenth section with 
a random start was selected from superior temporal gyrus blocks and processed for Nissl staining, and primary 
auditory cortex (Brodmann area 41) was identified using cytoarchitectonic criteria (Sweet et al., 2004). Three Nissl-
stained sections in which primary auditory cortex was cut perpendicular to the pial surface were selected for each 
subject, and sections adjacent to or nearby these sections were chosen for immunohistochemistry. (Middle) Cohort 
2: Four primary auditory cortex blocks per subject were selected using a systematic uniformly random sampling 
scheme (Gundersen, 2002), designed to sample four primary auditory cortex blocks from each subject with equal 
probability. The central section of each block was stained for Nissl substance and used to delineate the cortical layer 
boundaries. From each selected block, one section adjacent to or nearby the center Nissl section was used in the 
present study. (Right) Antipsychotic-exposed macaques: Left hemisphere coronal superior temporal gyrus sections 
were generated similar to cohort 1 sections. Cytoarchitectonic criteria were used to identify primary auditory cortex, 
and three primary auditory cortex containing sections from each animal were selected for immunohistochemistry 








identified on each of the adjacent Nissl-stained sections to determine the total layer 3 area for each subject. A 
contour outline (white) of the deepest one third of layer 3 was drawn in Stereo Investigator (MicroBrightField Inc., 
Colchester, Vermont). The contours were aligned with the glutamate decarboxylase 65-labeled tissue sections using 
pial surface fiduciaries traced from the Nissl-stained sections. (B) A sampling grid was generated in Stereo 
Investigator to generate 12 to 14 sampling sites for each human subject and approximately 20 sites for each 
nonhuman primate subject. The grid size was determined based on the total deep layer 3 area across all tissue 
sections for a subject and the desired number of sampling sites per subject (12 for cohort 1 and 14 for cohort 2). The 
grid was then randomly rotated over the contour, and a sampling site was marked at every intersection between the 
grid and the deep layer 3 contour (shown as counting frames for the purpose of illustration; see text for description 
of the associated point rule used in this study). (C) At each sampling site, a 10 μm-thick stack of 46 image planes, 




 For cohort 2 subjects, we were also able to estimate GAD65-IR bouton number because 
of the tissue processing methods used to generate auditory cortex tissue sections.  To do this, 
mean object densities were calculated as described in equations 4 and 5 of Dorph-Petersen et al. 
(Dorph-Petersen et al., 2009b) using the numerical density (NV) approach with the following 
modification: the distances of each individual mask object from the central axis were not 
included in the calculation under the reasonably robust assumption of homogeneity on the scale 
of the sampling site (~50 µm).  Instead, object counts at each sampling site were weighted by 
multiplying object count at each site by the distance of the sampling site from the central axis.  
Deep layer 3 volumes for each subject were calculated as described in equations 1-3 of Dorph-
Petersen et al. (2009b) by multiplying the volume fraction of deep layer 3 sampled by the total 
primary auditory cortex volume.  Bouton number for each subject was then generated by 
multiplying the NV by the total deep layer 3 volume (Dorph-Petersen et al., 2009b). 
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3.2.7 Statistical analyses 
For each human and macaque subject, mean density, fluorescence intensity, and volume of 
GAD65-IR puncta in deep layer 3 of primary auditory cortex were calculated.  Among the 
human subjects, the analyses of GAD65-IR bouton volume, density, and mean intensity were 
conducted separately using two multivariate analysis of covariance (MANCOVA) models: a 
primary model that included diagnosis and cohort as fixed effects, subject pair (nested in cohort) 
as a blocking factor, and tissue storage time and exposure time as covariates; and a secondary 
model without subject pair as a blocking factor, that included diagnosis, sex, and cohort as fixed 
effects and age, PMI, tissue storage time, and exposure time as covariates.  To help satisfy the 
normality requirement for MANCOVA models, mean fluorescence intensity was analyzed on the 
natural logarithm scale.  To account for the correlation among sampling sites within each subject 
and among sampling sites within each section for each subject, site and section nested in subject 
were included as random effects in each MANCOVA model.  Inclusion of tissue thickness, 
subject handedness, or immunohistochemistry assay order in the models had negligible impact 
on diagnostic group differences and, thus, the results reported are from MANCOVA models 
omitting these factors. 
 The analysis of GAD65-IR bouton number (cohort 2 subjects only) was conducted using 
two analysis of covariance (ANCOVA) models: a primary model that included diagnosis and 
pair as fixed effects, and tissue storage time as a covariate; and a secondary model without pair 
as a factor that included diagnosis and sex as fixed effects, and age, PMI, and tissue storage time 
as covariates.  Correlations between dendritic spine density and GAD65-IR bouton fluorescence 
intensity or density for cohort 1 subjects (as spine density measures were not available for cohort 
2 subjects) (Sweet et al., 2009) were assessed using Pearson’s correlation.   
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 Based on the mean densities, fluorescence intensities, and volumes for each subject, two 
sample t tests were used to determine the effect of the following: antipsychotic use, co-morbid 
alcohol or substance abuse, independent living status at time of death, history of cannabis use, 
death by suicide, diagnosis of schizoaffective disorder, and benzodiazepine, antidepressant, or 
anticonvulsant medication status at time of death.  In these analyses, the percent changes of 
bouton density, fluorescence intensity, and volume in subjects with schizophrenia (relative to 
normal controls) within each subject pair were the response variables of interest. 
To compare mean bouton density, fluorescence intensity, and volume between 
antipsychotic exposed and control macaques, MANCOVA models were used, each of which 
included drug treatment as a fixed effect, pair as a blocking factor, and exposure time as a 
covariate, and site and section nested in animal were included as random effects.  Due to the 
similarity of storage time within each pair, storage time was not included as a covariate. 
 All statistical tests were two-sided and conducted at the 0.05 significance level 
3.3 RESULTS 
3.3.1 GAD65-IR bouton density, intensity, and volume 
The fluorescence intensity of GAD65-IR puncta in deep layer 3 of the primary auditory cortex of 
subjects with schizophrenia was significantly decreased in both the primary (F(1, 25.2) = 12.52, p = 
0.002) and secondary statistical models F(1, 46.5) = 15.74, p = 0.0002; Figure 3.2).  Estimated 
mean (95% CI) fluorescence intensities derived from the primary model were 5.94 (5.73, 6.15) 
and 5.42 (5.21, 5.64) gray scale units on the natural logarithm scale in normal controls and 
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subjects with schizophrenia, respectively, reflecting a 40.5% reduction in relative fluorescence 
intensity in subjects with schizophrenia.   
The density of GAD65-IR puncta was not significantly altered in subjects with 
schizophrenia compared to controls, in either the primary (F(1, 24) = 0.84, p =0.369) or secondary 













 Figure 3.2. Within-bouton level of glutamate decarboxylase 65 protein is reduced in subjects with 
schizophrenia.  (A) Mean puncta fluorescence intensity for each schizophrenia-control subject pair in cohort 1 
(open circles and triangle) and cohort 2 (filled circles). Reference line represents schizophrenia = control subject 
values, where points below the line indicate a pair where control subject > schizophrenia and points above the line 
indicate schizophrenia > control subject. (B) Diagnostic group mean puncta fluorescence intensity for control (C) 
and schizophrenia (S) subjects in cohorts 1 (open bars) and 2 (gray bars). Error bars are ± SEM. (C) Representative 
projection image of glutamate decarboxylase 65-immunoreactive boutons from control subject 451 and 
schizophrenia subject 317 (cohort 1, pair 9, represented by open triangle in [A]). Scale bar represents 10 μm. Images 
are displayed across equivalent gray scale ranges. 
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The reduction of GAD65-IR puncta volume in subjects with schizophrenia relative to 
normal controls was nearly statistically significant in the primary model (F(1, 26.6) = 3.75, p = 
0.063), and was statistically significant in the secondary model (F(1, 49.6) = 4.80, p = 0.033; Figure 
3.3B).  This effect was largely driven by the cohort 2 subject pairs in both the primary (F(1, 10.7) = 
11.24, p = 0.007) and secondary (F(1, 17.8) = 10.72, p = 0.004) statistical models.  Estimated mean 
(95% CI) volumes derived from the primary model were 0.499 (0.484, 0.515) and 0.465 (0.449, 
0.481) µm3 for control subjects and subjects with schizophrenia in cohort 2, respectively, 
reflecting a 6.8% reduction in subjects with schizophrenia.  Because we suspected that the 
volume decrease in cohort 2 might be driven by the significant decrease in fluorescence 
intensity, we repeated the primary and secondary MANCOVA models for volume with mean 
intensity as a covariate, using both cohorts.   There was a highly significant effect of intensity 
(primary model: F(1,655) = 114.16, p < 0.001; secondary model: F(1,669) = 102.78, p < 0.001), but 
the effect of diagnosis on bouton volume was still significant (primary model: F(1, 25.1) = 8.39, p = 













Figure 3.3. Glutamate decarboxylase 65-immunoreactive puncta density and volume in deep layer 3 of 
primary auditory cortex of subjects with schizophrenia.  (A) (Top) Mean puncta density for each schizophrenia-
control subject pair in cohort 1 (open circles) and cohort 2 (filled circles). Reference line represents schizophrenia = 
control subject values, where points below the line indicate a pair where control subject > schizophrenia and points 
above the line indicate schizophrenia > control subject. (Bottom) Diagnostic group mean puncta density for control 
(C) and schizophrenia (S) subjects in cohorts 1 (open bars) and 2 (gray bars). (B) (Top) Mean puncta volume for 
each schizophrenia-control subject pair in cohort 1 (open circles) and cohort 2 (filled circles). Reference line 
represents schizophrenia = control subject values, where points below the line indicate a pair where control subject > 
schizophrenia and points above the line indicate schizophrenia > control subject. (Bottom) Diagnostic group mean 
puncta volume for control (C) and schizophrenia (S) subjects in cohorts 1 (open bars) and 2 (gray bars). Error bars 
are ± SEM. 
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3.3.2 Independent living status 
We found that the percent reduction in mean GAD65-IR bouton fluorescence intensity relative to 
matched controls was significantly greater for schizophrenia subjects who were not living 
independently at time of death than for those who were (t24 = 2.77, p = 0.011; Figure 3.4).  In 
contrast, there was no significant relationship between independent living status and the percent 























Figure 3.4. Relationship between independent living status of schizophrenia subjects and the reduction in 
mean glutamate decarboxylase 65-immunoreactive (GAD65-IR) bouton fluorescence intensity.  The percent 
change in GAD65-IR bouton fluorescence intensity in subjects with schizophrenia is significantly greater in pairs 
where the schizophrenia subject was not living independently at time of death [t(24) = 2.77, p = 0.011]. Horizontal 
lines indicate mean pairwise percent change relative to control subjects. Gray dashed line indicates zero percent 
change. There was no significant relationship between independent living status and percent change in GAD65-IR 





3.3.3 Clinical factors 
We tested for associations between GAD65-IR mean bouton density, fluorescence intensity, or 
volume and a number of clinical factors.  We identified a significantly greater percent increase in 
GAD65-IR bouton density in subjects who were taking benzodiazepines at time of death (See 
Appendix B.1 and Appendix Figure B.2 for details).   
3.3.4 Correlation between dendritic spine density and GAD65-IR bouton fluorescence 
intensity and density in cohort 1 subjects 
Given the importance of balanced excitatory and inhibitory neurotransmission in neural 
processing of auditory stimuli (Wehr and Zador, 2003; Wu et al., 2008), and in modulating 
neural oscillations (Atallah and Scanziani, 2009), we hypothesized that there are concurrent 
reductions in inhibitory and excitatory components of primary auditory cortex circuitry.  We 
examined whether GAD65-IR bouton mean intensity was correlated with previously measured 
spinophilin-IR puncta density in deep layer 3 of primary auditory cortex for cohort 1 subjects 
(Sweet et al., 2009).  We found that GAD65-IR bouton fluorescence intensity is significantly 
correlated with dendritic spine density in this cohort of subjects (r = 0.525, p = 0.003; Figure 
3.5A).  The strength of the correlation was observed to be greater for schizophrenia subjects 
compared to control subjects (Control: r = 0.379, p = 0.162; Schizophrenia: r = 0.505, p = 0.055).  
In addition, we found a significant correlation between the percent changes in GAD65-IR puncta 
fluorescence intensity and dendritic spine density in schizophrenia subjects (r = 0.745, p = 0.001; 
Figure 3.5B).  Similarly, we observed a correlation between GAD65-IR bouton density and 
spinophilin-IR spine density (r = 0.457, p = 0.01; Appendix Figure B.3).  The strength of this  
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correlation was also greater for schizophrenia subjects than control subjects (Control: r = 0.351, 
p = 0.2; Schizophrenia: r = 0.583, p = 0.02).  Finally, the percent reductions in GAD65-IR 
boutons and spinophilin-IR spine densities in schizophrenia subjects relative to controls were 





Figure 3.5. Correlations between mean and percent change in glutamate decarboxylase 65-immunoreactive 
(GAD65-IR) puncta fluorescence intensity and spine density in primary auditory cortex.  (A) Mean GAD65-IR 
puncta fluorescence plotted as a function of spinophilin-immunoreactive (IR) puncta density for each subject in 
cohort 1. Open circles = control subject, filled circles = schizophrenia subject. Dashed line represents the regression 
line. (Pearson r = 0.525, p = 0.003). (B) The percent change in GAD65-IR puncta mean fluorescence intensity 
plotted as a function of the percent change in spinophilin-IR puncta density for pairs in cohort 1 (schizophrenia 




3.3.5 Estimation of GAD65-IR bouton number in cohort 2 subjects 
We were able to estimate the total number of GAD65-IR puncta in primary auditory cortex deep 
layer 3 for the 12 subject pairs of cohort 2 and found that the absolute numbers of GAD65-IR 
boutons were not altered in schizophrenia in either the primary (F(1, 10) = 0.644, p = 0.441) or 
secondary (F(1, 18) = 0.065, p = 0.802) ANCOVA models (Figure 3.6).  Because of the 
differences in tissue processing methods, we were not able to estimate bouton number in subject 





Figure 3.6. Glutamate decarboxylase 65-immunoreactive puncta number in deep layer 3 of primary auditory 
cortex of subjects with schizophrenia.  (Left) Mean puncta number for each schizophrenia-control subject pair in 
cohort 2. Reference line represents schizophrenia = control subject values, where points below the line indicate a 
pair where control subject > schizophrenia and points above the line indicate schizophrenia > control subject. 






Figure 3.7. Chronic antipsychotic exposure does not alter glutamate decarboxylase 65-immunoreactive 






3.3.6 Antipsychotic exposed monkeys 
We observed no effect of chronic haloperidol exposure on relative fluorescence intensity 
(F(1,3)=1.72; p=0.281), density (F(1, 18.6)=0.51; p=0.483), or volume (F(1, 2.88)=2.82; p=0.195) of 
GAD65-IR puncta in deep layer 3 of primary auditory cortex (Figure 3.7). 
3.4 DISCUSSION 
We found that GAD65-IR bouton fluorescence intensity was decreased within deep layer 3 in 27 
subjects with schizophrenia relative to matched control subjects.  Because the intensity data that 
we collect using our microscopy and image processing methods are linearly related to underlying 
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object fluorophore content (Fish et al., 2008), we interpret the decrease in bouton fluorescence 
intensity as a decrease in within-bouton GAD65 protein content.  However, caution must be used 
in interpretation of the magnitude of protein reduction, as the stoichiometry of the binding of this 
antibody to GAD65 protein in tissue is not known for certain to be linear.  The reductions in 
GAD65-IR bouton fluorescence and decreased spine density were correlated within subjects in 
the 15 subject pairs for whom both measures were available.   Finally, we report that the 
reductions in GAD65-IR bouton fluorescence intensity were larger in those subjects who were 
not living independently at time of death. 
3.4.1 GAD65 protein studies 
The few prior studies that have examined GAD65 protein levels in the cortex of subjects with 
schizophrenia report mixed results.  Assessments of protein by Western blot suggest that GAD65 
protein level is unchanged in prefrontal and occipital cortices in subjects with schizophrenia 
(Guidotti et al., 2000; Dracheva et al., 2004), and one study in temporal cortex reported a non-
significant 27% decrease in GAD65 compared to controls (Impagnatiello et al., 1998).  
Differences between these reports of GAD65 protein levels and our own could be due to cohort-
specific differences in subject characteristics such as age and post-mortem interval, but most 
likely can be attributed to the different methods used.  We may have observed a larger reduction 
in GAD65 protein expression because in contrast to the Western blot studies where GAD65 
protein from a less specific region was analyzed, we measured GAD65 protein at its site of 
action within boutons. For example, in a recent study using a similar approach to assess GAD67 
protein, a larger deficit was found within boutons than within total gray matter when both were 
assessed in the same subjects (Curley et al., 2011).  A potential biological explanation for the 
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discrepancy between total gray matter and within-bouton levels of GAD65 and GAD67 protein 
is that transport of GAD65/67 protein from the soma to the axon bouton is impaired in subjects 
with schizophrenia.  This could result in relatively normal levels of protein detected unless 
within-bouton protein levels are examined exclusively.  Future immunohistochemistry studies 
could test this possibility by quantifying GAD65 fluorescence within the somata of inhibitory 
neurons.  Another possible source of discrepancy is that different cortical regions were 
examined, and reduction of GAD65 protein may not occur universally, but may be more 
pronounced in auditory cortex.  Future studies will be necessary to evaluate whether reduced 
GAD65 protein within inhibitory boutons is specific to deep layer 3 or is a feature across cortical 
layers in primary auditory cortex and other regions. 
3.4.2 GAD65-IR bouton density, number, and volume 
We found that the density of GAD65-IR inhibitory boutons was unaltered in deep layer 3 of 
primary auditory cortex, despite significantly reduced bouton fluorescence intensity.  Our finding 
that GAD65-IR bouton density is unchanged in schizophrenia agrees with a previous report that 
GAD65-IR puncta density is unaltered in the anterior cingulate and prefrontal cortices (Benes et 
al., 2000).  A potential difficulty in interpreting a lack of change in bouton density between 
groups is that gray matter volume, particularly in the STG, is consistently reported to be reduced 
in schizophrenia (McCarley et al., 1999; Hirayasu et al., 2000; Kasai et al., 2003; Rajarethinam 
et al., 2004; Salisbury et al., 2007; Takahashi et al., 2009).  Therefore, even though we identified 
no change in bouton density in schizophrenia, it is possible that the number of boutons is 
reduced, and an accompanying reduction in regional gray matter volume masks this effect when 
bouton density is calculated—this is known as “the reference trap” (Braendgaard and Gundersen, 
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1986).  The stereological techniques described in Dorph-Petersen et al. (Dorph-Petersen et al., 
2009b) that we used to generate the tissue sections for cohort 2 allowed us to systematic 
randomly sample the entire primary auditory cortex.  Our previous study showed no significant 
reduction in auditory cortex layer 3 gray matter volume in schizophrenia (Dorph-Petersen et al., 
2009b).  Similarly, using unbiased stereological principles of sampling we estimated the number 
of GAD65-IR boutons in auditory cortex deep layer 3 for each subject and found that the 
absolute numbers of GAD65-IR boutons were not altered in schizophrenia.   
We identified a reduction in mean bouton volume in subjects with schizophrenia, which 
was significant within one cohort (cohort 2) of schizophrenia subjects relative to matched 
controls.   Given the difference between control and schizophrenia subject GAD65-IR bouton 
fluorescence intensity in cohort 2 pairs, we tested whether reduced intensity mediated the 
reduction in volume. Instead, we found that after correcting for bouton fluorescence intensity the 
association of reduced GAD65-IR bouton volume with schizophrenia was strengthened.    This 
evidence suggests that the reduction in GAD65-IR bouton volume is not fully attributable to 
reduced GAD65 fluorescence intensity and may be an effect of schizophrenia.  If so, reduced 
bouton volume may further contribute to inhibitory bouton impairment and lead to reduced 
inhibitory neurotransmission, as bouton size is positively correlated with the number of active 
zones (Ruiz et al., 2011; Chen et al., 2011a).  However, caution must be used in the 
interpretation of this finding, as reduced bouton volume in schizophrenia subjects was only 
observed in one of our two cohorts studied. 
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3.4.3 Clinical factors 
We assessed the association between GAD65-IR bouton alterations and a number of clinical 
factors, including whether the subject had a diagnosis of schizoaffective disorder or 
schizophrenia, died by suicide, was living independently at time of death, had a history of 
cannabis use or alcohol or other substance abuse.  We found that the percent reduction in 
GAD65-IR bouton fluorescence intensity was greater in those subjects who were not living 
independently at time of death.  One study has shown that tone matching ability is particularly 
impaired in schizophrenia subjects who require long-term residential care (Rabinowicz et al., 
2000), and reductions in auditory MMN amplitude are correlated with impairments in daily 
function in patients (Rasser et al., 2011).  Social perception and emotion responsivity are 
independently correlated with functional outcome in schizophrenia patients (Mathews and Barch, 
2010).  Taken together, these findings indicate that reduction of GAD65 protein levels within 
inhibitory boutons, auditory processing, and social and emotional cognition are all associated 
with poor functional outcome in schizophrenia. 
A number of our subjects were taking antipsychotics, benzodiazepines, antidepressants, 
or anticonvulsant medications at time of death.   For a discussion of the association of these 
medications with GAD65 bouton characteristics see Appendix B.2 Discussion.  
3.4.4 Implications for regulation of the synthesis of GABA by GAD65 in schizophrenia 
GAD65 exists predominantly in the inactive apoenzyme form and readily associates with 
synaptic vesicle membranes (Chang and Gottlieb, 1988), localizing it to the presynaptic bouton 
where it is available to synthesize GABA for release.  Association of inactive GAD65 with its 
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cofactor PLP to form the active holoenzyme form of GAD65 is promoted by increased 
metabolism during periods of synaptic activity (reviewed in (Martin et al., 1991)).  GAD65 thus 
serves as a molecular switch, allowing GABA synthesis to be up-regulated during conditions of 
high GABA demand, i.e. during periods of high interneuron firing rates (Tian et al., 1999).  
Impairments in inhibitory transmission during increased neuronal activity have been 
demonstrated in GAD65 knockout mice, which despite having no difference in baseline levels of 
GABA (Asada et al., 1996), exhibit impaired neural plasticity (Choi et al., 2002) and behavioral 
deficits (Kash et al., 1999).  Our finding of reduced GAD65 protein within inhibitory boutons in 
schizophrenia therefore suggests that up-regulation of GABA production would be impaired 
when interneurons fire at high rates, leading to depletion of GABA and depression of inhibitory 
synapses under these conditions. 
3.4.5 Implications for specific inhibitory neuron populations 
Evidence suggests that GAD65 is the predominant GAD isoform expressed in the cannabinoid 
(CB1) receptor-IR boutons of cholecystokinin (CCK) expressing interneurons, whereas GAD65 
and GAD67 are co-expressed in the boutons of parvalbumin (PV) -IR basket cells and GAD67 is 
the predominant isoform in the axon cartridges of chandelier neurons (Fish et al., 2011).  
Therefore, reduced GAD65 protein expression in CCK boutons is likely to greatly impair the 
function of these interneurons.  Activating CB1 receptors decreases GABA release from CCK-IR 
neurons, and disrupts the M100 component of auditory evoked potentials, as well as 
hippocampal and cortical theta and gamma range oscillatory activity in rats (Hajos et al., 2000).  
Further, reduced event related gamma activity is observed in chronic cannabis users (Edwards et 
al., 2009), paralleling electrophysiological disruptions observed in schizophrenia (Javitt et al., 
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1994; Kwon et al., 1999b; Brenner et al., 2003; Light et al., 2006; Spencer et al., 2008; Krishnan 
et al., 2009; Hamm et al., 2011).  Decreased GAD65 protein within CCK boutons would reduce 
GABA available for release from these neurons, which would have a similar effect to that of 
CB1 receptor agonists, suggesting that such an alteration could at least in part be responsible for 
the disrupted oscillatory activity and auditory evoked potentials associated with schizophrenia.  
Reduced GAD65 protein could also impair PV-IR basket cell function.  PV-IR basket cells 
exhibit high firing rates (reviewed in (Markram et al., 2004)), a condition under which GAD65 is 
thought to be necessary for maintaining adequate levels of GABA needed for release (Tian et al., 
1999; Patel et al., 2006). These fast-spiking interneurons are important for modulating the 
responses of primary auditory cortex pyramidal neurons to auditory stimuli (Wu et al., 2008) and 
for the induction of gamma oscillations (Cardin et al., 2009; Sohal et al., 2009), which are 
abnormal in schizophrenia.  In contrast, chandelier cells, the terminals of which express 
predominantly GAD67 (Fish et al., 2011), would probably be less affected by reduced GAD65 
protein than PV-IR and CCK-IR interneurons.  Taken together, impairment of GABA release as 
the result of decreased GAD65 protein in CCK-IR and PV-IR boutons may contribute to some 
features of abnormal auditory cortex function and auditory processing in schizophrenia.  Future 
studies determining whether reduced GAD65 expression is common to all GABAergic boutons 
in schizophrenia or specific to a certain population of interneurons will provide more information 
as to how reduced within-bouton expression of GAD65 protein impacts inhibitory neuron 
circuitry in schizophrenia. 
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3.4.6 Impaired GAD65-mediated GABA synthesis could disrupt auditory processing 
Impaired GABAergic neurotransmission resulting from loss of GAD65 may impair the 
processing of stimuli in auditory cortex.  Altering inhibition impairs the frequency tuning and 
response properties of auditory cortex neurons (Chen and Jen, 2000; Wang et al., 2000; Wang et 
al., 2002).  An auditory stimulus elicits both excitation and inhibition in auditory cortex which 
shape the postsynaptic response to the stimulus.  Inhibition which roughly balances excitation 
contributes to the frequency selectivity of pyramidal neurons by scaling down the level of 
excitation in response to non-characteristic frequencies (Wehr and Zador, 2003) and by 
narrowing the tuning curve of the postsynaptic response through a lateral inhibition mechanism 
(Wu et al., 2008).  Reduced inhibition caused by reduced GAD65 in schizophrenia may broaden 
frequency tuning of auditory cortex neurons and thus, impair stimulus discrimination.  
 Reduced GABA available for release resulting from loss of GAD65 protein could also 
contribute to alterations in gamma-range aSSRs to modulated tones and noise measured in 
subjects with schizophrenia (Krishnan et al., 2009; Hamm et al., 2011).  Rapid adjustments in 
levels of inhibition balance large fluctuations in excitation during gamma oscillations and 
regulate the oscillation frequency (Atallah and Scanziani, 2009; Mann and Mody, 2010).  If 
insufficient GABA is available for release during this process due to reduced GAD65 protein, 
this could lead to the reductions of gamma band power and phase synchrony in schizophrenia 
(Krishnan et al., 2009).  Interestingly, in human visual cortex, GABA concentration is directly 
proportional to the frequency of gamma oscillations, and is inversely related to stimulus 
discrimination threshold (Edden et al., 2009).  If the same is true for auditory cortex, reduced 
GABA synthesis resulting from decreased GAD65 protein may contribute to disruptions in 
gamma oscillations and auditory discrimination impairments in schizophrenia.   However, the 
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relationship between steady state GABA levels and GAD65 protein remains to be determined, 
and studies of GABA levels in human cortex in report conflicting findings (Choe et al., 1994;  
Stanley et al., 1995; Yoon et al., 2010). 
3.4.7 Reduced GAD65 protein levels may compensate for reduced excitatory activity 
We observed a correlation between GAD65-IR bouton fluorescence intensity and dendritic spine 
density reductions, a finding that is consistent with other studies which have demonstrated that 
GAD expression and spine density are often co-regulated in cerebral cortex.  Additionally, we 
found that dendritic spine density and percent reduction were significantly correlated with 
GAD65-IR bouton density and percent reductions in schizophrenia subjects.  Reduced dendritic 
spine density occurs in multiple cortical regions in schizophrenia (Lewis and Sweet, 2009), and 
reduced expression of GABAergic markers is also conserved across cortical regions (Lewis et 
al., 2005; Hashimoto et al., 2008; Fung et al., 2010).  Further, correlation between expression 
levels of excitatory and inhibitory synapse markers in the prefrontal cortex appears to be stronger 
in schizophrenia subjects than in controls (Fung et al., 2011).  We also observed stronger 
correlations between spine density and both within-bouton GAD65 protein and GAD65-IR 
bouton density in schizophrenia subjects compared with control subjects.  This raises the 
possibility that reduced inhibition and reduced spine density are related pathologies in 
schizophrenia.   
Several lines of evidence indicate that reducing or disrupting GAD activity can have 
stability-promoting effects on dendritic spines.  Monocular deprivation results in elimination of 
spines in layer 2/3 of visual cortex, but when GAD65 is disrupted, monocular deprivation-
induced loss of spines does not occur (Mataga et al., 2004).  Further, GAD65 knockout mice are 
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reported to have elevated spine density (Mataga et al., 2004), and spine density increases when 
cultured neurons are exposed to the GAD inhibitor mercaptopropionic acid (Murphy et al., 
1998).  Conversely, studies using a variety of methods have demonstrated that reducing neuronal 
activity or sensory input decreases expression of GAD (Hendry and Jones, 1988; Welker et al., 
1989; Patz et al., 2003; Hartman et al., 2006).  Therefore, our finding of correlated reductions in 
within-bouton GAD65 protein and spine density would be unlikely to indicate that reduced 
GAD65 expression causes spine loss in schizophrenia. Instead, reduced excitatory drive from the 
loss of dendritic spines may lead to a compensatory reduction in GAD65 protein expression.  
This could be evaluated by determining whether a reduction in within-bouton GAD65 expression 
occurs subsequent to accelerated loss of spines, e.g. during normal adolescent spine pruning 
(Huttenlocher, 1979; Rakic et al., 1986) or in animal models of adolescent onset spine reduction 
(Cahill et al., 2009). 
3.4.8 Conclusions 
In summary, our study is the first to find that GAD65 protein levels are reduced within GAD65-
expressing boutons of primary auditory cortex in subjects with schizophrenia.  This reduction 
may impair inhibitory transmission auditory processing, causing impaired oscillatory activity and 
disrupting stimulus discrimination.  Understanding the cell types in which GAD65 expression is 
reduced in schizophrenia will be important for the future design of therapies directed at this 
pathological feature.  Similarly, studies that investigate the temporal relationship between 
GAD65 protein and excessive dendritic spine loss will be important to determine how to best 
target these features for prevention.   
 104 
4.0  DEVELOPMENTAL TRAJECTORIES OF EXCITATORY SYNAPTIC 
STRUCTURES AND WITHIN-BOUTON GAD65 PROTEIN IN MOUSE AUDITORY 
CORTEX BETWEEN EARLY ADOLESCENCE AND YOUNG ADULTHOOD 
 
Abstract 
Schizophrenia onset often occurs during adolescence and young adulthood, leading to the 
hypothesis that an increase in the normal pruning of excitatory synapses that occurs in the cortex 
during adolescence contributes to symptom development.  Previously, we have identified 
disruptions of dendritic spines and within-bouton levels of GAD65 protein in the primary 
auditory cortex of individuals with schizophrenia, suggesting that excitatory and inhibitory 
synapse pathology could be related.  Based on this relationship between alterations of dendritic 
spines and GAD65 protein levels in schizophrenia, we wanted to determine whether decreases in 
levels of GAD65 occur subsequent to spine pruning in auditory cortex during adolescence.  We 
used immunohistochemistry and quantitative fluorescence microscopy to measure spines, 
VGluT1-expressing excitatory boutons and GAD65-expressing inhibitory boutons at 4, 8 and 12 
weeks postnatal in auditory cortex of wild type mice and mice lacking kalirin, a protein which is 
implicated in schizophrenia and is important for adolescent spine development in frontal cortex.  
We observed reductions in numbers of spines and VGluT1-positive boutons in auditory cortex 
between early adolescence and young adulthood, consistent with other reports of excitatory 
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synapse pruning in mice.  We observed a decrease in levels of within-bouton GAD65 protein 
between late adolescence and young adulthood, suggesting that spines and GAD65 protein levels 
undergo coordinated reductions during adolescence as well as in schizophrenia.  Surprisingly, 
there were only subtle alterations in spines and excitatory boutons in mice lacking kalirin, 
indicating that molecular regulators of spine pruning may be slightly different in auditory 
compared to frontal cortex.  Future work is necessary to explore whether adolescence represents 
a developmental window when synapses are vulnerable to schizophrenia pathophysiology as 
well as accessible to preventative measures. 
4.1 INTRODUCTION 
The onset of schizophrenia symptoms typically occurs during late adolescence and young 
adulthood (Tandon et al., 2009), an observation which has led to the hypothesis that abnormal 
adolescent developmental processes in regions undergoing relatively protracted maturation may 
contribute to the emergence of schizophrenia symptoms (Feinberg, 1982; McGlashan and 
Hoffman, 2000).  Imaging studies have shown evidence for accelerated gray matter loss around 
the time of first psychotic episode (Kasai et al., 2003; Pantelis et al., 2007). A key adolescent 
neurodevelopmental process is the pruning of synapses in the cortex, where synapse density 
peaks prior to adolescence, then declines during adolescence before reaching adult levels 
(Huttenlocher, 1979; Rakic et al., 1986; Zecevic et al., 1989; Glantz et al., 2007).  Reduced 
dendritic spine density is a feature of multiple brain regions in schizophrenia, including auditory 
cortex (Sweet et al., 2009). Abnormal or excessive synapse pruning during adolescence could 
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cause reduced dendritic spine density and decreased gray matter volume in individuals with 
schizophrenia (Bennett, 2011).   
Schizophrenia is associated with disruptions in both excitatory and inhibitory cortical 
synapses (Lewis, 2009; Penzes et al., 2013), and alterations in markers for inhibitory 
neurotransmission are reported in several cortical regions in schizophrenia (Hashimoto et al., 
2008).  In the primary auditory cortex of subjects with schizophrenia, we have shown that 
within-bouton protein levels of the 65 kDa isoform of glutamate decarboxylase (GAD65) are 
reduced, and that this reduction is correlated with reduced dendritic spine density (Moyer et al., 
2012) (see chapter 3).  This raises the possibility that reduced inhibition and reduced spine 
density are related features of auditory cortex pathology in schizophrenia.  However, evidence 
for co-existence of excitatory and inhibitory synapse disruption in schizophrenia does not reveal 
whether a primary reduction in spine density could lead to secondary changes in inhibitory 
boutons, or vice versa.   
GAD65 expression has been shown to be activity dependent (Wei and Wu, 2008).  If 
reduced spine density in individuals with schizophrenia is indicative of altered excitatory circuit 
activity, expression of GAD65 may be affected as a consequence.  Studies have demonstrated 
that decreased neuronal activity or sensory input are associated with reduced expression of GAD 
(Hendry and Jones, 1988; Welker et al., 1989; Patz et al., 2003).  Thus, dendritic spine loss in 
auditory cortex in subjects with schizophrenia could precipitate a reduction in within-bouton 
GAD65 protein.  On the contrary, there is a lack of support for the reverse direction and 
experimental evidence suggests that a primary decrease in GAD65 would be unlikely to cause 
decreased spine density.  For example, it has been shown that GAD65 KO mice, which exhibit 
decreased inhibitory transmission during sustained neuronal activity (Tian et al., 1999), are 
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reported to have elevated, rather than reduced, dendritic spine density (Mataga et al., 2004).  
Also, spine density increases when cultured hippocampal neurons are exposed to 
mercaptopropionic acid, a GAD inhibitor (Murphy et al., 1998).  Together, this suggests that if a 
causal relationship between reduced spine density and GAD65 expression exists, it is unlikely 
that reduced GAD65 expression would cause spine loss in individuals with schizophrenia.  
Rather, reduced spine density in individuals with schizophrenia may lead to a subsequent 
reduction in GAD65 levels.   
Adolescence is a time when a relationship between spines and GAD65 may be 
particularly dynamic, as this is when pruning of spines occurs.  If changes in GAD65 levels 
occur subsequent to spine pruning during this time, then increased pruning during adolescence 
may also lead to reduced GAD65 levels in individuals with schizophrenia.  Therefore, 
adolescence may be a period during which preventative interventions to reduce spine loss and 
inhibitory bouton impairment in auditory cortex could be implemented.  However, we must first 
understand the anatomical and molecular changes of auditory cortex excitatory and inhibitory 
synapses that result from spine pruning.   
The molecular mechanisms regulating excitatory synapse pruning during adolescence in 
the cortex are largely unknown, although factors involved in regulating spine stability and 
elimination could potentially be involved (Tada and Sheng, 2006).  Knock-out (KO) mice for the 
gene encoding the protein kalirin have an adolescent-onset deficit in dendritic spine density in 
frontal cortex (Cahill et al., 2009).  Kalirin is a guanine nucleotide exchange factor (GEF) 
localized to spines and dendrites in the brain, and is responsible for activation of Rho GTPases, 
such as Rac1 (Penzes and Jones, 2008), which increases dendritic spine stability and spine 
growth (Yoshihara et al., 2009a).  In the auditory cortex of subjects with schizophrenia, protein 
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levels of the kalirin-9 isoform are increased (Deo et al., 2012), while studies in frontal cortex 
suggest that kalirin levels may be reduced (Hill et al., 2006; Rubio et al., 2012). Therefore, we 
sought to determine whether kalirin loss has an effect on adolescent synapse pruning in auditory 
cortex of mice, as it does in frontal cortex. 
In the present study, we hypothesized that within-bouton GAD65 protein levels decline 
subsequent to adolescent spine pruning in the primary auditory cortex.  To evaluate this, we 
quantified the trajectories of excitatory and inhibitory synapse components in the superficial 
layers of the mouse primary auditory cortex between early adolescence and young adulthood.  
To model the effects of a genetically mediated dendritic spine disruption during adolescent 
auditory cortex development, we also quantified markers of spines, and excitatory and inhibitory 
boutons across adolescence in the kalirin KO mouse.  We found that levels of GAD65 protein 
within inhibitory boutons decrease between late adolescence and young adulthood in wild type 
mouse auditory cortex, subsequent to the onset of excitatory synapse pruning.  Kalirin KO mice 
did not demonstrate reduced spine number compared to WT mice, and demonstrate no decrease 
in spine number between early adolescence and young adulthood, suggesting that adolescent 
spine pruning is disrupted in the absence of kalirin.  These findings provide clues to the 
molecular processes that may be important for normal adolescent development of excitatory and 
inhibitory synapses in auditory cortex and how disruptions in adolescent synapse pruning can 
contribute excitatory and inhibitory synapse pathology in schizophrenia. 
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4.2 MATERIALS AND METHODS 
4.2.1 Experimental animals 
Experiments were carried out using kalirin knockout (KO) and wild type (WT) mice.  KO mice 
were generated as described previously by inserting the neomycin resistance cassette in place of 
exons 27-28, the site of the GEF1 domain (Cahill et al., 2009).  Mice were rederived on the 
C57Bl/6NJ background at The Jackson Laboratory.  Heterozygous breeders were crossed to 
generate KO and WT experimental animals.  Animals were identified with metal ear tags and tail 
snip DNA samples were obtained for genotyping prior to weaning at approximately postnatal 
day 24.  Only male animals were included in experiments because of the effects of estrogen on 
dendritic spine density and GAD protein (Murphy et al., 1998), and its interactions with kalirin 
(Ma et al., 2011).  Animals were housed in standard microisolator caging in groups of up to 4, 
maintained on a 12 hour light / dark cycle (lights on at 7 a.m.) and were provided with food and 
water ad libitum.  Cohorts of mice were used for behavioral testing (see chapter 5) and then 
sacrificed at postnatal day 31, 58, or 85 +/- 4 days (hereafter referred to as 4, 8, and 12 weeks of 
age).  These ages correspond in general to early adolescence, late adolescence, and young 
adulthood in rodents (Spear and Brake, 1983; Spear, 2000; Kilb, 2012). All experimental 
procedures were approved by the Institutional Animal Care and Use Committee at the University 
of Pittsburgh. 
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4.2.2 Tissue generation 
Mice were weighed and deeply anaesthetized with Nembutal (150 mg/kg) and transcardially 
perfused with ice cold normal saline.  Brains were rapidly extracted, bisected, and left 
hemispheres were immersed in 4% paraformaldehyde for 48 hours at 4oC.  Hemispheres were 
allowed to sink in a 30% sucrose solution before being coronally sectioned at 40 µm on a 
cryostat.  Sections were stored in ethylene glycol cryoprotectant at -30oC until use.  Brains from 
6 animals per genotype x age group were analyzed. 
4.2.3 Auditory cortex mapping 
Every sixth section was stained for Nissl substance using a 0.1% thionin solution in acetate 
buffer to identify primary auditory cortex and laminar boundaries.  Animals were blocked into 
groups of six (one genotype x age group member per block) and coded during mapping so that 
the investigator was blind to genotype and age group.  Area Au1 was identified on the Nissl 
sections using a mouse brain atlas (Paxinos and Franklin, 2004).  Using StereoInvestigator 
(MicroBrightField), a contour outline of cortical layers 2 through 4 was drawn, and the volume 
of these layers in left hemisphere Au1 was estimated for each subject (Figure 4.1A).  Three 
auditory cortex containing sections per subject were randomly selected, and adjacent sections 







All sections were processed in a single immunohistochemistry assay run.  Sections were rinsed 
in 0.1 M phosphate buffer, and incubated in 1% NaBH4 in phosphate buffer for 30 minutes to 
reduce tissue autofluorescence.  Sections were thoroughly rinsed and incubated for 3 hours in 
blocking buffer containing 5% normal goat serum, 1% bovine serum albumin, 0.1% lysine, 0.1% 
glycine, and 0.3% Triton-X.  The sections were incubated overnight at 4oC in blocking buffer 
containing unconjugated goat anti-mouse monovalent Fab-fragment IgG to reduce goat anti-
mouse secondary antibody labeling of blood vessels.  Sections were then incubated for 48 hours 
in blocking buffer containing the primary antibodies: anti-spinophilin antibody raised in rabbit at 
1:1,000 (Millipore, Billerica, MA), anti-VGluT1 antibody raised in guinea pig at 1:250 
(Millipore, Billerica, MA), anti-GAD65 antibody raised in mouse at 1:250 (Millipore, MAB351).  
Following the primary incubation, sections were rinsed and incubated for 24 hours at 4oC in 
secondary antibody solution in blocking buffer: Alexa Fluor 488 conjugated anti-rabbit antibody 
raised in goat at 1:500 (Invitrogen, Carlsbad, CA), biotinylated anti-guinea pig antibody raised in 
goat at 1:200 (Vector Laboratories, Burlingame, CA), Alexa Fluor 405 conjugated anti-mouse 
antibody raised in goat at 1:500 (Invitrogen, Carlsbad, CA).  Sections were rinsed again and 
incubated in 1.5 µl/ml Alexa Fluor 568 conjugated phalloidin and 1:500 dilution of Alexa Fluor 
647 conjugated streptavidin for 24 hours at 4oC.  Finally sections were rinsed again, mounted on 
gel coated slides, allowed to dry for 1 hour at room temperature, rehydrated for 10 min and 







Figure 4.1. Example of contouring of layers 2 through 4 of mouse area Au1, blind deconvolution of 
immunoreactive puncta, and schemating depicting overlap of phalloidin and spinophilin labels for dendritic 
spine quantification.  A.Coronal section stained for Nissl substance.  An outline including cortical layers 2, 3, and 4 
of area Au1 is shown in red. B. Projection image taken from a confocal Z stack after blind deconvolution, showing 
puncta fluorescently labeled to identify f-actin (red), spinophilin (green), and VGluT1 (blue) in the left image, and 
VGluT1 (red) and GAD65 (green) in the right image.  Scale bar is 10 µm. C. Enlargement of presumptive spine 
from image in B and illustration of overlap between spinophilin and f-actin immunoreactivity.  At least one voxel of 
overlap was required to include an immunoreactive object as a spine in our analysis. 
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4.2.5 Microscopy 
Image collection was carried out using an Olympus (Center Valley, PA) BX51 WI upright 
microscope equipped with an Olympus DSU spinning disk confocal, super corrected Olympus 
PlanAPON 1.42 N.A. oil immersion objective, ORCA-R2 CCD camera (Hamamatsu, 
Bridgewater, NJ), MBF CX9000 front-mounted digital camera (MicroBrightField, Inc., Natick, 
MA), BioPrecision2 XYZ motorized stage with linear XYZ encoders (Ludl Electronic Products, 
Ltd., Hawthorne, NY), excitation and emission filter wheels (Ludl Electronic Products, Ltd., 
Hawthorne, NY), Sedat Quad 89000 filter set (Chroma Technology Corp., Bellows Falls, VT) 
and Lumen 220 metal halide lamp (Prior Scientific, Rockland, MA).  The microscope was 
controlled using StereoInvestigator (MicroBrightField, Inc.) and SlideBook (Intelligent Imaging 
Innovations, Denver, CO) software.  Confocal sampling sites were generated based on the Au1 
layer 2-4 contour total areas for each mouse such that approximately 15 sites were sampled per 
animal.  For imaging, animals were randomly blocked into groups of six, with one mouse from 
each genotype/age group combination in each block.  At each sampling site, total tissue thickness 
was measured.  Image stacks were collected with a step size of 0.25 µm between Z axis planes in 
the stack, starting from 10 µm below the tissue surface closest to the coverglass and stepping up 
until the tissue surface was reached, yielding a 10 µm thick (Z axis depth) stack comprised of 40 
individual 2-dimensional planes.  Collected image planes were 512 x 512 pixels, and exposure 
times for 568, 488, and 405 channels were held constant.  Due to a gradual decline of 647 
channel fluorescence over the course of imaging, exposure time in the 647 channel was increased 
halfway through imaging (for animals in blocks 4 through 6).  Therefore, statistical models 
involving 647 channel (VGluT1-immunoreactive objects) included exposure time as a factor.  
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Mean site thickness did not differ by genotype (F1,30 = 0.380; p = 0.542) but did differ by age 
(F1,30 = 5.206; p = 0.011) so mean site thickness was included in statistical models as a covariate. 
4.2.6 Image processing and analysis 
Collected image stacks were post-processed offline, using SlideBook and Automation Anywhere 
software (Automation Anywhere, Inc., San Jose, CA) to automate keystrokes and increase image 
processing efficiency.  Intensity levels attributable to electrical fluctuations of the camera sensor 
was subtracted from each channel, by determining the mean intensities (gray scale values) for 
each channel with identical exposure and capture settings as the tissue image stacks, and 
subtracting these values from all pixel intensities in the image stacks.  Images were then 
deconvolved using the autoquant (blind deconvolution) algorithm in SlideBook (see Figure 4.1B 
for example of deconvolved micrographs).  Finally, a transformation was applied to each channel 
to enhance detection of object edges during the automated segmentation process.  Gaussian 
filters with two different standard deviations (σ = 2 and σ = 0.7) were applied to each channel, 
and the intensities of the channel transformation with the larger standard deviation (σ = 2) were 
subtracted from the channel intensities transformed with the smaller (σ = 0.7), to yield a new 
channel used in segmentation.  This deconvolved and edge-enhanced image stack was then 
subject to intensity segmentation coupled with morphological selection using our iterative 
masking approach (Fish et al., 2008).  For each channel, the initial intensity threshold was 
determined in advance by the experimenter, and with each subsequent iteration the intensity 
threshold was increased.  For the 405 channel, the initial intensity threshold was set to 150, 
increased by 50 gray levels until 500  was reached, increased by 100 until 1000 was reached, 
increased by 500 until 3000 was reached, and increased by 1000 until 8000 was reached.  For the 
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488 channel, the initial intensity threshold was set to 400, increased by 50 until 1000 was 
reached, increased by 100 until 2000 was reached, increased by 500 until 5000 was reached, and 
increased by 1000 until 14000 was reached.  For the 568 channel, the initial intensity threshold 
was set to 100, increased by 50 until 500 was reached, increased by 100 until 2000 was reached, 
increased by 500 until 3000 was reached, and increased by 1000 until 8000 was reached.  For the 
647 channel, the initial threshold was set at 200, increased by 50 until 500 was reached, 
increased by 100 until 2000 was reached, increased by 500 until 3000 was reached, and 
increased by 1000 until 8000 was reached.  After each segmentation step, mask objects were size 
gated (405, 568, and 647: 0.03 to 1 µm3; 488: 0.03 to 0.5 µm3) were selected and merged with 
the mask generated in the prior segmentation step.  Immunoreactive (IR) puncta data (mean 
intensity, mean volume) were extracted from these image stacks using the generated mask to 
identify objects of interest.  To obtain accurate intensity information, object intensities were 
derived from the deconvolved, but not Gaussian-filtered channels.   
One limitation of using phalloidin to label dendritic spines is that it has a high affinity for 
the f-actin found in astrocytic end feet surrounding blood vessels (Capani et al., 2001) as well as 
that found in dendritic spines (Fifkova and Delay, 1982).  Therefore, not all phalloidin-positive 
objects in our images are dendritic spines, as blood vessels are reported to account for 4% of the 
total cortical volume in mice (Schuz and Palm, 1989).  Similarly, although spinophilin is highly 
concentrated in dendritic spines (Ouimet et al., 2004), it is also localized to the dendrites of 
parvalbumin interneurons (Muly et al., 2004).  Therefore, we required that phalloidin-positive 
objects quantified as dendritic spines have at least one voxel of overlap with the spinophilin-IR 
object mask, and that the spinophilin-IR objects have at least one voxel of overlap with the 
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phalloidin-positive object mask.  This increases the likelihood that we are quantifying dendritic 
spines, as they are f-actin enriched objects expressing spinophilin protein (Figure 4.1C). 
Density of mask objects was determined by taking the total number of mask objects for 
each animal, divided by the sum of the total volumes of each sampling site.  The volume of each 
sampling site was (256 pixels x 0.108 µm/pixel)2  or 2,823 µm2 multiplied by the height of the 
disector (10 µm).  Puncta number for each animal was then generated using the Nv x Vref 
approach by multiplying the density by the estimated volume of left hemisphere area Au1 layers 
2-4. 
4.2.7 Statistical analyses 
ANOVA models with age and genotype as between subjects factors were used to examine group 
differences in body weight and gray matter volume of area Au1 layers 2 through 4.  ANCOVA 
models with genotype as between subjects factors and mean site thickness as a covariate were 
used to test for age and genotype differences in spine and bouton number, mean fluorescence 
intensity, and volume.  In VGluT1-IR puncta models, 647 channel exposure time was also 
included as a fixed factor in the model, to control for an adjustment made in imaging this channel 
halfway through the animals.  Genotype comparisons between age groups, and age comparisons 
within genotypes were carried out using Bonferroni correction for multiple comparisons.   
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4.3 RESULTS 
4.3.1 Au1 layer 2, 3 and 4 cortical volume reduced in kalirin KO 
Unexpectedly, we did not find a significant overall effect of age on Au1 layers 2, 3 and 4 volume 
(F(2,30) = 1.884; p = 0.169).  As the kalirin KO is reported to have reduced dendritic spine density 
(Cahill et al., 2009) in frontal cortex at 12 weeks of age, and neuropil including excitatory 
synapses comprises 85% of the mouse cortical volume, we wanted to determine whether gray 
matter volume of the region of interest was reduced.  The estimated volume of cortical layers 2 
through 4 of left hemisphere Au1 was reduced in the KO compared to the WT animals (F(1,30) = 
4.561; p = 0.041; Figure 4.2A).  Body weight was also significantly reduced in the KO 
compared to the WT (F(1,30) = 5.090; p = 0.032; Figure 4.2B); however, there was an age by 
genotype interaction (F(2,30) = 3.329; p = 0.049), revealing that weight is not significantly reduced 
in KO until 12 weeks.  This is consistent with impaired growth in another kalirin KO model 
(Mandela et al., 2012).  However, we found that body weight does not predict regional volume 
overall (F(1,35) = 0.777; p = 0.384) or within any individual age group (4 week: F(1,11) = 0.106; p = 
0.752; 8 week: F(1,11) = 0.027; p = 0.874; 12 week:  F(1,11) = 2.364; p = 0.155).  This suggests that 
reduced regional volume in the KO is not solely attributable to smaller body size.  To account for 
the difference in regional volumes between genotypes, we report number rather than density of 








Figure 4.2. Superficial auditory cortex gray matter volume and body weight in kalirin KO and WT mice.   A. 
Estimated gray matter volume of area Au1 layers 2 through 4 across adolescence in WT and kalirin KO mice.  KO 
mice have reduced regional volume overall relative to WT. *p < 0.05.  B. Weight of WT and KO mice across 
adolescence.  12 week old KO mice are smaller than 12 week old WT mice. *p < 0.05. N = 6 per age x genotype 







4.3.2 Numbers of presumptive spines and intracortical excitatory boutons decrease 
between early adolescence and early adulthood 
To identify dendritic spines in the region of interest, we used fluorophore conjugated phalloidin, 
a mushroom toxin that binds f-actin.  To enhance specificity for spines, we quantified phalloidin-
labled puncta that exhibit overlap with spinophilin-immunoreactive (-IR) puncta.  We found that 
numbers of phalloidin and spinophilin co-labled puncta significantly decreased between 4 and 12 
weeks of age (F(2,29) = 6.720; p = 0.004; Figure 4.3A).  The same pattern was observed when we 
examined numbers of spinophilin-IR puncta that overlap with phalloidin-labeled puncta 
(Appendix Figure C.1).  We examined numbers of VGluT1-IR puncta to determine if 
presynaptic components of excitatory synapses are also decreasing in number during this time.  
We saw that the number of VGluT1-IR puncta decreases between 4 and 12 weeks (F(1,28) = 6.191; 













 Figure 4.3. Evidence for 15-20% reduction of excitatory synapse number between early adolescence and 
young adulthood in superficial primary auditory cortex.  A. The numbers of phalloidin-labeled puncta decrease 
between 4 and 12 weeks of age in WT mice.  There is a trend-level reduction in puncta number in the KO compared 
to the WT at 4 weeks of age. *p < 0.05 vs 4 week old WT.  #p < 0.10 4 week old WT vs KO.  B. The numbers of 
VGluT1-IR puncta decrease between 4 and 12 weeks in the WT and KO mice, and overall the number of VGluT1-
IR puncta is reduced in the KO. *p < 0.05 vs 4 week old, asterisk color denotes genotype.  Brackets and asterisk 







4.3.3 Spine number is not reduced in auditory cortex of kalirin KO mice 
Spine density is reported to be lower in frontal cortex of young adult but not pre-adolescent 
kalirin KO mice (Cahill et al., 2009).  We wanted to determine whether this also occurs in 
auditory cortex. There was a trend toward an overall reduction of phalloidin-labled puncta 
number in the KO mice (F(1,29) = 3.470; p = 0.073), and we observed a trend toward a reduction 
in puncta number in the KO at 4 weeks compared to the WT (F(1,29) = 2.995; p = 0.096).  The 
developmental effect between the two genotypes was similar, in that there was a trend toward an 
effect of age on puncta number in the KO (F(2,29) = 2.928; p = 0.069) and a significant effect of 
age in the WT (F(2,29) = 4.929; p = 0.014; Figure 4.3A).   
However, when we examined presumptive excitatory boutons, we found that kalirin KO 
mice had a reduced number of VGluT1-IR puncta compared to the WT (F(2,28) = 4.747; p = 
0.038; Figure 4.3B).  The decrease in puncta number with age was significant in both genotypes: 
(WT: (F(2,28) = 3.569; p = 0.042; KO (F(2,28) = 3.729; p = 0.037)), suggesting the decrease in 
VGluT1-IR puncta with age occurs to a similar extent in both genotypes. 
4.3.4 Changes in GAD65-IR puncta occur between late adolescence and early adulthood 
and are disrupted in kalirin KO mice 
We found significant reductions in GAD65-IR puncta fluorescence intensity (F(2,29) = 10.769; p < 
0.001) and GAD65-IR puncta number between 4 and 12 weeks of age (F(2,29) = 5.439; p = 0.010; 
Figure 4.4A).  Specifically, the reductions in fluorescence intensity (p=0.001) and puncta 





Figure 4.4. Changes in characteristics of GAD65-expressing boutons across adolescence and early adulthood.  
A. The mean GAD65 fluorescence intensity within GAD65-IR puncta significantly decreases between 8 and 12 
weeks in WT mice.  The mean GAD65 fluorescence intensity within GAD65-IR puncta is significantly greater in 
KO compared to WT at 12 weeks of age.  *p < 0.05 KO vs WT at 12 weeks, **p < 0.01 vs 4 and 8 week old WT.  
B. The number of GAD65-IR puncta decreases between 4 and 12 weeks in the WT mice.  #p < 0.10; **p < 0.01. N 










The mean GAD65-IR puncta fluorescence intensity was not different overall between KO 
and WT mice (F(1,29) = 0.776; p = 0.386; Figure 4.4B).  The decrease in GAD65 fluorescence 
with age was highly significant in the WT (F(2,29) = 12.633; p < 0.001) but not in the KO (F(2,29) = 
2.272, p = 0.121).  Further, the mean GAD65-IR puncta fluorescence intensity is significantly 
greater in the KO than the WT at 12 weeks (F(1,29) = 5.024, p = 0.033), suggesting increased 
within-bouton GAD65 protein in young adult KO mice relative to WT.  Numbers of GAD65-IR 
puncta did not differ between kalirin KO and WT mice (F(1,29) = 0.730; p = 0.400).  However, 
numbers of GAD65-IR puncta decreased with age in the WT (F(2,29) = 5.694; p = 0.008) and did 
not decrease in the KO (F(2,29) = 1.519; p = 0.236).   
4.3.5 Within-spine spinophilin and f-actin fluorescence intensity 
Spinophilin is a postsynaptic excitatory synapse protein that is prevalent in dendritic spines and 
serves a variety of structural and functional roles (reviewed in (Sarrouilhe et al., 2006)).  
Importantly, it has been shown that cortical spinophilin protein levels decline during adolescence 
in rat (Allen et al., 1997), and that spinophilin may play a role in spine elimination (Feng et al., 
2000).  Therefore, we wanted to know how levels of spinophilin protein per spine change during 
this time period.  We found a significant reduction in spinophilin fluorescence intensity within 









Figure 4.5. Changes in characteristics of dendritic spines across adolescence and early adulthood.  A. The 
mean spinophilin-label fluorescence intensity within phalloidin-positive objects significantly decreases across 
adolescence in WT mice and reaches trend level significance between 4 and 12 weeks in KO mice.  The mean 
spinophilin fluorescence intensity within phalloidin-labeled objects is significantly reduced in KO compared to WT 
at 4 weeks of age.  *p < 0.05, **p < 0.01, vs 4 week old WT; #p < 0.10 vs 4 week old KO.  B. The mean 
fluorescence intensity of the phalloidin label within phalloidin-positive objects does not change across adolescence.  









The reduction in mean puncta spinophilin fluorescence intensity with age could be 
attributed to the increase in spine volume that we observed between 4 and 12 weeks (Figure 
C.1), without a corresponding increase in the size of the spinophilin immunoreactive portion of 
the spine.  However, we found that the sum spinophilin intensity of all voxels in the spine also 
decreased with the same pattern as the mean intensity (F(2,29) = 13.716; p < 0.001), whereas if the 
reduction in intensity was solely attributable to increasing spine volume, this would have 
increased or remained unchanged.  
We hypothesized that kalirin loss could disrupt spinophilin levels within dendritic spines 
as the two proteins have been shown to interact (Penzes et al., 2001).  Although we saw no 
overall difference in spinophilin fluorescence intensity between KO and WT mice (F(1,29) = 
2.200; p = 0.149) (Figure 4.5A), there was a trend toward an age by genotype interaction effect 
(F(2,29) = 3.073; p = 0.062), and we found that spinophilin fluorescence intensity was significantly 
lower in the KO compared to the WT at 4 weeks of age (F(2,29) = 7.703; p = 0.010).  The 
reduction in within-spine spinophilin fluorescence intensity with age was significant in the WT 
mice (F(2,29) = 17.870; p < 0.001) and was trend-level in the KO (F(2,29) = 3.143; p = 0.058).  In 
the WT mice, within-spine spinophilin fluorescence intensity decreased between 4 and 8 weeks, 
as well as between 8 and 12 weeks. 
We examined the mean fluorescence intensity attributable to the phalloidin label to 
determine whether f-actin content of spines changes across adolescence or is altered in the 
absence of kalirin.  However, we saw no change in puncta fluorescence intensity over 




Here we report decreases in numbers of dendritic spines, intracortical excitatory boutons, and 
GAD65-expressing inhibitory boutons in mouse auditory cortex between early adolescence and 
young adulthood (summarized in Figure 4.6).  In WT mice, we found that spine numbers 
decreased between early adolescence and young adulthood, while levels of GAD65 protein 
within inhibitory boutons decreased between late adolescence and young adulthood, suggesting 
that excitatory synapse pruning begins first and is followed by a subsequent reduction in GAD65 
protein levels.  This provides evidence that spines and GAD65 protein levels are co-regulated in 
development, and lends insight into potential developmental origins of the correlation between 

















Figure 4.6. Summary of developmental trajectories, age and genotype effects for spines and  intracortical 
excitatory bouton numbers, within-spine spinophilin protein, within-bouton GAD65 protein, and GAD65-
expressing inhibitory bouton number.  Values expressed as a percentage of the 4 week old WT values.  Dotted 
lines connecting data points are used to illustrate developmental trajectories, but all markers were assessed in 
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independent groups of animals.  Age effects denoted by horizontal lines above graph, with genotype indicated by 
line color. Genotype effects indicated by colored astericks, vertical line indicates overall genotype effect.  *p < 0.05; 
**p < 0.01; ***p < 0.001. 
 
 
4.4.1 Pre- and postsynaptic components of excitatory synapses are pruned in auditory 
cortex between early adolescence and young adulthood 
We found that numbers of dendritic spines and VGluT1-IR intracortical excitatory boutons in 
layers 2, 3 and 4 of mouse auditory cortex decline by 15 to 20% between early adolescence and 
young adulthood.  This is consistent with spine changes in mouse frontal cortex during this 
developmental period (20% decrease; (Zuo et al., 2005)) and likely represents adolescent 
excitatory synapse pruning as reported in other mammalian species (Huttenlocher, 1979; Rakic 
et al., 1986; Zecevic et al., 1989; Glantz et al., 2007).  It is possible that excitatory synapse 
numbers continue to decline after 12 weeks of age; in mouse frontal cortex synapse numbers are 
found to stabilize by 4 months (Alvarez and Sabatini, 2007).  Therefore, future studies should be 
done to determine whether spine and excitatory bouton numbers in auditory cortex continue to 
decline at ages later than 12 weeks. 
4.4.2 GAD65 protein within inhibitory boutons decreases between late adolescence and 
young adulthood in auditory cortex 
Our results indicate that within-bouton GAD65 protein decreases between late adolescence and 
young adulthood in auditory cortex.  Importantly, our findings suggest that pre- and postsynaptic 
components of excitatory synapses are pruned between early adolescence and young adulthood, 
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while levels of GAD65 protein within inhibitory boutons decrease between the end of 
adolescence and young adulthood.  This indicates within-bouton GAD65 protein reduction 
occurs subsequent to the onset of spine pruning during adolescence, and provides a 
neurodevelopmental context for the reduced within-bouton GAD65 protein observed in auditory 
cortex of subjects with schizophrenia. 
Few studies have examined levels of GAD65 protein during adolescent development.  
GAD65 immunoreactivity in the rat primary somatosensory cortex increases slowly between 
postnatal day (P) 6 and P33 (Kiser et al., 1998).  Xu et al. (Xu et al., 2010) examined protein 
levels of GAD65 in the rat auditory cortex and found an increase across postnatal development; 
however, the oldest age examined in the study was P56 (8 weeks), corresponding to the end of 
adolescence, whereas we also examined 12 week old young adult animals.  GAD65 protein 
levels in human visual cortex also peak relatively late, at approximately age 20 (Pinto et al., 
2010).  However, in visual cortex, GAD65 levels slowly declined through old age, whereas we 
observed a more dramatic reduction between late adolescence and young adulthood.     
Down-regulation of GAD65 protein during normal adolescent development could be a 
mechanism reducing the likelihood of spine elimination toward the end of adolescent spine 
pruning.  GAD65 KO mice show impaired long term depression (LTD) (Choi et al., 2002) a 
plasticity mechanism that favors spine shrinkage and elimination (Bosch and Hayashi, 2012).  
Spine elimination in visual cortex in response to monocular deprivation does not occur in 
GAD65 KO mice (Kanold et al., 2009), suggesting that loss of GAD65 protects against 
plasticity-induced spine loss.  Lower levels of within-bouton GAD65 protein in auditory cortex 
of subjects with schizophrenia may then be a compensatory response to excessive spine pruning 
during adolescence.  The mechanisms regulating GAD65 expression are not yet fully understood, 
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but transcription is influenced by CREB-mediated BDNF signaling (Sanchez-Huertas and Rico, 
2011) and also through epigenetic control (Zhang et al., 2011).  Interestingly, BDNF levels in the 
cortex peak during adolescence and decline between 2 and 4 months of age in rats (Katoh-Semba 
et al., 1997) and there is some evidence that BDNF levels are abnormal in schizophrenia 
(reviewed in (Green et al., 2011)). 
A potential confounding factor in our study is that the C57Bl/6 background is associated 
with young adult onset high frequency hearing loss, which could impact GAD expression in the 
auditory cortex.  C57Bl/6 mice show substantial loss of cochlear hair cells by 12 weeks of age 
(Spongr et al., 1997), and begin to exhibit high frequency hearing loss beginning between 12 and 
16 weeks of age, and remapping of frequency responsiveness in auditory cortex occurs at the 
same time (Willott et al., 1993).  Induced high-frequency hearing loss has been shown to reduce 
GAD65 expression in areas of auditory cortex responding to high frequencies (Yang et al., 2011).  
However, another study reports increased GAD immunoreactivity following induction of hearing 
loss around the time of hearing onset (Sarro et al., 2008).  Future studies should evaluate GAD65 
protein levels between late adolescence and young adulthood in a strain with no known hearing 
loss during this time, such as the CBA/CaJ strain, to determine if the reduction in GAD65 protein 
is a feature of adolescent development or a consequence of peripheral hearing impairment. 
We also identified a substantial decrease in GAD65-IR bouton number between late 
adolescence and adulthood.  This is consistent with findings in rat visual cortex, where the 
number of type II synapses, which would include inhibitory synapses, decreases substantially 
between P28 and P90 (Blue and Parnavelas, 1983).  A small decrease in symmetric synapse 
density is also reported during this time period in mouse somatosensory cortex (De Felipe et al., 
1997).  However, another report in rat somatosensory cortex indicates that inhibitory synapse 
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numbers do not decrease between postnatal days 30 and 60 (Micheva and Beaulieu, 1996).  Yet, 
it may be that the reduction in inhibitory bouton number occurs later than P60 (approximately 8 
weeks) which was the oldest age examined, as our data suggest that the reduction occurs 
primarily between 8 and 12 weeks of age.   In general, most studies in primate cortex indicate 
that inhibitory synapses do not undergo pruning during adolescence. In monkey prefrontal 
cortex, parvalbumin-immunoreactive puncta density increases during adolescence (Erickson and 
Lewis, 2002).  However, densities of parvalbumin and GABA transporter (GAT-1) labeled 
cartridges of chandelier neurons are reported to decrease over adolescence (Anderson et al., 
1995), though this may be attributable to developmental changes in markers, rather than loss of 
synapses (Lewis and Gonzalez-Burgos, 2008).  In the present study, it is possible that the 
decrease in within-bouton GAD65 protein led to reduced detectability of boutons, causing the 
apparent decrease in number.  Future studies using alternative bouton inhibitory synapse 
markers, such as GAT-1 or postsynaptic GABAA receptor subunits, should be done to clarify the 
developmental trajectory of inhibitory synapse number in auditory cortex between early 
adolescence and young adulthood. 
It is important to keep in mind that reduction in the number of GAD65-IR boutons 
between early adolescence and young adulthood does not necessarily indicate a reduction in the 
total population of inhibitory boutons, as we did not quantify inhibitory boutons that express 
only the 67 kDa isoform (Fish et al., 2011). Future studies are needed to determine how GAD67-
expressing boutons and within-bouton GAD67 protein change in auditory cortex during this 
time.   Also, future studies will be necessary to determine if the reduction in within-bouton 
GAD65 protein that occurs between late adolescence and young adulthood is specific to a 
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particular population of GABAergic interneurons, as this will provide insight into how function 
of different interneuron subtypes changes during late adolescence and young adulthood. 
We found that within-spine spinophilin protein content decreases by about 30% between 
early adolescence and young adulthood.  This is consistent with the reported decrease in 
spinophilin protein in rat total cortex homogenate between the third postnatal week and 
adulthood (Allen et al., 1997).  Spinophilin plays a role in the PSD as a scaffolding protein, and 
interacts with a host of molecular factors involved in regulating spine function, such as protein 
phosphatase 1 (PP1) and f-actin (reviewed in (Sarrouilhe et al., 2006)). Spinophilin has been 
shown to be important for spine stability and formation, as well as long term depression (LTD) 
(Feng et al., 2000).  If LTD contributes to spine elimination during adolescence (Selemon, 2013), 
and spinophilin plays a role in LTD, then higher within-spine spinophilin protein content earlier 
in adolescence could promote LTD-mediated spine elimination, while reduction in spinophilin 
protein over the course of adolescence may increase spine stability and slow down the process of 
spine elimination toward the end of adolescence and young adulthood.   
4.4.3 Effects of kalirin loss on development of excitatory and inhibitory synapse 
components in auditory cortex between early adolescence and young adulthood 
Previous work has found that protein levels of the kalirin-9 isoform are elevated, and other 
isoforms are unchanged, in the primary auditory cortex of subjects with schizophrenia (Deo et 
al., 2012).  Therefore, the kalirin KO does not serve as a model of auditory cortex disruption in 
schizophrenia, but can provide insight into the roles of kalirin in the auditory cortex during 
adolescent development and in disease.  In frontal cortex, dendritic spine density is no different 
between KO and WT mice prior to adolescence, but is significantly reduced in the KO by young 
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adulthood (Cahill et al., 2009).  In contrast, there was no deficit in spine number in the 
superficial auditory cortex of kalirin KO mice.  Our findings suggest that there may be 
differences in molecular factors important for regulating frontal and auditory cortex spines 
during adolescence.  Future studies should determine whether distributions of other GEFs 
(Rossman et al., 2005) differ between frontal and auditory cortices and if so, can compensate for 
loss of kalirin in the auditory cortex.  It is also possible that kalirin may have different functional 
roles in dendritic spine formation and stability in the primary auditory cortex compared to the 
frontal cortex.  The kalirin KO also did not exhibit evidence of significant reduction in spine 
number between early adolescence and young adulthood.  Numbers of spines were about 15% 
lower at early adolescence compared with wild type mice, although this was only a statistical 
trend.  By late adolescence and young adulthood, numbers of spines in the KO were comparable 
to the WT.   This is likely due to the different trajectories, where spine number decreases in the 
WT between early adolescence and young adulthood but does not change in the KO.  Our results 
suggest that although there is no overall effect of kalirin loss on spine number in the auditory 
cortex, there may be subtle changes that alter spine pruning during adolescence in KO mice.     
We did see that kalirin KO mice exhibit overall reduced numbers of VGluT1-IR boutons.  
This is consistent with in vitro work showing that transfection of cultured hippocampal neurons 
with kalirin-7 targeting shRNA leads to a reduction in the number of VGluT1-IR puncta (Ma et 
al., 2011).  Our findings suggest that overall numbers of intracortical excitatory synapses may be 
reduced in auditory cortex of kalirin KO mice.  Further, numbers of VGluT1-IR boutons 
decreaed between early adolescence and young adulthood in the KO as well as the WT mice.  It 
is worth noting that the decrease in numbers of VGluT1-IR boutons between early adolescence 
and young adulthood in the KO were no different from WT, while the KO showed no significant 
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change in numbers of spines during this time.  This finding suggests the possibility that pre- and 
postsynaptic components of excitatory synapses are pruned independently during adolescence.  
In the auditory cortex of individuals with schizophrenia spine density is reduced while excitatory 
boutons are unchanged (Chapter 2), which represents the opposite, but still discordant, 
relationship that we observed in the kalirin KO.  Therefore, the kalirin KO may provide an 
opportunity to model the effects of disconnect between spine and excitatory bouton changes in 
auditory cortex of subjects with schizophrenia. 
Kalirin protein appears to be necessary for the decrease in within-bouton GAD65 levels 
and number of GAD65-IR puncta between the end of adolescence and young adulthood.  In vitro 
transfection of hippocampal interneurons with exogenous kalirin-7 reduces GAD65 
immunoreactivity (Ma et al., 2011).  Our findings support the opposite relationship, where loss 
of endogenous kalirin protein leads to a relative increase, or a failure to decrease, levels of 
GAD65 protein.  The effects of kalirin on GAD65 protein are likely mediated by loss of kalirin 
at postsynaptic sites of excitatory synapses onto GABAergic interneurons, as kalirin is expressed 
in both glutamatergic and GABAergic neurons.  In a global knockout model, it is difficult to 
tease apart whether the failure to downregulate GAD65 in young adulthood is attributable to 
kalirin at excitatory synapses onto interneuron dendrites versus changes in global circuit activity 
caused by loss of kalirin.  We may gain more insight into this issue by studying mice with an 
interneuron-specific knockdown of kalirin, using a mouse line such as the parvalbumin-Cre line 
to restrict loss of kalirin to parvalbumin-expressing interneurons. 
Spinophilin is known to interact with kalirin in vitro (Penzes et al., 2001), and consistent 
with this observation, we found that that spinophilin protein levels within spines are reduced in 
the KO at 4 weeks.  The fact that we saw no alteration in spinophilin protein levels at 8 or 12 
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weeks suggests that kalirin is not necessary to maintain spinophilin in spines after 4 weeks of 
age, or other factors are able to compensate for kalirin loss in this regard.  For example, 
spinophilin associates with Tiam1 (Buchsbaum et al., 2003), another Rac-GEF.  Future work 
should investigate whether spinophilin protein levels in the auditory cortex of the kalirin KO fail 
to undergo upregulation during postnatal development (Allen et al., 1997), or develop normal 
levels followed by an earlier or accelerated decrease in within-spine protein levels. 
4.4.4 Conclusions 
In order to design preventative measures to mitigate spine and GAD65 reductions in auditory 
cortex of schizophrenia patients, we first need to understand whether one feature occurs as a 
consequence of the other.  Here we report evidence that dendritic spine and excitatory bouton 
numbers decrease in mouse auditory cortex between early adolescence and young adulthood, 
with a subsequent reduction of within-bouton levels of GAD65 protein occurring between late 
adolescence and young adulthood.  This supports the idea that the GAD65 protein deficit in 
schizophrenia is a consequence of dendritic spine loss in auditory cortex, and further suggests a 
developmental window when GAD65 protein reduction may occur.  Our findings also suggest 
different roles of kalirin in regulating stability of dendritic spines during adolescence in frontal 
and auditory cortices.  Together, these results enhance our understanding of regulation of 
excitatory and inhibitory synapses in auditory cortex during adolescence.  Further investigation 
is needed to understand the molecular factors influencing development of excitatory and 
inhibitory synapses during adolescence, and how these factors contribute to the pathophysiology 
of schizophrenia. 
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5.0  DEVELOPMENT OF GAP-MEDIATED PREPULSE INHIBITION OF THE 
ACOUSTIC STARTLE REFLEX ACROSS ADOLESCENCE IN MICE  
 
Abstract 
Auditory sensory processing impairments in individuals with schizophrenia may underlie some 
symptoms and contribute to poor disease outcomes.  We have reported alterations in primary 
auditory cortex synapses in subjects with schizophrenia.  It has been suggested that abnormal 
synapse refinement in individuals with schizophrenia during adolescence could contribute to 
these alterations.  In the mouse auditory cortex, we have observed that numbers and molecular 
features of excitatory and inhibitory synapses change between early adolescence and young 
adulthood.  Therefore, we sought to characterize how auditory cortex function changes during 
adolescence in mice, and in kalirin KO mice that demonstrate disrupted excitatory and inhibitory 
synapse development during this time period.  We used silent gap-prepulse inhibition of the 
acoustic startle reflex (gap-PPI), to assess auditory cortex function, as evidence has shown that 
gap-PPI depends on the integrity of the auditory cortex.  To determine if changes in gap-PPI 
could be attributable to auditory cortex function and not a consequence of maturation of other 
PPI circuit components, we also measured noise-prepulse mediated PPI (noise-PPI).  Finally, to 
determine whether observed developmental changes in gap-PPI might reflect non-specific 
consequences attributable to the relatively early onset of high frequency hearing loss evident in 
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some inbred mouse strains, we also examined gap-PPI in 3 mouse strains with differing temporal 
patterns of high frequency hearing loss.  We observed an increase in gap-PPI between early and 
late adolescence in WT mice.  Kalirin KO mice exhibited detectable gap-PPI responses, but did 
not show any increase between early adolescence and young adulthood.   Gap-PPI responses 
increased during adolescent development in normal hearing CBA/CaJ mice and in C57Bl/6J 
mice, which exhibit young adult onset high-frequency hearing loss.  In contrast, DBA/2J mice, 
which exhibit high-frequency hearing loss by early adolescence, showed a loss of gap-PPI 
responses by early adulthood.  Our findings indicate that normal development leads to 
improvement in gap-PPI responses during adolescence.  The timing of this improvement, and the 
lack of improvement in the kalirin KO mice, suggest excitatory synapse pruning in the auditory 
cortex may contribute to the improvement in gap processing, as kalirin KO mice do not 
demonstrate pruning of auditory cortex spines during adolescence.   
5.1 INTRODUCTION 
Individuals with schizophrenia exhibit auditory processing impairments that may contribute to 
deficits in verbal and social cognition, negative symptoms and ultimately poor disease outcome 
(Rabinowicz et al., 2000; Javitt, 2009).  Excitation and inhibition in auditory cortex are important 
in generating the electrophysiological measures of auditory processing that are impaired in 
schizophrenia (Javitt et al., 1996; Krishnan et al., 2009), and excitatory and inhibitory synapse 
abnormalities contribute to auditory cortex pathology (Moyer et al., 2012; Moyer et al., 2013) 
(see chapters 2 and 3).  Accelerated thinning of auditory cortex gray matter occurs around the 
time of schizophrenia onset in adolescence and young adulthood (Pantelis et al., 2007), when 
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synaptic pruning takes place in the cortex (Huttenlocher, 1979; Rakic et al., 1986; Zecevic et al., 
1989; Glantz et al., 2007).  Postmortem studies of auditory cortex of individuals with 
schizophrenia indicate that both spines and within-bouton GAD65 protein levels are reduced 
(Sweet et al., 2009; Moyer et al., 2012).  In mouse auditory cortex, spine pruning occurs between 
early adolescence and young adulthood (Chapter 4), and within-bouton levels of GAD65 protein 
decrease between the end of adolescence and young adulthood.  This suggests that excitatory and 
inhibitory synapses in auditory cortex continue to develop during adolescence and early 
adulthood, and their development may be disrupted in schizophrenia.  A better understanding of 
the functional development of auditory cortex associated with adolescent excitatory and 
inhibitory synapse maturation may lead to development of tests for abnormal development of 
auditory cortex circuitry that could eventually be implemented in early schizophrenia diagnosis 
or prevention.  
Detection of silent gaps embedded in noise depends in part on auditory cortex function.  
Bilateral silencing of the cortex with KCl (Ison et al., 1991) and more specifically, bilateral 
lesions of the auditory cortex (Bowen et al., 2003) impairs silent gap detection, while responses 
to noise offset and noise pulses are unaffected.  Behavioral approaches for assessing silent gap 
detection utilizing prepulse inhibition of the acoustic startle reflex (PPI) have been used to 
evaluate auditory processing in mice (Truong et al., 2012).  PPI can be used as a readout to 
assess stimulus detection without training or conditioning (Fitch et al., 2008).  PPI occurs when a 
brief, non-startling stimulus (the prepulse) precedes and attenuates the response to a startle 
eliciting stimulus (Hoffman and Searle, 1965) which is typically a loud noise burst.  Paradigms 
utilizing noise prepulses of increasing intensity over a low level background noise are used to 
assess PPI as a measure of sensorimotor gating (Swerdlow et al., 2001).  Studies have shown that 
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while PPI responses to silent gap “prepulses” embedded in noise (gap-PPI) are impaired when 
the auditory cortex is compromised, PPI responses to noise-intensity prepulses (noise-PPI) 
remain intact (Ison et al., 1991; Bowen et al., 2003).  This suggests that auditory cortex plays a 
role in gap-PPI, and gap-PPI may be an indicator of whether auditory cortex circuitry is 
functioning normally. 
Silent gap detection improves over adolescence in rats (Friedman et al., 2004; Sun et al., 
2008; Sun et al., 2011), suggesting that it may be a useful assessment of auditory cortex 
maturation during this developmental period, though it is not yet known if silent gap detection 
improves during adolescence in mice.  We have found that kalirin KO mice exhibit subtle 
disruptions in adolescent development of auditory cortex synaptic components (see Chapter 4).  
If normal development of synaptic components is important for the maturation of gap-PPI 
responses, then gap-PPI responses might be abnormal in kalirin KO mice during this time period. 
Assessment of silent gap detection has a great deal of translational relevance, as gap 
detection plays a role in speech comprehension (Elangovan and Stuart, 2008), and is impaired in 
subjects with schizophrenia (Thonnessen et al., 2008).  Currently, a number of genetic mouse 
models of various aspects of schizophrenia neuropathology exist (O'Tuathaigh et al., 2007).  
Gap-PPI could be used to determine how schizophrenia-relevant genetic manipulations impact 
auditory processing in mice.  However, a confounding factor of many genetic mouse models is 
the incidence of high-frequency hearing loss in several strains, including the popular C57Bl/6 
strain background (Mikaelian, 1979).  High frequency components of the carrier noise in which 
the silent gaps are embedded have been shown to be important for gap-PPI responses in mice 
(Radziwon et al., 2009).   It is not known if gap-PPI responses differ between different inbred 
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strains commonly used as genetic backgrounds for disease models, particularly in those with pre-
adolescent or young adult onset high frequency hearing loss. 
In the present study, we ask whether gap-PPI responses improve over adolescence in 
mice, whether loss of kalirin is associated with alterations in gap-PPI responses, and whether 
gap-PPI during adolescence and young adulthood differs between different inbred strains with 
varying degrees of high frequency hearing loss.    We found that gap-PPI responses increase in 
WT mice over adolescence, but not in mice lacking kalirin.  This was not attributable to a 
general PPI increase, as noise-PPI responses did not increase during this time.  Gap-PPI 
responses did not improve between adolescence and young adulthood, and in fact were reduced 
in adulthood in DBA/2J mice, which demonstrate high-frequency hearing loss beginning at about 
4 weeks of age.  Together, our findings suggest that increased gap-PPI responses in mice over 
adolescence could be an indicator of functional maturation of auditory cortex synapses.  
Importantly, gap-PPI responses vary by strain, which underscores the importance of considering 
strain background when evaluating genetic models of schizophrenia. 
5.2 MATERIALS AND METHODS 
5.2.1 Experimental animals 
Experiments were carried out using kalirin knockout (KO) and wild type (WT) mice.  KO mice 
were generated as described previously by inserting the neomycin resistance cassette in place of 
exons 27-28, the site of the GEF1 domain (Cahill et al., 2009).  Mice were rederived on the 
C57Bl/6NJ background at The Jackson Laboratory.  Heterozygous breeders were crossed to 
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generate KO and WT experimental animals.  Only male animals were included in experiments to 
avoid effects of estrogen and estrous phase on prepulse inhibition of acoustic startle (Koch, 
1998; Charitidi et al., 2012).  Animals were maintained on a 12 hr light / dark cycle (lights on at 
7 am) and were provided with food and water ad libitum.  Mice were used for behavioral testing 
beginning at postnatal day 28, 55, or 82 +/- 4 days (hereafter referred to as 4, 8, and 12 weeks of 
age).  Each mouse was tested at only a single age.     
For comparison of inbred strains, male CBA/CaJ, C57Bl/6J, and DBA/2J mice were 
obtained from the Jackson Laboratory at 3, 7, and 11 weeks of age +/- 3 days.  Animals were 
housed 4 per cage and remained undisturbed for 5 days before behavioral testing started to allow 
them to acclimate to the animal facility.  Four animals of each strain/age combination underwent 
behavioral testing at a time in each cohort, for a total of 16 animals per age/strain group (N = 15 
in the 4 week-old CBA/CaJ group).  Mice were tested at only one age.  All experimental 
procedures were approved by the Institutional Animal Care and Use Committee at the University 
of Pittsburgh. 
5.2.2 Auditory testing 
Mice received two days of acclimation prior to behavioral testing.  On the first day, cages were 
carried from the colony holding room to the testing room, and the animal holding apparatus from 
the acoustic startle test chamber was placed in the home cage for approximately 30 minutes.  On 
the second acclimation day, cages were again brought to the testing room and animals placed in 
the test chambers for approximately 30 minutes, with ambient noise (no auditory stimuli 
presented).  The next day, acoustic startle testing began, with the gap detection-PPI session done 
the first day, the acoustic startle reflex and noise-intensity-PPI session the second day.  Each day 
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the order in which mice were tested was randomized, and they were also randomly distributed 
between test chambers.  Acclimation and test sessions were carried out at the same time of day, 
during the second half of the light portion of the cycle. 
5.2.3 Acoustic startle reflex and noise-PPI 
The acoustic startle reflex (ASR) is an involuntary response which occurs after exposure to a 
startle-eliciting acoustic stimulus.  To assess this reflex, mice were placed on a force- sensing 
piezoelectric transducer enclosed within a sound attenuating chamber (14 x 19.5 x 10.875 in, -35 
+/- 2 dB attenuation) (Kinder Scientific, Poway, CA).  The platforms were calibrated to 1 +/- 
0.05 N prior to each gap-PPI session.  Acoustic stimuli (full range white noise) were delivered 
via a built-in speaker centered above the animal enclosure.  Noise stimuli were calibrated using a 
digital sound pressure level meter (model 33-2055, accuracy +/- 2 dB at 114 dB, range 50- 126 
dB, RadioShack, Fort Worth, TX).   Animals were able to turn freely during the session, but 
were prevented from rearing by the height of the animal enclosure.   
At the start of the session, mice were placed in the test chamber and acclimated in the 
chamber for 5 minutes while exposed to the background white noise (65 dB, A-weighting).  
Following the acclimation, mice were presented with a series of 3 different trial types: startle 
only trials, prepulse trials, and background only trials.  During startle only trials, the background 
intensity lasted for a randomized intertrial interval (ITI) of 15 to 25 ms before the startle eliciting 
stimulus occurred.  The startle-eliciting stimulus was an increase in the noise background 
intensity, up to 75, 85, 95, 105, or 115 dB, lasting for 40 ms.  The mouse’s startle response 
(displacement) was sampled in 1-ms bins for 70 ms beginning with the onset of the startle-
eliciting stimulus.  During prepulse trials, following the random ITI, an increase of 5, 10, 15, or 
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20 dB over the background noise intensity lasting for 40 ms preceded the 115 dB startle-eliciting 
stimulus by a 100-ms interstimulus interval (ISI).  During background-only trials, only the 
background noise was played, and the animal’s displacement was measured following the 
random ITI.  The trials were pseudorandomized into 10 blocks, with one trial of each type per 
block.  Five consecutive startle only trials were presented at the beginning and end of the session 
to assess startle response attenuation over the course of the session, which lasted approximately 
40 minutes.  The maximum startle response in the 70-ms recording window was calculated 
automatically by the Startle Monitor software (Kinder Scientific, Poway, CA).   
5.2.4 Gap-PPI 
To assess detection of silent gaps, we used a modified prepulse inhibition of acoustic startle 
reflex paradigm (Turner et al., 2006; Fitch et al., 2008).   At the start of this session, mice were 
acclimated for 5 minutes in the chamber to a 70-dB white noise background.  During the course 
of this session, mice were presented with 3 different trial types, startle-only trials, gap trials, and 
background-only trials.  During the gap trials, a silent gap (1, 2, 4, 7, 10, 20, 40 or 100 ms in 
duration) was embedded in the background noise following a random ITI of 15 to 25 sec (Figure 
5.1).  The 70-dB background noise returned during the 100-ms ISI before the startle eliciting 
stimulus (105 dB, 40 ms noise pulse).  During startle-only trials, no silent gap preceded the 
startle eliciting stimulus, and background only trials consisted of only background noise for the 
duration of the ITI.  Trials were pseudorandomized in 10 blocks, each comprising one trial of 
each type.  As above, 5 consecutive startle-only trials were presented at the beginning and end of 
the session to assess startle response attenuation over the course of the session, which lasted 




Figure 5.1. Diagram illustrating gap-PPI trial design and predicted responses.  A. Gap-PPI trials consisted of a 
70 dB white noise background that persisted for the duration of the random duration intertrial interval (ITI).  The 
“prepulse” stimulus was a silent gap embedded in the background noise, which varied from 1 to 100 ms in duration.  
The offset of the gap was followed by a 100 ms interstimulus interval (ISI) during which the 70 dB background 
noise returned  After the ISI, the startle eliciting noise stimulus occurred, which was a 105 dB noise pulse lasting 40 
ms.  The maximum displacement (response amplitude) of the mouse was recorded beginning at the onset of the 
startle-eliciting stimulus.  As the magnitude of prepulse inhibition of the startle reflex (PPI) is proportional to the 
salience of the prepulse, a shorter gap duration trial (B) should elicit relatively less PPI, or a larger startle amplitude, 




5.2.5 Statistical analyses 
Effects of genotype and age on the acoustic startle responses in WT and KO mice were tested 
using repeated measures ANOVA, with startle eliciting stimulus intensity as the within-subjects 
factor, and age and genotype as between-subjects factors.   For gap-PPI analyses, startle reflex 
amplitude from trials from gap durations 1 and 2 ms, 4 and 7 ms, 10 and 20 ms, and 40 and 100 
ms were binned.  Percent inhibition of startle response was calculated for each gap duration bin 
as 100*[(mean startle-only trial response – mean binned gap trial response)/mean startle-only 
trial response].  For the noise-PPI experiments, percent inhibition of startle response was 
calculated for each noise prepulse stimulus using a similar equation, as 100*[(mean startle-only 
response – mean noise prepulse trial response)/ mean startle-only trial response].  For both gap- 
and noise-PPI, genotype and age group comparisons of percent inhibition were tested using 
repeated measures ANOVA with gap duration bin or noise-prepulse intensity level as a within-
subjects factor, and age and genotype as between-subjects factors.  To control for variability 
between acoustic startle chambers, test chamber was included as a factor.  Genotype and age 
comparisons within groups were carried out using Bonferroni correction for multiple 
comparisons.   
Startle amplitude data from individual animals was evaluated with a repeated measures 
ANOVA model for within-animal effects of gap duration to identify which animals exhibited 
significant modulation of the startle response amplitude by silent gaps (significant main effect of 
gap).  Proportions of each age/genotype or age/strain group that did and did not exhibit 
modulation of the startle reflex by gap were compared using χ2 or Fisher’s exact tests.   
Group level gap detection thresholds were determined comparing the mean percent 
inhibition for each gap duration bin against zero using a one-sample t-test.  The threshold was 
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defined as the first of at least two consecutive gap duration bins where the percent inhibition was 
significantly different from zero.  Group level threshold to startle was assessed using t-tests 
determining whether the mean response amplitudes for each startle eliciting stimulus intensity 
were different from mean response-amplitudes during background only, no-stimulus trials.  The 
lowest of two consecutive startle eliciting stimulus intensities to elicit a response different from 
the response during the background only trials was defined as the threshold to startle. 
Statistical tests were conducted at the 0.05 significance level, and were done using SPSS 
software (IBM Corporation, Armonk, NY).  When appropriate, degrees of freedom were 
corrected for deviations from sphericity using the Greenhouse-Geisser adjustment. 
5.3 RESULTS 
5.3.1 Gap-PPI improves over adolescence in WT but not kalirin KO mice 
We found a significant effect of age on gap-PPI responses overall (F(2,95) = 5.346, p = 0.006).  We 
did not see any effect of genotype (F(1,95) = 0.592, p = 0.444) or an age by genotype interaction 
(F(2,95) = 1.852, p = 0.163).  However, the effect of age was highly significant in the WT mice 
(F(2,95) = 6.730, p = 0.002), but did not reach significance in the KO (F(2,95) = 1.013, p = 0.367).  
Mean gap-PPI increased significantly in WT mice between 4 and 8 weeks of age (p = 0.001) 
(Figure 5.2).  We examined group-level thresholds for gap-PPI as a secondary measure of gap 
detection ability.  The group-level thresholds for gap-PPI decreased between 4 and 8 weeks of 
age in the WT mice, but did not change between age groups in the KO mice. 
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 Figure 5.2. Gap-PPI in kalirin WT and KO mice at 4, 8, and 12 weeks of age.  Magnitude of gap-PPI as a 
function of increasing binned gap durations in WT (A) and KO (B) mice.  Block arrows indicate gap detection 
threshold for 4 week (solid) 8 week (light fill) and 12 week (white fill) groups.   C. Average gap-PPI for all gap 
durations in WT and KO mice by age.  Mean gap-PPI increases significantly between 4 and 8 weeks in WT mice but 
not in KO mice.  Significance markers indicate comparisons vs. 4 week old WT.  #p < 0.10, **p < 0.01.  Animal 
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numbers per group- Genotype: Age (N): WT: 4 weeks (18), 8 weeks (17), 12 weeks (18); KO: 4 weeks (13), 8 
weeks (15), 12 weeks (22).  Error bars are ± SEM. 
 
 
To determine whether the numbers of animals that do and do not demonstrate modulation 
of the startle response by gap-prepulses differed between age and genotype groups, we also 
evaluated the proportion of WT and KO animals in each age group that showed significant 
modulation of the acoustic startle reflex by silent gaps.  We did not find a significant effect of 
age on the proportions of WT mice at 4, 8, and 12 weeks of age that demonstrated significant 
gap-PPI (χ2 = 4.6, df = 2, p = 0.102).  Similar to the WT, we did not find any age differences on 
the proportions of KO animals that showed significant modulation of the startle reflex by silent 
gaps (χ2 = 0.8, df = 2, p = 0.660).  Additionally, proportions of animals showing modulation of 
the startle reflex by gaps at each age did not differ by genotype (Fisher’s exact test, 4 weeks: p = 












Table 5.1. Proportions of kalirin WT and KO animals that do and do not demonstrate significant modulation 
of acoustic startle by silent gap prepulses.  Numbers of WT and KO animals that do (y) and do not (n) show 
significant modulation of startle by silent gap prepulses do not differ by age (rows).  Further, proportions of animals 
that do and do not show modulation of acoustic startle do not differ by genotype at any age group (columns). % 
















When we repeated the binned-gap repeated measures analysis including only the animals 
that did show significant effect of gap duration on startle response were included, the results 
were similar (Appendix Figure D.1).  We again found a significant overall effect of age on gap-
PPI responses (F(2,61) = 6.839; p = 0.002).  We saw no overall differences in KO gap-PPI 
compared to WT mice (F(1,61) = 0.091; p = 0.764); however, there was a significant age by 
genotype interaction effect (F(2,61) = 3.757; p = 0.029).  Again, we saw that although the effect of 
age on gap-PPI is highly significant in the WT animals, there was no effect of age on gap-PPI in 
the KO mice (F(2,61) = 1.481; p = 0.235).  Specifically, gap-PPI increased between 4 and 8 weeks 
of age in WT mice (p = 0.007).  Further, we observed trends toward increased gap-PPI in the KO 
relative to WT at 4 weeks of age (p = 0.051) and decreased gap-PPI in the KO at 12 weeks of age 
(p = 0.069).   
5.3.2 Noise-PPI does not change during adolescence in WT and kalirin KO mice 
To determine if the increase in gap-PPI responses during adolescence in WT mice was 
attributable to an overall increase in PPI responses during this time, we examined noise-prepulse 
inhibition of the acoustic startle reflex.  There was no overall effect of age (F(2,95) = 0.674, p = 
0.512).  However, we observed a highly significant main effect of genotype (F(1,95) = 7.025, p = 
0.009), and a significant age by genotype interaction effect (F(2,95) = 3.775, p = 0.026).  There 
were no significant effects of age in either genotype (WT: F(2,95) = 2.230, p = 0.113; KO: F(2,95) = 
2.454, p = 0.091). Genotype differences were present only in the 12 week group (F(1,95) = 15.830, 
p < 0.001) and not in the 4 week (F(1,95) = 0.034, p = 0.854) or 8 week groups (F(1,95) = 0.483, p = 
0.489).  (Figure 5.3).   All age and genotype groups demonstrated significant prepulse inhibition 
in response to all noise prepulse intensities tested (p < 0.01). 
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Figure 5.3. Noise-PPI in kalirin WT and KO mice at 4, 8, and 12 weeks of age.  Magnitude of noise-PPI as a 
function of increasing prepulse intensity in WT(A) and KO (B) mice.  C) Average noise-PPI for all prepulse 
intensities in WT and KO mice by age. **p < 0.01.  Animal numbers per group- Genotype: Age (N): WT: 4 weeks 
(18), 8 weeks (17), 12 weeks (18); KO: 4 weeks (13), 8 weeks (15), 12 weeks (22).  Error bars are ± SEM. 
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Acoustic startle reflex amplitude has been previously reported to be reduced in kalirin 
KO compared to WT mice (Cahill et al., 2009;Mandela et al., 2012).  We also found an overall 
effect of genotype on acoustic startle reflex amplitude (F(1,95) = 24.685, p < 0.001) (Appendix 
Figure D.2).  The acoustic startle reflex was significantly reduced in the KO in the 8 week (F(1,95) 
= 14.756, p < 0.001) and 12 week (F(1,95) = 15.265, p < 0.001) but not in the 4 week old group 
(F(1,95) = 0.978, p = 0.325).  There was a trend toward an overall effect of age which did not reach 
significance (F(2,95) = 2.681, p = 0.074).  We defined threshold to startle as the first of two 
consecutive stimulus intensities to elicit a change in response amplitude compared to the 
background (no stimulus) trials.  In the 12 week old animals, the KO threshold to startle was 
greater than the WT threshold, but threshold to startle in all groups was reached with either 85 or 
95 dB noise pulses. 
5.3.3 Gap-PPI increases between early adolescence and young adulthood in CBA/CaJ and 
C57Bl/6J, but not in DBA/2J mice 
None of the strains exhibited significant changes in gap-PPI responses with age (CBA/CaJ: F(2,42) 
= 1.819, p = 0.175; C57Bl/6J: F(2,43) = 1.695, p = 0.196; DBA/2J: F(2,43) = 0.797, p = 0.457).  
However, we observed age by gap interaction effects in the CBA/CaJ and C57Bl/6J strains 
(CBA/CaJ: F(4.333, 90.985) = 2.469, p = 0.046; C57Bl/6J: F(6,129) = 2.397, p = 0.031).  Our analyses 
indicated a significant effect of age in these strains on the mean gap-PPI response to 40-100 ms 
gap durations (CBA/CaJ: F(2, 42) = 3.209, p = 0.050; C57Bl/6J: F(2,43) = 4.682, p = 0.014).  No age 
by gap interaction effect was observed in the DBA/2J mice (F(6,129) = 1.195, p = 0.313) (Figure 
5.4); however, 12 week old DBA/2J mice failed to demonstrate significant PPI in response to any 
of the gap durations tested.  Increasing background noise intensity in attempt to increase saliency 
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had no effect on prepulse inhibition in response to gaps in the DBA/2J mice of any age group 
(effect of background intensity: (F(1,66) = 0.041, p = 0.841; intensity by age interaction: F(2,66) = 
























Figure 5.4. Gap-PPI in CBA/CaJ, C57Bl/6J, and DBA/2J at 4, 8, and 12 weeks of age.  Mean gap-PPI in 4, 8, 
and 12 week old CBA/CaJ (A) C57Bl/6J (B) and DBA/2J (C). Significance markers indicate age effects within each 
strain that were present at indicated gap duration bins. *p < 0.05.  Arrows indicate group gap detection thresholds in 
4 week old (solid), 8 week old (light fill), and 12 week old (white fill) animals.  D) Average gap-PPI for all gap 
durations in CBA/CaJ, C57Bl/6J and DBA/2J mice by age.  No significant overall age effects were observed in any 
strain.  Animal numbers per group- Strain: Age (N): CBA/CaJ: 4 weeks (15), 8 weeks (16), 12 weeks (16); 
C57Bl/6J: 4 weeks (16), 8 weeks (16), 12 weeks (16); DBA/2J: 4 weeks (16), 8 weeks (16), 12 weeks (16).  Error 
bars are ± SEM. 
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We found that gap detection thresholds of CBA/CaJ mice were already maximal at 4 
weeks and did not change between 4 and 12 weeks of age (4 weeks: 1-2 ms, 8 weeks: 1-2 ms, 12 
weeks: 1-2 ms).  However, gap detection thresholds of C57Bl/6J mice decreased between 4 and 
12 weeks (4 weeks: 40-100 ms, 8 weeks: 10-20 ms, 12 weeks: 4-7 ms).  In contrast, gap 
detection thresholds of DBA/2J mice did not decrease between 4 and 8 weeks of age (4 week: 
40-100ms, 8 week: 40-100 ms) and could not be measured at 12 weeks, but our data suggest the 
threshold for this group is greater than 100 ms. 
We also evaluated the proportion of animals in each strain by age group that showed 
modulation of the startle reflex by silent gaps.  We did not observe any changes with age in the 
proportion of animals that showed gap responsiveness in CBA/CaJ (χ2 = 2.69, df = 2, p = 0.264), 
C57Bl/6J (Fisher’s exact test: p = 1.00), or DBA/2J (Fisher’s exact test: p = 1.00) (Table D.1).  
At 4 weeks, there were no differences in the proportions of each strain that showed modification 
of startle by gaps (Fisher’s exact test: p = 0.103); however there were significant strain 
differences in proportions of animals that showed significant modification of startle by gaps at 8 
(Fisher’s exact test: p = 0.009) and 12 weeks (Fisher’s exact test: p = 0.0007).  No analyses were 
carried out on only the animals with significant modulation of startle by gaps due to the low 
numbers (< 50%) in the C57Bl/6J and DBA/2J groups. 
5.4 DISCUSSION 
Here we report that gap-PPI responses increase across the time period between early and late 
adolescence in wild type C57Bl/6NJ mice (Figure 5.5).  This does not appear to be attributable 
to increased PPI in general, as noise-PPI responses did not significantly increase during this time.  
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Kalirin KO mice failed to show any significant changes in gap-PPI between early and late 
adolescence.  It is possible that this is a functional indicator of abnormal auditory cortex synapse 
development in mice lacking kalirin (see chapter 4).  Gap-PPI responses increased for long 
duration gaps between early adolescence and young adulthood in C57Bl/6J and CBA/CaJ mice.  
DBA/2J mice, which exhibit early adolescent onset high frequency hearing loss, did not show 
any increase in gap-PPI responses between early adolescence and young adulthood, probably 



















 Figure 5.5. Trajectories of gap-PPI and noise-PPI magnitude across adolescence and young adulthood in WT 
and kalirin KO mice.  A) Mean gap-PPI responses increase during adolescence in WT but not kalirin KO mice.  
Horizontal lines and significance markers indicate overall age effects for WT (black) and KO (blue).  **p < 0.01; 
n.s. not significant. B) Mean noise-PPI responses do not change significantly with age in either WT or kalirin KO 
mice.  Consistent with other studies, kalirin KO mice exhibit a deficit in noise-PPI in young adulthood.  **p < 0.01 










5.4.1 Improved gap-PPI in WT but not kalirin KO during adolescence 
We found an increase in gap-PPI between 4 and 8 weeks of age in wild type mice of the 
C57Bl/6NJ background, suggesting that gap-PPI matures during adolescence in mice of this 
strain.  This agrees with a previous study that gap detection threshold decreases between 1 and 2 
months of age in rats (Friedman et al., 2004; Sun et al., 2008; Sun et al., 2011).  As auditory 
cortex has been shown to be required for detection of silent gaps (Ison et al., 1991; Bowen et al., 
2003) we speculate that pruning of excitatory synapses in auditory cortex during this time (see 
chapter 4) may contribute to maturation of gap-PPI. 
In contrast to the WT mice, we saw no improvement of gap-PPI over adolescence in the 
kalirin KO mice.  This suggests that the process of gap-PPI maturation is impaired in the absence 
of kalirin.  Further, we observed a trend toward increased gap-PPI in 4 week old kalirin KO 
animals compared to WT when we included only animals that demonstrated significant gap-
prepulse modulation of the startle reflex (Figure D.1).  In this analysis, the gap detection 
threshold was higher in 4 week old WT compared to KO, suggesting that gap-PPI is already at 
“mature” levels in early adolescent kalirin KO mice, and then remains unchanged while WT gap-
PPI matures across adolescence.  This parallels our findings of auditory cortex spine numbers 
between early adolescence and young adulthood in WT and kalirin KO mice (see chapter 4).  In 
WT mice, spine numbers decrease between early adolescence and young adulthood, while in 
spine numbers were already slightly reduced in early adolescence of mice lacking kalirin and did 
not decrease further by young adulthood.  Thus, it may be that primary auditory cortex spine 
pruning contributes to the maturation of gap-PPI.  Further studies to examine the relationship 
between auditory cortex spine pruning and gap-PPI should be done in other models of dendritic 
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spine disruption, such as mice lacking Abl-related gene (Arg) kinase, which exhibit a deficit in 
frontal cortex spine density throughout adolescence (Gourley et al., 2012). 
Our data also suggest that the failure of kalirin KO mice to show improvement in gap-PPI 
over adolescence is not fully attributable to abnormal PPI responses in general (Cahill et al., 
2009).  We found that mice lacking kalirin do not demonstrate impaired noise-intensity PPI until 
young adulthood.  Therefore, failure of gap-PPI responses to increase during adolescence is 
likely not attributable to general PPI impairment.  Alternatively, it may be that gap-PPI is more 
sensitive to earlier impairments in mechanisms common to both noise and gap-PPI, and so it is 
possible that general impairment of PPI circuitry contributes to both observations.  This could be 
confirmed using non-PPI paradigms, such as conditioned suppression (Heffner et al., 2006) to 
assess gap detection in adult kalirin KO mice. 
5.4.2 Development of noise intensity-PPI and acoustic startle reflex impairments in 
kalirin KO mice 
Cahill et al (2009) reported impaired prepulse inhibition of the acoustic startle reflex with noise 
prepulses of increasing intensity and reduced startle response in adult kalirin KO mice.  A 
conflicting report using a different kalirin KO model reported a reduction in acoustic startle 
response, but no deficit in noise-intensity prepulse inhibition (Mandela et al., 2012) in animals 
between 2 and 3 months of age.  We found that prepulse inhibition is impaired in kalirin KO 
mice beginning in young adulthood, while a deficit in acoustic startle reflex amplitude is 
apparent at the end of adolescence.  Therefore, we have identified a potential developmental 
explanation which reconciles the previously reported conflicting findings.  It may be possible to 
observe an overall impairment in acoustic startle reflex without an accompanying deficit in 
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noise-PPI prior to young adulthood.  This highlights the need to consider developmental changes 
which may occur during and following adolescence when evaluating genetic animal models.   
5.4.3 Improvement in gap-PPI during adolescence in CBA/CaJ and C57Bl/6J  
We found that gap-PPI improves between early adolescence and young adulthood in CBA/CaJ 
and C57Bl/6J inbred strains, reflected in increased PPI for long duration gaps and, for the 
C57Bl/6J, by reduced gap-PPI thresholds.  The improvement with age in these strains was not as 
robust as in the WT mice of the C57Bl/6NJ background.  Differences in traditional noise-PPI 
between the C57Bl/6N and 6J substrains have been reported (Grottick et al., 2005).  Similar to 
that study we observed greater magnitudes of noise-PPI and lower amplitude of the acoustic 
startle response in the C57Bl/6NJ-WT mice.  It may be that the substrains also differ in gap-PPI, 
and further illustrates the importance of strain (and substrain) considerations when evaluating 
genetic animal models. 
5.4.4 Impaired gap-PPI in DBA/2J mice during late adolescence and adulthood 
Studies have shown that high frequency components of sound may contribute to the detection of 
silent gaps in noise by mice (Radziwon et al., 2009).  The fact that DBA/2J mice show no 
increase in gap-PPI responses and no decrease in gap-PPI threshold over adolescence, and a lack 
of significant gap-PPI with gaps < 100 ms by 12 weeks, is consistent with this observation.  Mice 
of the DBA/2J strain background demonstrate high frequency hearing loss which begins at about 
4 weeks of age (Willott et al., 1994).  Therefore, the poor gap-PPI performance that we observed 
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is likely attributable to progressive inability to detect high frequency components of sound 
required for silent gap detection.   
5.4.5 Methodological considerations 
Modification of the acoustic startle reflex by silent gaps embedded in a constant acoustic 
background has been used as a behavioral measure to determine the presence of tinnitus 
(perception of ringing in the ears) in animals (Turner et al., 2006).  Evidence to support the role 
of the auditory cortex in gap processing comes from experiments where the auditory cortex is 
lesioned (Bowen et al., 2003), or after functional decortication with potassium chloride (Ison et 
al., 1991).  Gap-PPI deficits have also been identified in the rat microgyria model of cortical 
developmental disruption (Peiffer et al., 2004; Threlkeld et al., 2009), and a middle cerebral 
artery occlusion stroke mouse model (Truong et al., 2012).   These studies all support the idea 
that compromised cortical function impairs gap-PPI.  However, a potential caveat of our use of 
this technique is that auditory cortex may be necessary, but subcortical components regulating 
noise-PPI are probably also important.  Therefore, the maturation in gap-PPI that we observed 
could be attributable to changes in any of those components, although in that case we might 
expect to observe the same increase in noise-PPI.  In particular, inferior colliculus responses to 
silent gaps demonstrate similar gap detection thresholds as behaviorally measured thresholds.  It 
is important to keep in mind that it is possible that maturation of other components of the 
auditory system, such as the inferior colliculus, may underlie the increase in gap-PPI we 
observed during adolescence.   
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5.4.6 Conclusions 
In summary we have found that gap-PPI responses increase between early and late adolescence 
in WT mice, but not in mice lacking kalirin.  Given that we have previously found subtle 
disruptions in trajectories of adolescent and early adulthood changes in excitatory and inhibitory 
synapses in auditory cortex of kalirin KO mice (see chapter 4), and auditory cortex is necessary 
for normal gap-PPI responses, it is possible that this finding reflects abnormal auditory cortex 
synapse development in mice lacking kalirin.  Future studies of gap-PPI in other genetic animal 
models of schizophrenia relevant excitatory synapse pathology will contribute to our 
understanding of the circuitry underlying the increase in gap-PPI during adolescence in mice.   
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6.0  GENERAL DISCUSSION 
6.1 SUMMARY OF FINDINGS 
Individuals with schizophrenia demonstrate auditory processing impairments that range from the 
most basic levels of tone discrimination all the way up to complex perceptual tasks such as 
comprehension of speech prosody and semantics.  These impairments likely contribute to some 
of the highly debilitating negative and cognitive symptoms of schizophrenia, for which there are 
few, if any, satisfactory treatments.  In order to develop new treatments and preventions for these 
debilitating symptoms, we must first understand the neurobiology of their origin.  As the clinical 
onset of schizophrenia commonly occurs later in adolescence and in young adulthood, 
adolescence represents a potential window where preventative measures could be implemented 
to mitigate or reverse neuropathological changes that contribute to symptom onset.  However, 
the adolescent developmental trajectories of the synaptic features in auditory cortex that we may 
wish to target with future preventative strategies have not been fully characterized.  The goals of 
these studies were to determine whether excitatory and inhibitory presynaptic bouton alterations 
contribute to schizophrenia primary auditory cortex synaptic pathology, and to evaluate, in a 
mouse model, adolescent developmental trajectories of auditory cortex synapse components 
affected in schizophrenia, and adolescent development of auditory cortex function.  In the 
following sections we will review the findings of the experimental chapters, and then discuss the 
 164 
broader implications of these findings in the context of an updated adolescent 
neurodevelopmental model of schizophrenia, highlighting the relationship between dendritic 
spines and within-bouton GAD65 protein in the primary auditory cortex.  Finally, we will 
discuss implications for interpreting our findings beyond the auditory cortex, and caveats 
associated with genetic mouse models of schizophrenia.   
6.1.1 Excitatory and inhibitory presynaptic components in auditory cortex in 
schizophrenia 
Because dendritic spine density is reduced in primary auditory cortex of subjects with 
schizophrenia, we hypothesized that presynaptic excitatory boutons are also reduced, which 
could indicate excitatory synapse loss.  In chapter 2, we determined that two populations of 
excitatory boutons in the primary auditory cortex, VGluT1-expressing intracortical excitatory 
and VGluT2-expressing thalamocortical boutons, are unaltered in density, number, and levels of 
VGluT protein in subjects with schizophrenia.  Another recent study also failed to identify 
changes in protein levels of VGluT1 and VGluT2 in the STG (Shan et al., 2013), which is 
consistent with the idea that numbers of excitatory boutons and their levels of VGluT protein are 
unaltered in the auditory cortex.  The lack of change in excitatory boutons was unexpected, given 
the previously observed reductions in auditory cortex deep layer 3 dendritic spines (Sweet et al., 
2009), which are the primary postsynaptic targets of glutamatergic boutons in the cortex.  Our 
findings could indicate a disproportionate number of excitatory boutons synapsing on dendritic 
shafts in the auditory cortex of subjects with schizophrenia.  Future studies using both 
quantitative fluorescence microscopy and electron microscopy methods can address this question 
by quantifying the proportions of VGluT1 and VGluT2- expressing boutons which form 
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synapses with dendritic spines versus dendritic shafts in individuals with schizophrenia 
compared to healthy controls.  We predict that there may be an increase in the proportion of 
dendritic shaft synapses in the auditory cortex relative to spine excitatory synapses, and results 
supporting this hypothesis have been described in other brain regions (Barksdale et al., 2012).  
Although the electrophysiological significance of shaft compared to spine synapses are not well 
understood, shaft synapses may elicit larger excitatory potentials in postsynaptic pyramidal 
neurons compared to spine synapses (Segal, 2010).   The downstream consequences of this for 
neuronal activity are not clear, but this may render pyramidal cells more vulnerable to other 
insults (Fishbein and Segal, 2007), and could have an effect on firing rates and input summation 
(Shepherd et al., 1989; Jaslove, 1992; Tsay and Yuste, 2004).  However, spines do contribute to 
segregation of frequency-specific inputs to neurons in primary auditory cortex (Chen et al., 
2011b) and so loss of spines may impair frequency tuning of primary auditory cortex neurons 
and contribute to tone discrimination deficits in schizophrenia.  Future studies should also 
determine whether protein levels of other glutamatergic synaptic components implicated in 
schizophrenia are altered (Mirnics et al., 2000), as this could impact excitatory synapse function 
independent of a reduction in the number of boutons, or levels of VGluT protein within boutons. 
Given the electrophysiological evidence for disruptions in aSSR and auditory evoked 
oscillatory activity in individuals with schizophrenia, we hypothesized that GABAergic signaling 
may be impaired in the primary auditory cortex.  In particular, we wanted to examine levels of 
the 65 kDa isoform of GAD, due to its role in fast, on-demand GABA production.  In chapter 3, 
we demonstrated that levels of GAD65 protein are reduced within inhibitory boutons in deep 
layer 3 of the primary auditory cortex.   Evidence suggests that primary auditory cortex is 
specialized for processing of fast temporal information, and inhibitory responses in auditory 
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cortex have been found to be faster than in other cortical areas (Hefti and Smith, 2000).  Reduced 
levels of GAD65 protein may indicate a reduction of GABA synthesis within inhibitory 
terminals.  This may be particularly detrimental during conditions requiring high rates of 
inhibitory neuron firing, when GAD65-mediated GABA synthesis is likely to be important (Tian 
et al., 1999).  High rates of interneuron firing may contribute to generation of auditory steady 
state responses and gamma range oscillatory activity, which are impaired in schizophrenia.  
Therefore, we propose that reduced GAD65 protein in auditory cortex inhibitory neurons could 
contribute to the abnormal auditory evoked steady state responses and impairments in gamma-
range oscillations observed in individuals with schizophrenia.  In section 6.2.2, we outline some 
potential mechanisms by which GAD65 protein reduction could occur. 
As balanced excitation and inhibition are important for processing auditory information 
(Wehr and Zador, 2003; Wu et al., 2008), we wanted to examine correlations between excitatory 
and inhibitory synaptic components in primary auditory cortex of subjects with schizophrenia.  
Interestingly, we observed that reductions in GAD65 protein are correlated with previously 
identified reductions in spinophilin-immunoreactive spine density in the same subjects (Sweet et 
al., 2009).  This suggests a relationship between levels of GAD65 and dendritic spines in the 
auditory cortex.    The implications of this relationship are discussed at length in section 6.2. 
6.1.2 Adolescent development of excitatory and inhibitory synaptic components of mouse 
primary auditory cortex and functional implications 
Given the evidence for correlated reductions in dendritic spines and GAD65 in auditory cortex of 
subjects with schizophrenia, we hypothesized that reductions in GAD65 occur following 
dendritic spine pruning in the auditory cortex during adolescence.  We also wanted to determine 
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if excessive dendritic spine pruning occurs in the auditory cortex in the absence of kalirin, a 
regulator of dendritic spine development and stability.  Additionally, we wanted to assess how 
the absence of kalirin affects development of excitatory and inhibitory synapse components in 
auditory cortex, which are disrupted in schizophrenia.  In chapter 4, we observed evidence for 
pruning of dendritic spines in auditory cortex of wild type mice between early adolescence and 
young adulthood.  This was accompanied by the subsequent onset of a marked reduction in 
within-bouton GAD65 protein between late adolescence and young adulthood.  This temporal 
relationship suggests that spine pruning precedes the onset of the reduction in GAD65 protein, 
which lends insight into the directionality of the correlation we observed between dendritic spine 
density and GAD65 protein reductions in schizophrenia.   
In contrast to what has been observed in the frontal cortex (Cahill et al., 2009), we did not 
find evidence for increased pruning of spines between early adolescence and young adulthood in 
the auditory cortex of the kalirin KO mice.  In fact, there was no evidence for spine pruning 
during this time in the kalirin KO, suggesting one of a few possibilities.  First, it may be that 
mice lacking kalirin fail to generate the normal number of dendritic spines in the auditory cortex 
during postnatal development, resulting in a reduced number of spines which are then not pruned 
during adolescence.  Second, it may be that dendritic spine pruning in auditory cortex occurs 
earlier in mice lacking kalirin, so that by early adolescence, mature numbers of spines are 
already attained.  It is also possible that either of these options is coupled with an adult phase of 
spine elimination (later than 12 weeks of age) that would ultimately lead to reduced spine density 
in the auditory cortex of the kalirin KO.  We can distinguish between these possibilities in future 
studies expanding the time window to examine spine density in early postnatal development 
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through later in adulthood in order to determine whether spine pruning occurs outside of 
adolescence in the kalirin KO.   
In chapter 5, we used gap-PPI as a measure of auditory cortex function, and hypothesized 
that abnormal adolescent spine development in the kalirin KO mice would be associated with 
impaired gap-PPI, while WT mice would show improvement in gap-PPI over adolescence.  We 
found that gap-PPI responses increase during adolescence in WT mice, similar to improvements 
in gap-PPI observed in rats (Friedman et al., 2004; Sun et al., 2008; Sun et al., 2011).  This was 
not attributable to a general increase in noise-PPI responses, suggesting that the improvement 
over adolescence is specific for gap-PPI and may indicate functional maturation of the auditory 
cortex.  In the kalirin KO mice, which do not demonstrate spine pruning in auditory cortex 
between early adolescence and young adulthood, gap-PPI responses also do not increase.  This 
suggests there may be subtle functional consequences for auditory cortex when adolescent spine 
pruning does not occur normally.  However, further studies of auditory cortex in animal models 
where excessive spine pruning occurs should be done to evaluate whether excessive adolescent 
spine pruning in the auditory cortex causes impairments in schizophrenia-relelvant auditory 
cortex function. 
Although inactivation and lesion studies in animals have demonstrated a role for the 
auditory cortex in gap-PPI (Ison et al., 1991; Bowen et al., 2003), the physiological mechanisms 
underlying cortical contributions to gap-PPI are not known.  A potential avenue by which the 
primary auditory cortex could influence PPI circuitry is via subcortical projections from layer 5 
neurons.  The inferior colliculus is an important component of the circuitry mediating PPI (Fendt 
et al., 2001).  The lack of an increase in gap-PPI with age in mice lacking kalirin could be 
mediated by the effects of kalirin loss in primary auditory cortex layer 5 pyramidal neurons, as 
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layer 5 neurons project back to the inferior colliculus (Mitani and Shimokouchi, 1985).  Further, 
kalirin protein expression in the cortex is particularly prominent in layer 5 pyramidal neurons 
(Ma et al., 2001).  The subtle disruptions in the development of excitatory and inhibitory 
synaptic components that we observed in layers 2 through 4 of the auditory cortex in the kalirin 
KO could influence layer 5 output to the inferior colliculus via feed forward projections to layer 
5 neurons from layer 2 and 3 pyramidal neurons.  Future studies will be necessary to elucidate 
the laminar contributions of primary auditory cortex to gap-PPI responses. 
6.2 CONSIDERATION OF AUDITORY CORTEX NEUROPATHOLOGY IN THE 
CONTEXT OF ADOLESCENT NEURODEVELOPMENT 
The fact that late adolescence and young adulthood typically correspond to emergence of 
psychotic symptoms in schizophrenia suggests that this period of postnatal development factors 
heavily in the pathogenesis of the disease.  A better understanding of the normal developmental 
processes occurring in the auditory cortex during this time will inform the development of 
preventative measures to counteract the pathophysiological mechanisms which lead to 
schizophrenia.  In the following sections we will discuss an updated model of synapse pathology 
in the auditory cortex of subjects with schizophrenia in the context of what we have learned 
about adolescent synaptic component development in the mouse auditory cortex.   
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6.2.1 Developmental context for the relationship between dendritic spine and GAD65 
protein reductions in auditory cortex of subjects with schizophrenia 
Dendritic spines are anatomical substrates for neural circuit plasticity, and growth and retraction 
of spines are associated with induced forms of plasticity such as long term potentiation and 
depression (LTP and LTD), respectively (Bosch and Hayashi, 2012).  We found that reduced 
within-bouton GAD65 protein levels are correlated with reduced dendritic spine density in deep 
layer 3 of primary auditory cortex of subjects with schizophrenia.  The correlation suggests that 
they may be related pathological features of schizophrenia.  In mouse auditory cortex, we found 
evidence that dendritic spine pruning occurs between early adolescence and young adulthood, 
while a reduction in within-bouton GAD65 protein levels occurs between the end of adolescence 
and early adulthood.  We cannot infer directionality of a relationship between dendritic spines 
and GAD65 protein based on the correlation we observed in schizophrenia.  However, the timing 
of the two features during adolescent development in the mouse suggests that a reduction in 
GAD65 protein could follow a reduction in dendritic spines.  Experimental evidence also favors 
this direction.  Decreased excitatory activity, which can accompany reductions in spines in 
cultured hippocampal neurons after treatment with pharmacological convulsants (Muller et al., 
1993), or decreases in sensory input, which alters sensory cortex excitability (Lambo and 
Turrigiano, 2013), lead to decreased GAD expression (Hendry and Jones, 1988; Welker et al., 
1989; Huntsman et al., 1995; Patz et al., 2003).  In contrast, a model where a primary deficit in 
GAD65 protein occurs first and subsequently elicits a reduction in dendritic spines is less 
favorable based on existing evidence.   For example, GAD65 KO mice, which exhibit decreased 
inhibitory transmission during sustained neural activity (Tian et al., 1999), are reported to have 
elevated, rather than reduced, dendritic spine density (Mataga et al., 2004).  Also, spine density 
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increases when cultured hippocampal neurons are exposed to mercaptopropionic acid, a GAD 
inhibitor (Murphy et al., 1998).  Finally, in the visual cortex, monocular deprivation-induced loss 
of dendritic spines in cortical layers 2 and 3 does not occur in the absence of GAD65 (Fagiolini 
and Hensch, 2000).  This suggests that reduction of GAD65 protects against plasticity-induced 
loss of dendritic spines.  Taken together, this evidence suggests that a primary deficit in 
inhibition would increase the density of dendritic spines, which is not the case in the auditory 
cortex of individuals with schizophrenia. Therefore, if a causal relationship between reduced 
spine density and GAD65 expression in schizophrenia does exist, it is unlikely that spine loss is a 
consequence of reduced GAD65 levels in schizophrenia.  In contrast, there is more evidence to 
support the idea that a primary reduction in dendritic spines could elicit subsequent reductions in 
GAD65 protein levels. 
We propose a developmental model of auditory cortex excitatory and inhibitory synapse 
impairment in schizophrenia, summarized in Figure 6.1.  Normally, dendritic spine pruning 
occurs during adolescence, and is followed by a reduction in within-bouton GAD65 protein 
levels between the end of adolescence and early adulthood.  In individuals with schizophrenia, 
excessive dendritic spine pruning is followed by a parallel excessive decrease in within-bouton 
levels of GAD65 protein.  It may be that the reduction in GAD65-mediated GABA synthesis is a 
compensatory response to reduced excitatory drive induced by a reduction of dendritic spines.  In 
the following sections, we present potential mechanisms by which excitatory activity can alter 
levels of GAD65 protein.  Also, we review evidence suggesting that the down-regulation of 
GAD65 protein at the end of adolescence could be a mechanism for decreasing the rate of spine 
elimination at the end of adolescence.  It should be noted that our findings are not by any means 
sufficient to determine a causal relationship between spine pruning and reduction of GAD65 
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during adolescence or in schizophrenia.  However, identification of the association between 
excitatory and inhibitory synaptic components in development and in schizophrenia lays the 
groundwork for future studies to further investigate the potential for a causal relationship, and 
what the mechanisms regulating such a relationship might be.  Further, we have identified the 
transition between the end of adolescence and the beginning of early adulthood as a 
developmental time period during which GAD65 protein levels in the auditory cortex are 
changing and could be vulnerable to perturbation. The validity of the model should be tested in 
future studies, using convergent models to both increase and decrease the extent of cortical spine 
















 Figure 6.1. Proposed adolescent developmental model for spine and GAD65 protein reductions in auditory 
cortex during adolescence and in schizophrenia.  Left. Spines (red) decrease in auditory cortex between early 
adolescence and young adulthood, followed by a reduction in within-bouton GAD65 protein levels (blue) between 
late adolescence and young adulthood.  In schizophrenia, deficits in within-bouton GAD65 protein develop 
subsequent to deficits in dendritic spine density (dashed lines).  Right.  Time course depicting deficits (difference 
from healthy controls).  Deficits in dendritic spines develop first (red), followed by deficits in GAD65 protein levels 
(blue).  We speculate that electrophysiological deficits (purple) in auditory processing develop subsequent to 




6.2.2 Mechanisms for GAD65 reduction in development and in disease 
The mechanisms regulating GAD65 expression are not yet fully understood, but multiple studies 
have demonstrated that GAD65 is regulated by excitatory activity.  First, there is evidence from 
studies of kalirin that excitatory synapses onto inhibitory interneurons influence levels of 
GAD65 protein.  Kalirin-7 protein is expressed adjacent to VGluT1-expressing puncta in 
cultured hippocampal interneurons (Ma et al., 2008), indicating that kalirin is a component of 
excitatory synapses onto the dendritic shafts of interneurons.  In chapter 4, we describe that 
between late adolescence and young adulthood the within-bouton levels of GAD65 protein 
decrease in the auditory cortex of WT mice.  However, in mice lacking kalirin, we did not 
observe a significant reduction in within-bouton GAD65 during this time.  Complementary to 
our results, expression of exogenous kalirin-7 in cultured hippocampal interneurons results in a 
decrease in GAD65 protein levels (Ma et al., 2011).  Together, this evidence suggests that kalirin 
expressed at postsynaptic sites of excitatory synapses onto interneurons is important for 
regulating GAD65 protein levels, and disruption of excitatory synapses by removing kalirin 
leads to altered regulation of GAD65 protein levels between late adolescence and young 
adulthood. 
 Blocking the NMDA subtype of ionotropic glutamate receptor has been shown to exert a 
substantial impact on interneuron activity (Homayoun and Moghaddam, 2007).   Decreased 
expression of GAD by blocking neuronal activity chemically or through sensory deprivation 
(Hendry and Jones, 1988; Welker et al., 1989; Huntsman et al., 1995; Patz et al., 2003) could be 
mediated through the NMDA subtype of ionotropic glutamate receptor.  In support of this, MK-
801 administration decreases levels of GAD65 mRNA in rat frontal and cingulate cortex 
(Laprade and Soghomonian, 1995). Although comparatively less work has been done 
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investigating consequences of NMDA signaling on GAD65, findings that blocking NMDA 
receptors reduces the expression of the 67 kDa isoform of GAD are well replicated (Qin et al., 
1994; Bacci et al., 2002; Paulson et al., 2003; Turner et al., 2010).  Evidence for NMDA receptor 
involvement in schizophrenia stems from observations that pharmacological antagonists, such as 
PCP and ketamine, that target NMDA receptors, recapitulate some of the symptoms of 
schizophrenia in otherwise healthy individuals, and exacerbate symptoms in individuals with 
schizophrenia (Javitt, 2007).  It may be that one of the long term consequences of altered 
glutamatergic signaling in schizophrenia (Moghaddam and Javitt, 2012) is a decrease in the 
levels of GAD65 protein in the auditory cortex of subjects with schizophrenia.     
GAD65 gene transcription is influenced by CREB-mediated BDNF signaling (Sanchez-
Huertas and Rico, 2011).  Pyramidal neurons secrete BDNF in an activity dependent manner 
(Cellerino et al., 1996; Marty et al., 1997) which then interacts with the trkB receptor expressed 
in GABAergic inhibitory neurons (Cellerino et al., 1996; Gorba and Wahle, 1999).  BDNF levels 
are sensitive to sensory input, as expression in visual cortex is decreased after monocular 
deprivation, and increased by exposure to light (Castren et al., 1992; Bozzi et al., 1995).  In the 
hippocampus, increased BDNF signal is correlated with increased GAD65 protein following a 
contextual fear conditioning paradigm (Chen et al., 2007).  Further, manipulating levels of 
BDNF in rat primary auditory cortex distorts development of tonotopic representations in the 
cortex, and alters expression of GABAA receptors (Anomal et al., 2013).  This suggests that 
BDNF is tightly linked to plasticity and inhibitory signaling in sensory cortices. 
 The developmental trajectory of BDNF expression in auditory cortex is not yet known in 
detail; however, in general, levels of BDNF in the rat auditory cortex increase between P12 and 
14 weeks (Zhou et al., 2011), although levels were not assessed during adolescence.  However, in 
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rat, BDNF levels in the cortex peak during adolescence and decline between 2 and 4 months of 
age (Katoh-Semba et al., 1997).  Future studies should determine whether the decline in BDNF 
expression between late adolescence and young adulthood also occurs in auditory cortex.  This 
decline in BDNF levels parallels the decrease we observed in GAD65 protein levels between late 
adolescence and young adulthood, consistent with the idea that BDNF signaling influences 
expression of GAD65.  Interestingly, there is some evidence that BDNF levels are abnormal in 
schizophrenia (Green et al., 2011).  If reduced BDNF signaling in schizophrenia plays a role in 
the reduction in GAD65 protein levels within boutons, a reduction in GAD65 mRNA, and 
cognate protein, within inhibitory neurons in the auditory cortex of subjects with schizophrenia 
may be a consequence.  
It is important to consider alternative mechanisms beyond gene transcription that could 
contribute to a change in GAD65 protein levels during development and in schizophrenia.  
Although translational mechanisms involved in GAD65 protein synthesis have not yet been 
elucidated, regulation of this process could change during development or be affected in 
schizophrenia.  Future studies comparing GAD65 mRNA and protein levels in deep layer 3 of 
primary auditory cortex of subjects with schizophrenia may be able to distinguish between 
transcriptional and translational mechanisms of GAD65 protein reduction in schizophrenia, or 
during development.  Another important step in GAD65 protein availability is its targeting to the 
presynaptic bouton, where it synthesizes GABA for packaging into vesicles. A dynamic 
palmitoylation and depalmitoylaion cycle is responsible for shuttling GAD65 back and forth 
between the golgi apparatus and the presynaptic bouton (Kanaani et al., 2008).  It will be 
important to further determine whether neuronal activity, developmental influences, and 
schizophrenia impact the mechanism targeting GAD65 to the presynaptic bouton.  Future studies 
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could address this by quantifying levels of GAD65 protein within the cell soma to determine if 
there is a relative increase in somal GAD65 protein in schizophrenia, which would be suggestive 
of a failed transport mechanism.  Further, it may be that protein degradation is altered in 
individuals with schizophrenia.  GAD65 is reported to have a relatively longer half-life when 
compared to GAD67 (Christgau et al., 1991), however if protein stability or degradation is 
affected in schizophrenia this could potentially cause a reduction in within-bouton GAD65 
protein.    
Finally, it must be noted that we cannot definitively infer GABA synthesis activity from 
levels of GAD65 protein.  Several activity-dependent mechanisms are in place to regulate the 
GABA synthesizing activity of GAD65.  First, GABA synthesis by GAD65 is highly activity 
dependent (Martin et al., 1991).  GAD65 exists mainly in the inactive apoenzyme form, and 
binding to its cofactor, pyridoxal 5’-phosphate (PLP), is required for conversion to the active 
holoenzyme form.  Factors promoting formation of the holoenzyme include free inorganic 
phosphate, which may originate from the breakdown of ATP during synaptic activity, while ATP 
itself actually competes for the PLP binding site and prevents formation of the holoenzyme 
(Battaglioli et al., 2003).  Therefore, increased metabolism of ATP during high levels of synaptic 
activity favors the conversion of apoGAD65 to holoGAD65 to promote increased GABA 
synthesis.  In vitro, GAD65 is activated via phosphorylation by protein kinase C (PKC) (Wei et 
al., 2004), thought to be mediated by PKCε, which is highly localized to presynaptic boutons in 
the brain (Tanaka and Nishizuka, 1994).  Interestingly, inhibition of PKC in vivo protects against 
stress-induced cortical spine loss in rats (Hains et al., 2009).  This could be further, albeit 
indirect, evidence that a decrease in GAD65 activity reduces the likelihood of spine elimination 
in the cortex.  Regulator of G-protein signaling-4 (RGS4) is reported to be disrupted in 
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schizophrenia and plays a role in inhibiting PKC signaling (Mirnics et al., 2001).   Excessive 
PKC signaling in individuals with schizophrenia would promote activation of GAD65, which 
could possibly offset the effects of reduced GAD65 protein on GABA synthesis.  The complex 
regulation of GAD65-mediated GABA synthesis suggests that considering factors such as 
protein phosphorylation and synaptic bouton energy metabolism will aid our understanding of 
inhibitory transmission in schizophrenia and adolescent development. 
6.2.3 Decrease in GAD65 protein as a signal for the end of adolescence 
We cannot say with any certainty what the biological relevance of a reduction of GAD65 protein 
within inhibitory boutons at the end of adolescence might be.  It has been proposed that LTD 
mechanisms play a role in adolescent spine pruning (Selemon, 2013).  Therefore, the end of 
adolescence may be characterized by a down-regulation in LTD-promoting mechanisms in the 
cortex until rates of spine elimination and formation are balanced in adulthood (Zuo et al., 2005).  
Given the impairment in LTD in mice lacking GAD65 (Choi et al., 2002), and the observation 
that one form of LTD in the prefrontal cortex during adolescence is dependent on GABAergic 
signaling (Caballero et al., 2013), we speculate that a reduction in GAD65 at the end of 
adolescence could reduce the propensity for LTD-induced spine elimination and bring adolescent 
spine pruning to a close.  Of interest, spinophilin, like GAD65, is necessary for long term 
depression (LTD), as knockout animals for either protein show LTD impairments (Feng et al., 
2000;Choi et al., 2002).  Evidence suggests that both proteins are important for LTD as well as 
spine elimination, as spinophilin knockout mice actually show an increase in spine density in the 
CA3 region of the hippocampus (Feng et al., 2000), and GAD65 KO mice are also reported to 
have an increased density of spines (Mataga et al., 2004).  We propose that, if LTD contributes 
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to spine elimination during adolescence (Selemon, 2013), and spinophilin and GAD65 are 
necessary for LTD, then increased levels of spinophilin and GAD65 protein prior to or early in 
adolescence may induce a favorable environment for adolescent spine pruning.   It is interesting 
that both within-spine levels of spinophilin protein and within-bouton levels of GAD65 protein 
decrease between early adolescence and young adulthood in mouse auditory cortex (chapter 4).  
When we consider our results together with results from a study of spinophilin protein in rat 
cortical homogenate (Allen et al., 1997) we see that spinophilin protein levels in cortex increase 
during postnatal development, and then decrease between early adolescence until adulthood.  
Similarly, when we interpret our GAD65 protein findings together with a study of GAD65 
protein levels in the auditory cortex during postnatal development (Xu et al., 2010), we see that 
GAD65 protein levels increase through the end of adolescence, then decline by young adulthood.  
Reductions in levels of spinophilin and GAD65 protein during the course of adolescence and 
young adulthood may shift the balance away from spine elimination and promote spine stability 
to slow down the process of spine pruning.  It will be important to determine in future studies if 
the within-spine and within-bouton trajectories of these two proteins occurs across cortical 
regions during adolescence or is a feature unique to auditory cortex.  The reduction in GAD65 
protein in auditory cortex of subjects with schizophrenia could stem from an increased reduction 
in GAD65 levels as a consequence of spine over-pruning, as a compensatory response to 
excessive spine elimination.  If spinophilin levels are also co-regulated with spine loss, then there 
may also be a reduction in within-spine levels of spinophilin protein in individuals with 
schizophrenia.  This has not yet been thoroughly addresssed in auditory cortex; however, 
spinophilin protein levels in auditory cortex homogenate appear to be unchanged in 
schizophrenia (Deo et al., 2013), consistent with evidence that spinophilin mRNA levels are 
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unaltered in prefrontal cortex (Weickert et al., 2004; Ide and Lewis, 2010).  Unaltered levels of 
spinophilin may be evidence of a failed compensatory mechanism in schizophrenia.  If a 
decrease in within-spine spinophilin protects against loss of spines, then this could represent a 
potential therapeutic target for preventing or mitigating spine loss in schizophrenia.  Future 
studies done to determine if spinophilin is altered within dendritic spines in individuals with 
schizophrenia will further inform our understanding of the relationship between spinophillin 
protein levels and spine loss in schizophrenia.   
6.2.4 Evidence for independent regulation of excitatory boutons and spines 
We observed a reduction in numbers of VGluT1-expressing presumptive excitatory boutons 
between early adolescence and young adulthood in the mouse in Chapter 4, suggesting that these 
components of auditory cortex circuits undergo refinement during adolescence in parallel with 
dendritic spine pruning.  A caveat to our interpretation is that our findings of unchanged density 
and number of excitatory boutons in primary auditory cortex of subjects with schizophrenia does 
not support a model where pre and postsynaptic components of excitatory axospinous synapses 
are concurrently over-pruned during adolescence.  Despite the fact that they did not demonstrate 
evidence of dendritic spine reduction between early adolescence and young adulthood, we 
observed evidence of reduction in intracortical excitatory bouton number in the kalirin KO mice, 
paralleling the changes in WT mice.  Both the human postmortem schizophrenia findings and the 
findings from adolescent development in the kalirin KO suggest that dendritic spines can be 
eliminated without a corresponding elimination of presynaptic excitatory boutons.  Evidence 
supporting differential regulation of spines and bouton dynamics comes from in vivo imaging in 
mouse sensory cortex, where spines exhibit higher rates of turnover than boutons (Majewska et 
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al., 2006).  It may be that independent LTD mechanisms contribute to spine and bouton loss 
during adolescent excitatory synapse pruning.  For example, a form of presynaptic NMDA 
receptor-mediated LTD has been shown to operate independently of postsynaptic signaling, and 
could be a mechanism for presynaptic depression prior to synapse elimination during 
development (Rodriguez-Moreno et al., 2013).  Different postsynaptic contacts of excitatory 
boutons may also impact the stability of the bouton.  In monkey primary visual cortex, numbers 
of shaft and spine synapse reach a developmental plateau at approximately the same age, but 
numbers of spine synapses undergo a much more dramatic reduction during puberty than shaft 
synapses (Bourgeois and Rakic, 1993).  Variation in the ratios between shaft and spine excitatory 
synapses during pre- and postnatal development suggests that there could be different 
mechanisms regulating these two synapse types.  Taken together, these findings suggest 
differential regulation of spines and boutons during adolescent development and potentially also 
in schizophrenia.  Future studies should be done to examine levels of proteins which have been 
shown to mediate shaft synapse formation, such as GRIP1 and ephrinB3 (Aoto et al., 2007) in 
auditory cortex of subjects with schizophrenia.  Further work examining the molecular 
mechanisms which regulate pruning of excitatory boutons, and importantly, spine- versus shaft-
targeting boutons, will further inform interpretations of the disconnect between excitatory 
boutons and spines in auditory cortex of individuals with schizophrenia. 
6.2.5 Adolescence as a window of opportunity for preventative measures 
Evidence suggests that neuropathological changes are occurring in auditory cortex during the 
time building up to onset of schizophrenia.  Reductions in gray matter volume of Heschl’s gyrus 
and planum temporale are reported in patients in both cross-sectional and longitudinal studies 
 182 
(Kwon et al., 1999a; Hirayasu et al., 2000; Kasai et al., 2003; Smiley et al., 2009).  First episode 
psychosis patients and ultra-high risk individuals who later develop psychosis show longitudinal 
reductions in superior temporal gyrus gray matter (Takahashi et al., 2009).  Longitudinal gray 
matter deficits that develop across adolescence in very early onset (< 12 years of age) 
schizophrenia patients progress in a manner that recapitulates what is reported in normal 
development, with deficits in superior temporal gyrus and prefrontal cortex appearing last 
(Thompson et al., 2001).  These changes in gray matter likely have functional consequences, as 
reductions in MMN responses to frequency and duration deviants are correlated with reduction 
in volume of Heschl’s gyrus (Rasser et al., 2011) and this relationship is already present at the 
first psychotic episode (Salisbury et al., 2007).  Also, groups at high risk of developing 
schizophrenia demonstrate impairments in auditory working memory, verbal memory, and verbal 
processing (Simon et al., 2007).  This evidence suggests that alterations in auditory cortex gray 
matter and symptoms which might stem from abnormal auditory processing are beginning to 
take shape during adolescence, and suggest that this is a time when prevention is needed to halt 
or reverse pathological processes. 
We have presented evidence suggesting that adolescence is a time when both dendritic 
spine density and within bouton levels of GAD65 protein are decreasing in auditory cortex.  Both 
of these are reduced in deep layer 3 of the auditory cortex of subjects with schizophrenia, and 
furthermore, the reductions are correlated.  We have proposed that abnormal regulation of 
adolescent synapse pruning may lead to excessive reductions in dendritic spines and GAD65 
protein in auditory cortex of subjects with schizophrenia.  Based on the review in the previous 
sections, it may be that GAD65 reduction within inhibitory boutons is a consequence of dendritic 
spine pruning and occurs as a compensatory mechanism to balance excitation and inhibition, or 
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to reduce the likelihood of spine elimination.   Blocking GAD activity and genetic ablation of 
GAD65 in animals increases spine density (Murphy et al., 1998; Mataga et al., 2004), or prevents 
plasticity-induced spine loss (Fagiolini and Hensch, 2000).  Therefore, manipulating levels of 
GAD65 in the prodromal phase or early stages of the illness could be a strategy to prevent or 
mitigate spine loss.   
6.3 DIFFERENCES BETWEEN PREFRONTAL AND AUDITORY CORTEX 
SYNAPSE DEFICITS IN SCHIZOPHRENIA: INSIGHTS FROM KALIRIN  
An important question that arises from the experimental results presented here is, are the findings 
we observed in auditory cortex in subjects with schizophrenia consistent across brain regions?  
Similarly, do our findings of development of synaptic components in auditory cortex between 
early adolescence and young adulthood generalize across cortical regions?  Primary auditory 
cortex shares many features common to all neocortical regions, and in particular shares similarity 
with other primary sensory regions such as primary somatosensory and visual cortices (Linden 
and Schreiner, 2003).  An important difference between sensory areas, at least in humans, is that 
imaging studies suggest that postnatal developmental changes in auditory cortex gray matter 
volume are more protracted than in primary visual and primary somatosensory cortices (Gogtay 
et al., 2004; Shaw et al., 2008), so in this respect auditory cortex is more similar to frontal 
cortical regions.  In humans, spine density in primary auditory cortex peaks at a later age than in 
visual cortex, but at a slightly earlier age compared to frontal cortex (Huttenlocher and 
Dabholkar, 1997).     
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A number of the excitatory and inhibitory synapse abnormalities that have been identified 
in primary auditory cortex of subjects with schizophrenia have been recapitulated in the 
prefrontal cortex, but some features appear to differ between the two regions (Table 6.1).  Some 
of the similarities in findings between the two regions include a decrease in pyramidal neuron 
somal volume (Pierri et al., 2001; Sweet et al., 2004) with no accompanying reduction in 
pyramidal neuron number (Thune et al., 2001; Dorph-Petersen et al., 2009b).  A deficit in 
dendritic spine density exists in both the dorsolateral prefrontal cortex and auditory cortex in 
subjects with schizophrenia (Glantz and Lewis, 2000; Sweet et al., 2009).  Reduced density of 
synaptophysin-immunoreactive axon boutons is present in primary auditory cortex of subjects 
with schizophrenia (Sweet et al., 2007) while immunoreactivity for synaptophysin is decreased 
in prefrontal cortex (Glantz and Lewis, 1997).  In prefrontal cortex neurons, levels of 
synaptophysin mRNA per neuron are unchanged (Glantz et al., 2007), suggesting it is not likely 
that reduced bouton density is attributable to reduction in within-bouton synaptophysin content, 
although this has not been ruled out.  The density of GAD65-expressing boutons is unchanged in 
both auditory and prefrontal cortex of subjects with schizophrenia (Moyer et al., 2012) (chapter 
3); (Benes et al., 2000).  In the auditory cortex, we found that densities of VGluT1-expressing 
intracortical excitatory and VGluT2-expressing thalamocortical excitatory boutons, and within-
bouton VGluT protein levels, are unaltered in individuals with schizophrenia (Moyer et al., 
2013) (chapter 2).  Intracortical excitatory and thalamocortical bouton densities and VGluT 
protein levels have not yet been assessed in prefrontal cortex, however findings of both 
unchanged and decreased VGluT1 mRNA have been reported for individuals with schizophrenia 
(Oni-Orisan et al., 2008; Fung et al., 2011).  Results are also conflicting for levels of GAD65 
mRNA in prefrontal cortex, although two reports agree that protein levels are unchanged in 
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prefrontal cortex in schizophrenia (Guidotti et al., 2000; Dracheva et al., 2004).  This is in 
contrast to what we have observed in the auditory cortex (Moyer et al., 2012) (chapter 3) where 
within-bouton GAD65 protein is significantly reduced.   
Studies of kalirin in schizophrenia have also yielded results that differ between auditory 
and prefrontal cortical areas.  One study has reported reduced mRNA expression of kalirin in the 
prefrontal cortex of subjects with schizophrenia, correlated with reduced spine density in the 
same region (Hill et al., 2006).  This study was done using probes specific for the kalirin-7 and 
kalirin-5 isoforms, suggesting that expression of these two isoforms is reduced in schizophrenia.  
A Western blot study evaluated levels of kalirin-7 protein in the anterior cingulate and 
dorsolateral prefrontal cortex and found reductions in both regions in subjects with schizophrenia 
(Rubio et al., 2012).  In contrast, a recent study found no change in levels of kalirin-7 protein in 
primary auditory cortex of subjects with schizophrenia and an increase in protein levels of 
kalirin-9 (Deo et al., 2012).  This indicates that kalirin isoforms are differentially altered in 
different cortical regions in schizophrenia.  Further support for different functional roles of 
kalirin between frontal and auditory cortex comes from evidence demonstrating that global loss 
of kalirin reduces spine density in the frontal cortex, but does not alter density of dendritic spines 
in the hippocampus (Cahill et al., 2009).  However, it should be noted that kalirin-7 specific 
knockout mice are reported to have reduced dendritic spine density in the hippocampus (Ma et 
al., 2008); although this could be attributable to up-regulation in kalirin-9 and kalirin-12 
expression (Penzes and Remmers, 2012).  Our findings indicate that global loss of kalirin also 
does not lead to an overall reduction in dendritic spine density in the superficial layers of the 
auditory cortex (chapter 4).  Therefore, kalirin expression may be particularly important in 
regulating spine stability in frontal cortex, and global loss of kalirin (Cahill et al., 2009) or 
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reduced kalirin expression in schizophrenia (Hill et al., 2006) may decrease spine stability and 
lead to spine loss in that region.   In contrast, kalirin, may not be critical for regulating stability 
of spines in primary auditory cortex, and kalirin expression may be affected in schizophrenia in 
such a way that the kalirin-9 isoform is actually overexpressed.  Further in support of differential 
regulation of kalirin between cortical regions in schizophrenia, levels of PAK1, a downstream 
target of kalirin signaling, are unchanged in the auditory cortex (Deo et al., 2013), and are 
reported to be elevated, although with decreased phosphorylation in the prefrontal cortex of 
subjects with schizophrenia (Rubio et al., 2012).  Taken together, the above evidence suggests 
that while there may be some global pathological features common to multiple cortical regions in 
schizophrenia, it should be noted that not all postmortem findings from schizophrenia studies can 














Table 6.1. Comparison of results of postmortem studies of synapse components in primary auditory cortex of 
subjects with schizophrenia with findings from prefrontal cortex. 
 
 
Component Primary auditory cortex Prefrontal cortex 
Pyramidal neuron  
somal volume  
↓ (Sweet et al., 2004)  ↓ (Pierri et al., 2001)  
Pyramidal neuron 
number  
↔ (Dorph-Petersen et al., 2009)  ↔ (Thune et al., 2001)  
Spines  ↓ spine density (Sweet et al., 2009)  ↓ spine density (Glantz and 
Lewis, 2000)  
Boutons  
 Intracortical excitatory 
 Thalamocortical  
 Inhibitory 
↓ synaptophysin bouton density 
(Sweet et al., 2007) 
 
↔ Intracortical excitatory bouton 
density (Moyer et al., 2013) 
 
↔  Thalamocortical bouton density 
(Moyer et al., 2013) 
 
↔  GAD65-expressing bouton 
density (Moyer et al., 2012)  
↓ synaptophysin bouton density 








↔ GAD65-expressing bouton 
density (Benes et al., 2000)  
GAD65  ↓ protein (Moyer et al., 2012)  ↔ mRNA, protein (Guidotti et al., 
2000)  
↑ mRNA, ↔  protein (Dracheva 
et al, 2004)  
VGluT  ↔  VGluT1 protein (Moyer et al., 
2013) 
 
↔  VGluT2 protein (Moyer et al., 
2013)  
↓ VGluT1 mRNA (Eastwood and 
Harrison, 2005) 
 
↔ VGluT1 mRNA (Fung et al, 
2011)  
Kalirin ↑ protein (kalirin-9) (Deo et al., 
2012) 
 
↔ protein (kal-7, -5, -12) (Deo et al., 
2012)  
↓ protein (kalirin-7) (Rubio et al., 
2012)  
 
↓ mRNA (kalirin-7) (Hill et al., 
2006) 
PAK1 ↔ protein (Deo et al., 2013)  ↓ PAK1 phosphorylation (Rubio 
et al., 2012) 
↑ PAK1 protein (Rubio et al., 
2012)  
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6.4 CONSIDERATIONS IN THE USE OF GENETIC MOUSE MODELS OF 
SCHIZOPHRENIA NEUROPATHOLOGY 
There are no animal models that are able to recapitulate all of the clinical features observed in 
individuals suffering from schizophrenia (Arguello and Gogos, 2006).  Modeling the 
heterogeneous symptoms of a complex and uniquely human neurodevelopmental disorder such 
as schizophrenia is a particularly challenging task (Powell and Miyakawa, 2006).  Animal 
models of schizophrenia have been developed using four main approaches: developmental, 
pharmacological, lesion, or genetic manipulation (Jones et al., 2011).  Genetic models have been 
developed to replicate genomic, mRNA, and protein-level changes observed in schizophrenia.  
Some of the most well-characterized genetic models are knock-out and knock-down models for 
DISC1 (Jaaro-Peled, 2009), neuregulin and ErbB4 (Mei and Xiong, 2008), dysbindin (Karlsgodt 
et al., 2011), and reelin (Krueger et al., 2006).  In the present studies, we have used the kalirin 
KO model to assess the consequences of genetically-mediated spine disruption on development 
of excitatory and inhibitory synapse components in auditory cortex and auditory cortex function 
between adolescence and young adulthood.  In the following section we will discuss a number of 
caveats associated with the use of genetic mouse models which are relevant for the 
interpretations of our results. 
To date, three different mouse models of kalirin loss of function have been developed.  
The knockout model that we used was generated through insertion of the neomycin resistance 
gene in place of exons 27 and 28, which encode the first GEF domain (KO) (Cahill et al., 2009).  
Another model is specific for the kalirin-7 isoform, and is generated by deleting its unique 3’-
exon (Kal7KO/KO) (Ma et al., 2008).  A third model is another global knockout (KalSRKO/KO) 
generated by targeting exon 13, within the spectrin repeat region (Mandela et al., 2012).  This 
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group also examined a variation where the knockout was restricted to the nervous system under 
control of the nestin promoter, to distinguish between nervous system specific and peripheral 
effects of kalirin loss.   
When interpreting findings in global gene knockout animal models, it is important to 
consider that effects could be attributable to loss of the gene throughout embryonic and postnatal 
development.  In the present studies, we examined auditory cortex synaptic components and 
function in the kalirin KO during a developmental window between early adolescence and young 
adulthood.  However, absence of kalirin protein likely contributes to effects outside of this 
developmental window.  For example, expression of kalirin-7 is up-regulated during postnatal 
development in the hippocampus and suggests a role of kalirin-7 in synaptogenesis (Ma et al., 
2003; Ma et al., 2008).  Although evidence suggests that a normal number of dendritic spines are 
present in the frontal cortex of kalirin KO mice prior to adolescence (Cahill et al., 2009) we 
cannot conclude that spinogenesis in the auditory cortex of mice lacking kalirin occurred 
normally.  Therefore, future studies will be necessary to determine whether synaptogenesis 
occurs normally in the auditory cortex of mice lacking kalirin.  Another potential confounding 
factor is that compensatory changes can occur when loss of the gene of interest induces 
alterations in related or interacting factors. This makes it difficult to determine whether 
phenotypes are attributable to the loss of the gene of interest or compensatory changes in 
function of other genes.  For this reason, expression levels of other GEFs in auditory cortex 
should be examined, to determine if changes in any of these could elicit the effects we observed 
in the kalirin KO mice.  Despite these confounds, global gene knockout models do have 
translational relevance.  Genetic disruptions that contribute to human disease are likely to be 
present throughout all stages of development, and may elicit some of the same compensatory 
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changes and alterations in developmental processes that occur in a mouse model (Gingrich and 
Hen, 2000). 
The unique molecular and physiological environments of different brain regions are also 
important to consider when interpreting the consequences of a genetic manipulation.  For 
example, the effects of loss of kalirin on spines appear to differ between brain regions.  The 
Kal7KO/KO mice demonstrate a reduction in hippocampal spine density, while the kalirin KO have 
reductions in frontal cortex spine density, but do not show alterations in hippocampal spine 
density (Cahill et al., 2009).  However, the differences between these two models may be 
attributable to up-regulation of the kalirin-9 and kalirin-12 isoforms reported in the Kal7KO/KO 
mice, which only demonstrate a 25% loss of total kalirin protein despite the fact that kalirin-7 is 
thought to account for 75% of forebrain kalirin levels in adult mice (Ma et al., 2008).  Kalirin-9 
and kalirin-12 possess the second GEF domain capable of activating RhoA, activation of which 
is reported to enhance spine elimination (Newey et al., 2005).  Up-regulation of these two 
isoforms may contribute to hippocampal spine elimination in Kal7KO/KO, but not in kalirin KO 
mice.  Kalirin disruption in schizophrenia also appears to differ between brain regions, as the 
kalirin-7 isoform is reduced in the prefrontal cortex of subjects with schizophrenia (Hill et al., 
2006; Rubio et al., 2012) while the kalirin-9 isoform is increased in the primary auditory cortex 
(Deo et al., 2012).  The global kalirin gene knockout eliminates all isoforms of the kalirin 
protein, which removes the potential confound that certain isoforms could be up-regulated to 
compensate for loss of another isoform.  However, in future studies it will be of interest to 
examine effects of loss of specific kalirin isoforms on primary auditory cortex synapse 
components and function.  Future studies specifically targeting the kalirin-9 isoform will be 
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useful to determine whether we can model schizophrenia-relevant effects of kalirin-9 in the 
mouse auditory cortex.   
Strain background has long been recognized as a potential confounding factor in 
interpreting studies of genetic models (Gerlai, 1996).  There are numerous genetic differences 
between inbred mouse strains that have the potential to interact with the phenotypic effects 
attributable to loss of kalirin (Taft et al., 2006).  Therefore, kalirin ablation could yield different 
phenotypic effects in different mouse strains.  It is also possible that the changes in synaptic 
components across adolescence in the WT mice that we presented may vary between strains.  
However, the influence of background strain on knockout mouse phenotype does contribute 
translational relevance, as humans with disease also have varying genetic backgrounds.  
Therefore, studying knockout models of kalirin and other relevant genes in multiple strain 
backgrounds may help to identify gene interaction effects that contribute to the expression of 
schizophrenia symptoms (Gingrich and Hen, 2000).    
An important consideration in our study is the effect of inbred strain background on the 
function of the auditory system.  The C57Bl/6 background demonstrate progressive hearing loss 
and associated auditory cortex plasticity that is evident behaviorally beginning around 3-4 
months of age (Willott et al., 1993), while anatomical changes in the cochlea are already present 
at 3 months of age (Spongr et al., 1997).  Therefore, a caveat of our interpretation that excitatory 
and inhibitory synapse components in the auditory cortex change across adolescence and young 
adulthood is that they could be attributable to plasticity in the auditory cortex induced by the 
early stages of high frequency hearing loss.  Future studies should be done to examine auditory 
cortex changes across adolescence in a strain which does not exhibit high frequency hearing loss 
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during adolescence, such as the CBA/CaJ, which would differentiate between changes 
attributable to adolescence and to hearing loss.  
Finally, it is important to consider that inbred strains differ in performance in behavioral 
tasks used to evaluate validity of schizophrenia models.  For example, and most relevant for 
interpretation of our findings, magnitude of the acoustic startle reflex and prepulse inhibition 
varies substantially between different inbred strains (Paylor and Crawley, 1997; Bullock et al., 
1997; Willott et al., 2003).  Although hearing loss would be expected to impair measurement of 
acoustic startle reflex and PPI using acoustic stimuli, ASR and PPI are not correlated with 
measures of hearing ability such as the acoustic brainstem response within strains (Willott et al., 
2003).  Considered together with many other strains, the C57Bl/6J strain is reported to have low 
to middle range ASR and PPI responses.   A mid-range level of PPI is ideal because it allows for 
evaluation of genetic manipulations that result in both increased and decreased levels of PPI.  
However, we observed relatively lower PPI responses to gap compared to noise prepulse stimuli, 
which may have made it more difficult to observe reductions in gap-PPI in kalirin KO.  Further, 
an already reduced level of noise-PPI in general in young adult kalirin KO mice contributes 
substantial ambiguity to our assessment of gap-PPI.  Finally, the range of PPI may be constrained 
in the kalirin KO mice due to reduced ASR, which could further confound PPI comparisons 
between KO and WT mice. Therefore, future studies should be done using an alternate 




In summary, evidence from electrophysiological, in vivo imaging, and postmortem tissue studies 
all suggest disruptions of the primary auditory cortex in individuals with schizophrenia.  
Improper functioning of the auditory cortex is likely to underlie behavioral deficits in auditory 
processing, contributing to certain aspects of negative and cognitive symptoms.  In this thesis, 
we investigated the contributions of excitatory and inhibitory presynaptic boutons to primary 
auditory cortex neuropathology.  We also examined the developmental trajectories of excitatory 
and inhibitory synapse components in the mouse primary auditory cortex.  This facilitates the 
interpretation of our findings of excitatory and inhibitory synaptic structure deficits in the 
context of the adolescent neurodevelopmental hypothesis of schizophrenia.  Our results indicate 
that there are correlated reductions in within-bouton GAD65 protein and dendritic spine density 
in the primary auditory cortex of subjects with schizophrenia.   In mouse auditory cortex, we 
found that within-bouton GAD65 protein decreases between late adolescence and young 
adulthood, subsequent to the onset of dendritic spine pruning in the auditory cortex between 
early adolescence and young adulthood.  The fact that we observed increases in a behavioral 
readout of auditory cortex functional integrity in the mouse during adolescence suggests that 
normal pruning of excitatory synaptic components in primary auditory cortex across adolescence 
may be important for auditory cortex function. 
Based on our findings, we propose a model where spines may be over-pruned in the 
auditory cortex of subjects with schizophrenia, accompanied by a subsequent excessive reduction 
in GAD65 protein.  Co-occurring deficits in components of excitatory and inhibitory synapses 
likely contribute to the auditory processing impairments that may underlie features of 
schizophrenia such as abnormal perception of semantic and emotional aspects of language, 
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ultimately contributing to poor functional outcome in patients.  As both spines and GAD65 
protein levels undergo changes during and following adolescence, the time period between early 
adolescence and young adulthood may be a developmental window of opportunity for mitigating 
or reversing these pathological features of primary auditory cortex in schizophrenia.  For 
example, our findings suggest that early adolescence may be a time period to intervene to 
prevent excessive spine pruning, and the late adolescent period could be targeted with measures 
to prevent excessive within-bouton GAD65 reduction.  Preventing the deficit in spine pruning 
may help to normalize electrophysiological measures of auditory processing that are 
dysfunctional in schizophrenia, such as the mismatch negativity response, which may depend on 
activity of supragranular excitatory synapses.  To inform the development of strategies to prevent 
the dendritic spine deficit in schizophrenia, future work should be done to increase our 
understanding of how molecular factors such as GAD65 and spinophilin may be involved in 
processes which promote or prevent spine elimination during adolescence.   
Lower levels of GAD65 protein within inhibitory boutons may contribute to the abnormal 
oscillatory and steady state responses observed in individuals with schizophrenia, and this could 
be determined using animal models.  It is possible that normalizing GAD65 protein levels within 
inhibitory boutons in auditory cortex could improve auditory processing in individuals with 
schizophrenia.  However, future studies are needed to determine whether decreased GAD65 
protein in the auditory cortex in schizophrenia is a compensatory response to mitigate excessive 
spine loss.  If so, blocking the reduction in GAD65 during adolescence could lead to an even 
greater reduction of spines in the auditory cortex of individuals with schizophrenia.  In this case, 
promoting an earlier onset of, or enhancing the reduction in GAD65 protein within auditory 
cortex inhibitory boutons may prove to be an effective strategy to slow excess spine pruning. 
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Future mechanistic studies in animal models and in vitro studies will aid the development of 
strategies to address deficits in both dendritic spines and within-bouton GAD65 protein in 
primary auditory cortex, and may help to reduce the severity of symptoms affected by poor 




CHAPTER 2 SUPPLEMENTAL MATERIALS 
A.1 SUPPLEMENTAL METHODS 
Table A.1. Control and schizophrenia subject characteristics for cohort 1 (top, green) and cohort 2 (bottom, 
blue).  Abbreviations: S/R/A, Sex/Race/Age; PMI, postmortem interval; Hand, handedness; Meds ATOD, 
medications used at time of death; ASCVD, atherosclerotic coronoary vascular disease; AAC, Alcohol Abuse, 
current at time of death; AAR, Alcohol Abuse, in remission at time of death; ADC, Alcohol Dependence, current at 
time of death; ADR, Alcohol Dependence, in remission at time of death; OAC, Other Substance Abuse, current at 
time of death; ODC, Other Substance Dependence, current at time of death; ODR, Other Substance Dependence, in 
remission at time of death;  L, Left; M, Mixed; R, Right; U, Unknown; B, Benzodiazepines; C, Anticonvulsants; D, 
Antidepressants; L, Lithium; N, No medications; O, Other medication(s); P, Antipsychotic; PA, Atypical 
Antipsychotic; PT, Typical Antipsychotic; U, Unknown; antipsychotic medication denoted by lowercase letter: ch, 
chlorpromazine; cl, clozapine; f, fluphenazine; h, haloperidol; l, loxapine; m, mesoridazine; o, olanzapine; p, 
perphenazine; r, risperidone; th, thiothixene; tr trifluoperazine; un, unspecified. Living independently ATOD: Y, 
yes; N, no.  Tobacco use current ATOD: Y, yes; N, no; U, unknown.  *Control subject 396 tested positive for 
benzodiazepines at autopsy; **Control subject 987 diagnosed with post traumatic stress disorder- in remission 39 
years. ‡Schizophrenia subject 1010 diagnosed with mild mental retardation.   
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B,C,O,PT: th N U




B,D,O,PA: r N Y
3 681 M/W/51 R 11.6 131.6 Hypertrophic 
cardiomyopathy
N 234 M/W/51 R 12.8 214.1 Cardiomyopathy Paranoid 
schizophrenia
N Y N







B,C,O,PT: h Y U




D,O,PT: f N Y




U 656 F/B/47 R 20.1 134.9 Suicide by gun shot Schizoaffective disorder, ADC O,PA: o Y Y
7 396* M/W/41 L 17.5 167.1 ASCVD Y 408 M/W/46 R 19.8 185.5 ASCVD Paranoid 
schizophrenia
B,D,O,PT: tr Y Y






PA: cl N Y
9 451 M/W/48 L 12 170.0 ASCVD U 317 M/W/48 U 8.3 201.4 Bronchopneumonia Undifferentiated 
schizophrenia
D,L,O,PT: l N U




O,PT: h Y N
11 412 M/W/42 R 14.2 184.5 Aortic stenosis N 466 M/B/48 U 19.0 168.0 ASCVD Undifferentiated 
schizophrenia
O,PA: cl N U







13 575 F/B/55 R 11.3 146.8 ASCVD Y 597 F/W/46 L 10.1 143.4 Pneumonia Schizoaffective 
disorder
D,O,PT: m Y Y












O,PT: ch Y Y




PT: ch N U






D,O,PT: h Y Y







D,O,P: un N Y
4 822 M/B/28 L 25.3 110.5 ASCVD N 787 M/B/27 L 19.2 116.7 Suicide by gunshot Schizoaffective 
disorder, ODC
O,PT: f N N









C,O,PT: th N Y
7 1047 M/W/43 R 12.4 69.3 ASCVD N 933 M/W/44 U 8.3 87.6 Myocarditis Disorganized 
schizophrenia
C,D,O,PA: o N N




B,O,PT: h N Y




U 1105 M/W/53 R 7.9 61.2 ASCVD Schizoaffective disorder PA: o N Y




C,O,PA: o,  
PT: ch,f
Y Y
11 987** F/W/65 R 21.5 78.5 ASCVD N 917 F/W/71 U 23.8 91.6 ASCVD Undifferentiated 
schizophrenia
O,PT: h,p N Y
12 1092 F/B/39 R 16.6 62.7 Mitral valve prolapse N 1010
‡ F/B/44 L 18.7 75.4 Sudden unexpected death
Undifferentiated 










Pair Case S/R/A Hand PMI (h)
Storage 
Time (mos) Cause of Death Case Meds ATOD
Storage 





A.2 SUPPLEMENTAL RESULTS 
A.2.1 VGluT1-IR puncta morphology 
The mean volume (F(1, 24.9) = 2.70, p = 0.113, 95% CI: (-0.03, 0.003)) and surface area (F(1, 23.7) = 
1.72, p = 0.202, 95% CI: (-0.05, 0.21)) of VGluT1-IR puncta were not different between 
schizophrenia and control subjects (data not shown).  However, the mean shape complexity of 
VGluT1-IR puncta was significantly reduced by 1.3% in subjects with schizophrenia compared 
to controls (F(1, 24.5) = 4.74, p = 0.039, 95% CI: (-0.02, -0.001)) (Figure A.1).  We observed no 
effect of chronic haloperidol exposure on volume (F(1, 3.02) = 0.20; p = 0.684, 95% CI: (-0.10, 
0.07)), surface area (F(1, 3.05) = 0.24; p = 0.656, 95% CI: (-0.81, 0.59)), or shape complexity (F(1, 3) 
= 0.27; p = 0.641, 95% CI: (-0.01, 0.01)) of VGluT1-IR puncta in deep layer 3 of primary 






 Figure A.1. VGluT1-IR bouton shape complexity.  (Left) Mean VGluT1-IR puncta shape complexity for each 
schizophrenia-control subject pair in cohort 1 (open circles) and cohort 2 (gray circles).  Reference line represents 
schizophrenia = control values, where points below the line indicate a pair where control > schizophrenia, and points 
above the line indicate schizophrenia > control.  (Right) Diagnostic group mean puncta shape complexity for control 









A.2.2 VGluT2-IR puncta morphology 
There were no diagnostic group differences in primary auditory cortex deep layer 3 VGluT2-IR 
puncta volume (F(1,142) = 0.15, p = 0.702, 95% CI: (-0.02, 0.01)), surface area (F(1, 22.6) = 0.27, p = 
0.605, 95% CI: (-0.16, 0.09)), or shape complexity (F(1, 24.1) = 1.52, p = 0.230, 95% CI: (-0.001, 
0.005)) (data not shown).  Also, there were no changes in VGluT2- IR puncta volume (F(1, 3.15) = 
2.60; p = 0.201), surface area (F(1, 3.09) = 1.14; p = 0.361), or shape complexity (F(1, 6.95) = 2.50; p 
= 0.158) in the antipsychotic exposed monkeys (data not shown).   
A.2.3 Association of clinical factors with VGluT1- and VGluT2-IR puncta measures 
We tested for associations between VGluT1- and VGluT2-IR bouton characteristics and a 
number of clinical factors to determine if bouton alterations were associated with any sub-groups 
of schizophrenia subjects.  Subjects living independently at time of death had a relative percent 
reduction in the fluorescence intensity of VGluT1-IR boutons, compared to those who were not 
living independently (living independently at time of death, mean percent change in fluorescence 
intensity (SD), Yes = 19.9 (29.3) % reduction relative to controls, No = 6.1 (29.1) % increase 
relative to controls; t25 = -2.20, p = 0.037).  We also found that schizophrenia subjects living 
independently at time of death showed a relative reduction in the density of VGluT2-IR boutons 
compared to those subjects who were not living independently at time of death (living 
independent at time of death; mean percent change in density (SD), Yes = 14.2 (19.1) % 
reduction relative to controls, No = 5.7 (22.5) % increase relative to controls; t25 = -2.27; p = 
0.032).  These findings should be interpreted with caution as the analyses were not corrected for 
multiple comparisons.  We did not identify any other significant relationships between other 
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bouton measures and clinical factors including living independently at time of death, diagnosis of 
schizoaffective disorder, antipsychotic use at time of death, class of antipsychotic, history of 
alcohol or other substance abuse, or death by suicide (See Tables A.2 and A.3).  A number of 
both control and schizophrenia subjects were known to be using tobacco at time of death.  We 
did not observe any associations between VGluT1- and VGluT2-IR bouton characteristics and 
tobacco use status at time of death (data not shown), suggesting tobacco use at time of death does 


















Table A.2. Relationship between VGluT1-IR puncta measurements and clinical variables.  T test results 
showing that relative percent reductions in VGluT1-IR puncta density, fluorescence intensity, volume, surface area, 
and shape complexity are not different depending on whether the schizophrenia subject was living independently at 
time of death, had antipsychotic use current at time of death (ATOD), was taking typical or atypical antipsychotics 
ATOD, had a history of alcohol or substance abuse, died by suicide, or had a diagnosis of schizoaffective disorder 














Table A.3. Relationship between VGluT2-IR puncta measurements and clinical variables.  T test results 
showing that relative percent reductions in VGluT2-IR puncta density, fluorescence intensity, volume, surface area, 
and shape complexity are not different depending on whether the schizophrenia subject was living independently at 
time of death (ATOD), had antipsychotic use current at time of death, was taking typical or atypical antipsychotics 
ATOD, had a history of alcohol or substance abuse, died by suicide, or had a diagnosis of schizoaffective disorder 








A.3 SUPPLEMENTAL DISCUSSION 
A.3.1 Methodological considerations 
One must be cautious in the interpretation of measures of puncta volume and surface area (and 
the resulting shape complexity calculated from these two measures) using our approach.   First, 
vesicular glutamate transporters are located in the vesicle membrane; therefore, VGluT-IR 
puncta may be more indicative of vesicle pools and do not necessarily reflect the entire volume 
and shape of the bouton.   Second, the voxel size of our data set is 0.215 x 0.215 x 0.220 µm³ 
resulting in a digitized estimation of the volume of each puncta that is derived from relatively 
few voxels, and is necessarily biased to some extent  (Ziegel and Kiderlen, 2010).  Moreover, the 
use of voxel-based measurements to estimate surface area is likely to be very biased, even when 
based upon high resolution data (Ziegel and Kiderlen, 2010).  Because there is no way to 
estimate the magnitude of the bias, or whether it may differ between schizophrenia and control 
subjects, our finding of a significant difference in shape complexity should be interpreted 
conservatively pending replication via another approach. 
A.3.2 Clinical and therapeutic implications of disconnect between spine loss and bouton 
preservation 
It should be noted that antipsychotic treatment may up-regulate the expression of VGluT2.  We 
observed nonsignificant increases in VGluT2-IR bouton density and fluorescence intensity in the 
chronic haloperidol exposed macaques relative to control macaques.  This is not surprising given 
that previous studies have reported that VGluT2 protein expression is increased in prefrontal 
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cortex of mice after chronic haloperidol exposure (Moutsimilli et al., 2008).  The haloperidol-
induced increase in VGluT2 protein in auditory cortex boutons of antipsychotic-exposed 
macaques is likely mediated by the D2 subtype of dopamine receptors located in the medial 
geniculate nucleus of the thalamus (Rieck et al., 2004).  Increased expression of VGluT2 mRNA 
has been reported in the thalamus of subjects with schizophrenia (Smith et al., 2001), and one 
could speculate that this is a result of chronic antipsychotic treatment.  We did not observe an 
increase in VGluT2 protein levels in our subjects with schizophrenia, although both cohorts 
trended in that direction.  It is possible that VGluT2 protein expression is decreased in subjects 
with schizophrenia and chronic antipsychotic exposure normalized this effect by elevating 
VGluT2 expression.   It is interesting that antipsychotic treatment is associated with increased 
VGluT2 expression, while our data suggest that decreased VGluT1 expression and decreased 
VGluT2-IR bouton density in the auditory cortex to be associated with better functional outcome 
(living independently at time of death).  However, studies report that antipsychotic treatment has 
no effect on auditory MMN in patients with schizophrenia (Umbricht et al., 1998; Schall et al., 
1998; Umbricht et al., 1999; Korostenskaja et al., 2005), while glutamatergic drugs do affect 
MMN (Javitt et al., 1996; Gunduz-Bruce et al., 2012).  Therefore, up-regulation of VGluT2 
mRNA in the thalamus may not have much of an effect on auditory stimulus processing in the 
primary auditory cortex of schizophrenia subjects treated with antipsychotics, despite beneficial 
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 Figure B.1 Specificity of GAD65 antibody.  (A) Western blot demonstrating labeling with mouse anti-GAD65 
monoclonal antibody (Millipore) (red) showing specificity for the lower molecular weight isoform of GAD in 
human (HU) and monkey (MK).  To demonstrate antibody specificity for the 65 kDa isoform, blots were labeled 
with rabbit anti-GAD67 antibody (Sigma-Aldrich) (green).  Red channel intensity is shown increased for 
visualization purposes on left half of blot.  Right half of blot shows GAD65 antibody labeling in wild type (WT) and 
GAD65-knockout (KO) mouse cortical gray matter.  GAD65 immunoreactivity is absent in the GAD65-KO tissue, 
as expected. (B) Human auditory cortex labeled with the GAD65 antibody (blue), as well as antibodies against 
vesicular glutamate transporters, VGluT1 (red) and VGluT2 (green), to label intracortical and thalamocortical 
glutamatergic boutons, respectively.  Projection image was processed with background subtraction and constrained 
iterative deconvolution (see Chapter 3.2.5).  No colocalization is observed between GAD65 antibody and excitatory 
bouton markers.  Scale bar is 10 µm. 
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B.2 SUPPLEMENTAL RESULTS 
B.2.1 Clinical factors 
We tested for associations between pair-wise changes in GAD65-IR mean bouton density, 
fluorescence intensity, and volume and a number of clinical confounds including: whether the 
subject had a diagnosis of schizophrenia or schizoaffective disorder, died by suicide, had a 
history of alcohol or other substance abuse, or was on or off antipsychotics, anticonvulsants, or 
benzodiazepines at time of death (Figure B.2).  We found a significant relationship between 
benzodiazepine use at time of death and percent change in GAD65-IR bouton density (t23 = 2.64, 
p = 0.015).  The mean (95% CI) percent change in bouton density for subject pairs in which the 
schizophrenia subject was taking benzodiazepines at time of death was a 17.7% (3.3%, 32.0%) 
increase relative to normal controls, and a 2.7% (-4.6%, 10%) decrease for subject pairs in which 
the schizophrenia subject was not taking benzodiazepines at time of death.   Additionally, we 
determined that there was no effect of subjects’ history of cannabis use or antidepressant use at 
time of death on the percent change in GAD65-IR mean bouton density, fluorescence intensity, 
or volume (data not shown; Cannabis: Intensity, t22 = 0.06, p = 0.953; Density, t22 = 0.42, p = 
0.677; Volume, t22 = 0.72, p = 0.481; Antidepressants: Intensity, t24 = -0.4, p = 0.692; Density, t24 







 Figure B.2. Percent change in GAD65-immunoreactive (IR) puncta features associated with schizophrenia 
subject clinical features and medication status at time of death.  (A) Percent change in GAD65-IR puncta 
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fluorescence intensity (left), density (middle) and volume (right) as a function of history of alcohol or substance 
abuse, death by suicide or diagnosis of schizoaffective disorder.  (B)  Percent change in GAD65-IR puncta 
fluorescence intensity (left), density (middle) and volume (right) as a function of current antipsychotic use at time of 
death, benzodiazepine use at time of death, or anticonvulsant drug use at time of death (ATOD).  Dotted line at 0% 

















Figure B.3. Correlations between subject mean values and schizophrenia subject relative percent changes in 
GAD65-immunoreactive (IR) puncta density and spine density in primary auditory cortex.  (A) Mean 
GAD65-IR puncta density plotted as a function of spinophilin-IR puncta density for each subject in cohort 1.  Open 
circles = control, filled circles = schizophrenia.  Dashed line represents the regression line (Pearson r = 0.457, p = 
0.01).  (B) The percent change in GAD65-IR puncta density plotted as a function of the percent change in 
spinophilin-IR puncta density for pairs in cohort 1 (schizophrenia subjects relative to matched controls).  Dashed 





B.3 SUPPLEMENTAL DISCUSSION 
B.3.1 Clinical factors 
GAD65-IR bouton fluorescence intensity, density, and volume did not differ between 
schizophrenia subjects who were on or off antipsychotic medication at time of death, or between 
monkeys chronically exposed to haloperidol and control monkeys.  This suggests that the 
reduction in GAD65-IR bouton fluorescence intensity observed in subjects with schizophrenia is 
not an effect of antipsychotic medications.  On the contrary, use of antipsychotic medications in 
our subjects may actually result in underestimation of the effect of disease on GAD65 
fluorescence intensities, as we observed a non-significant trend toward increased GAD65-IR 
bouton fluorescence intensity in the antipsychotic exposed monkeys.    
 A number of our subjects were taking benzodiazepines, antidepressants, or anticonvulsant 
medications at time of death (see Table A.1).  Because of the potential impact of these 
medications on the GABAergic system ((Mijnster et al., 1998), reviewed in (Costa and Guidotti, 
1979; Treiman, 2001)) we tested for significant effects of their use at time of death.  We did not 
find any significant effects of benzodiazepines, anticonvulsants, or antidepressants on the 
fluorescence intensity of GAD65-IR boutons.  From this, we conclude that our finding of 
decreased within-bouton GAD65 protein is not caused by exposure to these medications.   
However, we found that schizophrenia subjects who were on benzodiazepines at time of death 
had a significantly larger percent increase (relative to controls) in the density of GAD65-IR 
boutons compared to schizophrenia subjects who were not on benzodiazepines at time of death, 
who actually had a percent decrease.  This association could indicate that benzodiazepines 
increase the density of GAD65-IR boutons, or that those subjects with greater GAD65-IR bouton 
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density are more likely to be treated with benzodiazepines; however, the most probable 
interpretation is that benzodiazepine exposure leads to a non-significant increase in GAD65 
protein levels within boutons, causing us to detect more GAD65-IR boutons in schizophrenia 
subjects who were taking benzodiazepines at time of death.  In support of this, chronic 
benzodiazepine exposure increases GAD65 mRNA (Izzo et al., 2001), and our data trend toward 
increased GAD65-IR bouton fluorescence intensity in subjects on benzodiazepines at time of 










CHAPTER 4 SUPPLEMENTAL MATERIALS 
C.1 SUPPLEMENTAL RESULTS 
C.1.1 Phalloidin-labeled puncta volume increases over adolescence 
We found that mean phalloidin-labled puncta volume increased significantly between early 
adolescence and young adulthood (F(2,29) = 5.922; p = 0.007; Figure C.1).  However, there was 
no difference in volume between KO and WT mice at any age (F(1,29) = 0.013; p = 0.910).  We 
observed that the increase in volume over adolescence is highly significant in the WT mice 









 Figure C.1. Phalloidin-labeled spine volume increases across adolescence and early adulthood in WT mice.  
Mean phalloidin-labled spine volume significantly increases between 4 and 12 weeks in WT mice. **p < 0.01, vs 4 
week old WT.  N = 6 per age x genotype group.  Error bars are ± SEM. 
 
 
C.1.2 VGluT1-IR puncta mean fluorescence intensity and volume between early 
adolescence and young adulthood 
We found that mean VGluT1-IR puncta fluorescence intensity decreased significantly between 
early adolescence and young adulthood (F(2,28) = 4.720; p = 0.017; Figure C.2.A), and there were 
no genotype differences in VGluT1-IR puncta fluorescence intensity (F(1,28) = 0.371; p = 0.547).  
However, the decrease in fluorescence intensity with age was significant in the KO (F(2,28) = 
4.220; p = 0.025) but not in the WT (F(2,28) = 1.287; p = 0.292).  This could indicate that 
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reduction in within-bouton VGluT1 fluorescence intensity is not a normal developmental process 
of adolescence and is a consequence of kalirin loss. 
We found that mean VGluT1-IR puncta volume decreased significantly between 4 and 12 
weeks of age (F(2,28) = 12.194; p < 0.001; Figure C.2.B).  There were no differences between WT 
and KO animals in mean volume of VGluT1-IR puncta (F(1,28) = 1.238; p = 0.275).  The decrease 
in puncta volume with age was highly significant in both genotypes (WT: (F(2,28) = 7.995; p = 

















 Figure C.2. Changes in VGluT1-IR boutons across adolescence and early adulthood.  A. Mean VGluT1-IR 
fluoresncence intensity decreases significantly between 4 and 12 weeks in KO mice. *p < 0.05, vs 4 week old KO.  
B. Mean VGluT1-IR bouton volume decreases significantly between 4 and 12 weeks in KO and between 8 and 12 
weeks in WT.  **p < 0.01; #p < 0.10 between 8 and 12 week old KO.  N = 6 per age x genotype group.  Error bars 
are ± SEM. 
 
 
C.1.3 Spinophilin-IR puncta measures between early adolescence and young adulthood 
The numbers of spinophilin-IR puncta decreased overall between 4 and 12 weeks of age (F(2,29) = 
5.389; p = 0.010) (Figure C.3A).  Similar to the phalloidin-labeled puncta results, we found a 
trend toward an overall decrease in spinophilin-IR puncta number in the KO compared to the WT 
(F(1,29) = 3.575 p = 0.069) and a trend toward reduced spinophilin-IR puncta number in the KO 
compared to the WT at 4 weeks (F(1,29) = 3.265; p = 0.081).  The decrease in spinophilin-IR 
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puncta number across adolescence was similar in the two genotypes, but was significant only in 
the WT (F(2,29) = 3.930; p = 0.031) and was trend level in the KO (F(2,29) = 2.594; p = 0.092). 
To verify the changes in spinophilin mean intensity within phalloidin-labled objects we 
also evaluated the mean spinophilin-IR puncta fluorescence intensity.  Similar to the results of 
spinophilin immunofluorescence within phalloidin-labeled spines, we found a highly significant 
reduction in mean spinophilin-IR puncta fluorescence intensity over adolescence (F(2,29) = 
17.360; p < 0.001).  We found no overall difference in spinophilin-IR puncta fluorescence 
intensity between WT and KO (F(1,29) = 1.285, p = 0.266; Figure C.3B), but there was a trend 
toward an age by genotype interaction (F(2,29) = 3.185; p = 0.056).  Spinophilin-IR puncta 
fluorescence intensity was significantly lower at 4 weeks in the KO compared to the WT (F(1,29) = 
4.460; p = 0.043), confirming a relative reduction in spinophilin protein levels in early 
adolescence in the KO.  The reduction in spinophilin-IR puncta mean intensity with age was 
significant for both genotypes (KO: (F(2,29) = 3.477; p = 0.044); WT (F(2,29) = 18.711; p < 0.001)).   
Spinophilin-IR puncta volume decreased from early adolescence to young adulthood 
(F(2,29) = 23.275; p < 0.001) Figure C.3C).  We did not see any difference in spinophilin-IR 
puncta volume between KO and WT (F(1,29) = 0.098 p = 0.757); however, we observed a trend 
toward an age by genotype interaction (F(2,29) = 2.541; p = 0.096).  The effect of age on 
spinophilin-IR puncta volume was highly significant in both genotypes (KO:(F(2,29) = 6.146; p = 
0.006);WT (F(2,29) = 22.215; p < 0.001)).  However, the changes in spinophilin-IR puncta volume 
and fluorescence intensity are highly correlated, so we cannot rule out whether the change in 




 Figure C.3. Changes in spinophilin-IR puncta across adolescence and early adulthood.  A.  Mean spinophilin-
IR puncta numbers decrease between 4 and 12 weeks in WT mice and are reduced with trend level significance at 4 
weeks in the KO mice.  *p < 0.05 vs 4 week WT; # p < 0.10 4 week WT vs KO.  B. Mean spinophilin-IR 
fluorescence intensity decreases significantly between 4 and 12 weeks in WT and KO mice. **p < 0.01 vs 4 and 8 
week WT; *p < 0.05, vs  4 week old KO.  Spinophilin intensity is significantly reduced in 4 week old KO compared 
to WT.  *p < 0.05.  C. Mean spinophilin-IR bouton volume decreases significantly between 8 and 12 weeks in WT 
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and 4 and 12 weeks in KO.  **p < 0.01; #p < 0.10 between 8 and 12 week old KO.  N = 6 per age x genotype group.  
Error bars are ± SEM. 
 
 
C.1.4 GAD65-IR puncta volume decreases over adolescence 
There was a significant reduction in the mean puncta volume across adolescence (F(2,29) = 14.577; 
p < 0.001) (Figure C.4). There was no difference in GAD65-IR puncta volume between KO and 
WT mice (F(1,29) = 1.580; p = 0.219), although there was a trend toward an age by genotype 
interaction (F(2,29) = 3.336; p = 0.050).  We found that mean puncta volume was significantly 
greater in the KO at 12 weeks of age (F(1,29) = 7.365; p = 0.011), and the reduction with age was 
trend level in the KO (F(2,29) = 2.986; p = 0.066) but highly significant in the WT (F(2,29) = 16.545; 
p < 0.001).  However, it should be noted that mean fluorescence intensity and volume are 













Figure C.4. GAD65-IR bouton volume decreases between 8 and 12 weeks in WT mice.  Mean GAD65-IR 
bouton volume decreases significantly between 8 and 12 weeks in WT mice, and is significantly greater in 12 week 
old KO compared to WT mice. **p < 0.01, vs 4 and 8 week old KO, *p < 0.05 12 week old WT vs KO.  N = 6 per 
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Table D.1. Proportions of CBA/CaJ, C57Bl/6J, and DBA/2J that do and do not demonstrate significant 
modulation of acoustic startle by silent gap prepulses.  Numbers of CBA/CaJ, C57Bl/6J, and DBA/2J that do (y) 
and do not (n) show significant modulation of startle by silent gap prepulses do not differ by age (rows).  Further, 
proportions of animals that do and do not show modulation of acoustic startle do not differ by strain at any age 
group (columns). % indicates percent of the total number of animals tested that do show significant modulation of 












 Figure D.1. Gap-PPI in WT and kalirin KO mice that individually demonstrated modulation of startle reflex 
by gap prepulses.  Magnitude of gap-PPI as a function of increasing binned gap durations in 4 week (A), 8 week 
(B) and 12 week (C) WT (black) and KO (blue) mice.  Arrows indicate gap detection threshold for each group, and 
arrow color indicates genotype.  D. Average gap-PPI for all gap durations in WT and KO mice by age.  Mean gap-
PPI increases significantly between 4 and 8 weeks in WT mice but not in KO mice.  Significance markers indicate 
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genotype comparisons, unless otherwise indicated.  #p < 0.10, *p < 0.05, **p < 0.01.  Animal numbers per group- 
Genotype: Age (N): WT: 4 weeks (10), 8 weeks (15), 12 weeks (12); KO: 4 weeks (8), 8 weeks (11), 12 weeks (13).  
Error bars are ± SEM. 
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 Figure D.2. Acoustic startle reflex and noise-PPI in 4, 8 and 12 week old WT and kalirin KO mice.  Acoustic 
startle reflex in kalirin KO mice is no different from WT at 4 weeks (A) but is reduced at 8 (B) and 12 (C) weeks of 
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age.  Threshold to startle is higher in kalirin KO mice at 12 weeks of age.  Noise-PPI in kalirin KO mice is not 
different from WT at 4 weeks (D) and 8 weeks (E) but is significantly reduced at 12 weeks (F).  Significance 
markers indicate genotype comparisons, #p < 0.1, *p < 0.05, **p < 0.01.  Animal numbers per group- Genotype: 
Age (N): WT: 4 weeks (18), 8 weeks (17), 12 weeks (18); KO: 4 weeks (13), 8 weeks (15), 12 weeks (22).  Error 
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